Processing 00000000.tx.1: BDNF Locally Potentiates GABAergic Presynaptic Machineries: Target-selective Circuit Inhibition Shizu Ohba, Takamitsu Ikeda, Yuji Ikegaya, Nobuyoshi Nishiyama, Norio Matsuki and Maki K. 

Phrase: "BDNF Locally"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   937   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   840   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   840   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]
   804   C1441547:Derived [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   804   C3245521:derived [Idea or Concept]

Phrase: "Potentiates"

Phrase: "GABAergic Presynaptic Machineries"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0337076:machinery [Manufactured Object]

Phrase: ":"

Phrase: "Target-selective Circuit Inhibition Shizu Ohba,"

Phrase: "Takamitsu Ikeda,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3613423:Ikeda [Eukaryote]

Phrase: "Yuji Ikegaya,"

Phrase: "Nobuyoshi Nishiyama,"

Phrase: "Norio Matsuki"

Phrase: "and"

Phrase: "Maki K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.2: Yamada Laboratory of Chemical Pharmacology, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Hongo, Bunkyo-ku, Tokyo, Japan Address correspondence to Maki K. 

Phrase: "Yamada Laboratory of Chemical Pharmacology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   797   C0525067:chemical laboratory [Chemical Viewed Functionally]
   760   C0022877:Laboratory [Manufactured Object,Organization]
   760   C3244292:laboratory [Functional Concept]

Phrase: "Graduate School of Pharmaceutical Sciences,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0870614:graduate school [Manufactured Object,Organization]
   760   C0036375:School [Manufactured Object,Organization]
   760   C0588053:Graduate [Population Group]
   760   C1547183:Graduate [Idea or Concept]

Phrase: "The University of Tokyo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040371:Tokyo [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Hongo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0720890:hongo [Organic Chemical,Pharmacologic Substance]

Phrase: "Bunkyo-ku,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1532717:ku [Quantitative Concept]
   861   C1881335:kU [Quantitative Concept]

Phrase: "Tokyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: "Address"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0376649:Address [Intellectual Product]
  1000   C1442065:Address [Spatial Concept]

Phrase: "correspondence to Maki K."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0282413:Correspondence [Intellectual Product]
Processing 00000000.tx.3: Yamada, Laboratory of Chemical Pharmacology, Graduate School of Pharmaceutical Sciences, The University of Tokyo, Hongo, Bunkyo-ku, Tokyo, Japan. 

Phrase: "Yamada,"

Phrase: "Laboratory of Chemical Pharmacology,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   819   C0525067:chemical laboratory [Chemical Viewed Functionally]
   770   C0022877:Laboratory [Manufactured Object,Organization]
   770   C3244292:laboratory [Functional Concept]

Phrase: "Graduate School of Pharmaceutical Sciences,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0870614:graduate school [Manufactured Object,Organization]
   760   C0036375:School [Manufactured Object,Organization]
   760   C0588053:Graduate [Population Group]
   760   C1547183:Graduate [Idea or Concept]

Phrase: "The University of Tokyo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0040371:Tokyo [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]

Phrase: "Hongo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0720890:hongo [Organic Chemical,Pharmacologic Substance]

Phrase: "Bunkyo-ku,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1532717:ku [Quantitative Concept]
   861   C1881335:kU [Quantitative Concept]

Phrase: "Tokyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: "Japan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]
Processing 00000000.tx.4: Email: maki{at}mol.f.u-tokyo.ac.jp .  Abstract Top Abstract Introduction Materials and Methods Results Discussion References  Inhibitory neurotransmission is critical for neuronal circuit formation. 

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: ":"

Phrase: "maki{at}mol.f.u-tokyo.ac.jp .  Abstract Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   786   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Inhibitory neurotransmission"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027793:Neurotransmission [Cell Function]

Phrase: "is"

Phrase: "critical for neuronal circuit formation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1511545:Critical [Qualitative Concept]
Processing 00000000.tx.5: To examine whether inhibitory neurotransmission receives target-selective modulation in the long term, we expressed the cDNA of brain-derived neurotrophic factor (BDNF), which has been shown to induce the augmentation of GABAergic synapses in vivo and in vitro, in a small population of cultured hippocampal neurons. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "examine"

Phrase: "whether"

Phrase: "inhibitory neurotransmission"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027793:Neurotransmission [Cell Function]

Phrase: "receives"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Receive [Qualitative Concept]

Phrase: "target-selective modulation in the long term,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0443264:Modulation [Spatial Concept]

Phrase: "we"

Phrase: "expressed"

Phrase: "the cDNA of brain-derived neurotrophic factor (BDNF),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "which"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "the augmentation of GABAergic synapses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1293122:Augmentation [Therapeutic or Preventive Procedure]

Phrase: "in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "in a small population"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0032659:Population [Quantitative Concept]
   861   C1257890:Population [Population Group]

Phrase: "of cultured hippocampal neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.6: At 48 h after transfection, the expression level of glutamic acid decarboxylase 65 (GAD65), a GABA synthetic enzyme that resides mainly in GABAergic terminals, was selectively enhanced around the BDNF-expressing neurons, in comparison with the neighboring control neurons interposed between the BDNF-expressing neurons and inhibitory neurons. 

Phrase: "At 48 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "after transfection,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "the expression level of glutamic acid decarboxylase 65 (GAD65),"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C3244092:expression level [Idea or Concept]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "a GABA synthetic enzyme"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0597548:synthetic enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0014442:Enzyme [Enzyme,Organic Chemical]
   743 E C0014445:enzymes [Functional Concept]

Phrase: "that"

Phrase: "resides"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2982691:Reside [Activity]

Phrase: "mainly in GABAergic terminals,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C0205088:Terminal [Temporal Concept]
   737   C1705314:Terminal [Manufactured Object]
   737   C1705315:Terminal [Spatial Concept]

Phrase: "was"

Phrase: "selectively"

Phrase: "enhanced around the BDNF-expressing neurons,"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   818   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   798   C1826397:NEURON-DERIVED NEUROTROPHIC FACTOR [Gene or Genome]
   798   C3472710:neuron-derived neurotrophic factor [Gene or Genome]
   764   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   764   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   742   C0006104:Brain [Body Part, Organ, or Organ Component]
   742   C0027882:Neurons [Cell]
   742   C1269537:Brain [Body Part, Organ, or Organ Component]
   742   C1441547:Derived [Qualitative Concept]
   742   C1521761:Factor [Functional Concept]
   742   C2349975:Enhanced [Activity]
   742   C2827422:Factor [Conceptual Entity]
   742   C3245521:derived [Idea or Concept]

Phrase: "in comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Comparison [Activity]

Phrase: "with the neighboring control neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "interposed between the BDNF-expressing neurons"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   818   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   798   C1826397:NEURON-DERIVED NEUROTROPHIC FACTOR [Gene or Genome]
   798   C3472710:neuron-derived neurotrophic factor [Gene or Genome]
   764   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   764   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   742   C0006104:Brain [Body Part, Organ, or Organ Component]
   742   C0027882:Neurons [Cell]
   742   C1269537:Brain [Body Part, Organ, or Organ Component]
   742   C1441547:Derived [Qualitative Concept]
   742   C1521761:Factor [Functional Concept]
   742   C2827422:Factor [Conceptual Entity]
   742   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "inhibitory neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.7: Exogenous BDNF application for 48 h also increased the GAD level and enhanced the GABA release probability. 

Phrase: "Exogenous BDNF application for 48 h also"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   739   C0185125:Application [Health Care Activity]
   739   C1947919:Application [Intellectual Product]
   739   C2347934:Application [Intellectual Product]
   739   C3539080:APPLICATION [Quantitative Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the GAD level"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0441889:Level [Qualitative Concept]
   812   C0456079:Level [Classification]
   812   C1547707:Level [Geographic Area]
   812   C2946261:Level [Pharmacologic Substance]
   756   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "the GABA release probability."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0033204:Probability [Quantitative Concept]
   755 E C0332148:Probable [Qualitative Concept]
Processing 00000000.tx.8: These potentiating effects were attenuated in inhibitory synapses on neurons expressing a dominant negative form of the BDNF receptor (tTrkB). 

Phrase: "These potentiating effects"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C1280500:effects [Qualitative Concept]
   827 E C2348382:Effect [Qualitative Concept]

Phrase: "were"

Phrase: "attenuated in inhibitory synapses"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   816   C1512777:Inhibitory Synapse [Cell Component]
   770   C0039062:Synapses [Body Space or Junction]
   770   C0332161:Attenuated [Qualitative Concept]
   770   C0599946:Attenuated [Activity]
   770   C3463820:Inhibitory [Activity]
   737 E C0598501:Synapsis [Cell Function]
   737 E C1633000:Synapsis [Plant]

Phrase: "on neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "expressing"

Phrase: "a dominant negative form of the BDNF receptor"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   772   C1333312:Dominant Negative Receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   738   C0205160:Negative [Qualitative Concept]
   738   C0348078:Form [Qualitative Concept]
   738   C0376315:Form [Manufactured Object]
   738   C1513916:Negative [Finding]
   738   C1522492:Form [Functional Concept]
   738   C1527180:Dominant [Functional Concept]
   738   C2825415:Negative [Conceptual Entity]
   738   C2825491:Negative [Qualitative Concept]

Phrase: "(tTrkB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]

Phrase: ")."
Processing 00000000.tx.9: This suggests that postsynaptic BDNF-TrkB signaling contributes to the target-selective potentiation of inhibitory presynaptic machineries. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that postsynaptic BDNF-TrkB signaling"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   795   C0037083:Signaling [Cell Function]
   795   C3537152:signaling [Biologic Function]
   710   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "contributes to the target-selective potentiation of inhibitory presynaptic machineries."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   739   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   739   C1521840:Target [Functional Concept]
   739   C1880177:Contribute [Activity]
   739   C2986546:TARGET [Diagnostic Procedure]
   739   C3463820:Inhibitory [Activity]
   706   C0337076:machinery [Manufactured Object]
Processing 00000000.tx.10: Since BDNF is expressed in an activity-dependent manner in vivo, this selectivity may be one of the key mechanisms by which the independence of functional neuronal circuits is maintained. 

Phrase: "Since"

Phrase: "BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "is"

Phrase: "expressed in an activity-dependent manner"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1561536:*Activity [Idea or Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "this selectivity"

Phrase: "may"

Phrase: "be"

Phrase: "one of the key mechanisms"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0205447:One [Quantitative Concept]

Phrase: "by which"

Phrase: "the independence of functional neuronal circuits"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0332291:Independent of [Functional Concept]
   753   C0085862:Independence [Idea or Concept]

Phrase: "is"

Phrase: "maintained."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1314677:Maintained [Functional Concept]
   966 E C0024501:Maintain [Activity]
Processing 00000000.tx.11: Key Words: GABA  GAD  hippocampus  independence  inhibitory synapse  plasticity  Introduction Top Abstract Introduction Materials and Methods Results Discussion References  Inhibitory neurotransmission, which is primarily mediated by GABA in the central nervous system (CNS), is critical for neuronal excitability. 

Phrase: "Key Words"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C1705313:Word [Idea or Concept]
   789 E C0439824:Verbal [Qualitative Concept]
   761 E C0871946:verb [Intellectual Product]

Phrase: ":"

Phrase: "GABA  GAD  hippocampus  independence  inhibitory synapse  plasticity  Introduction Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   786   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Inhibitory neurotransmission,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027793:Neurotransmission [Cell Function]

Phrase: "which"

Phrase: "is"

Phrase: "primarily"

Phrase: "mediated by GABA"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0016904:GABA [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]

Phrase: "in the central nervous system (CNS),"
Meta Candidates (Total=19; Excluded=7; Pruned=0; Remaining=12)
  1000   C0927232:Central Nervous System [Body System]
  1000   C1269563:Central nervous system [Body System]
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0205099:Central [Spatial Concept]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   827   C1879652:Central - [Laboratory Procedure]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]

Phrase: "is"

Phrase: "critical for neuronal excitability."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1511545:Critical [Qualitative Concept]
Processing 00000000.tx.12: Recent electrical recordings in behaving animals have highlighted the importance of inhibitory transmission in natural neuronal activity. 

Phrase: "Recent electrical recordings in behaving animals"

Phrase: "have"

Phrase: "highlighted"

Phrase: "the importance of inhibitory transmission"

Phrase: "in natural neuronal activity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0205177:Activity [Functional Concept]
   827   C0439167:% activity [Quantitative Concept]
   827   C0441655:Activity [Activity]
   827   C1561536:*Activity [Idea or Concept]
Processing 00000000.tx.13: It was found that in any given behavioral condition, >90% of hippocampal CA1 pyramidal neurons are considered to be silent, whereas almost all of the inhibitory interneurons are active (Freund and Buzsaki, 1996; Henze et al., 2000). 

Phrase: "It"

Phrase: "was"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that in any given behavioral condition,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0004927:Behavioral [Individual Behavior]
   753   C0012634:condition [Disease or Syndrome]
   753   C0348080:Condition [Qualitative Concept]
   753   C1705253:Condition [Conceptual Entity]
   753   C2986890:Behavioral [Idea or Concept]

Phrase: ">90% of hippocampal CA1 pyramidal neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0019564:Hippocampal [Body Part, Organ, or Organ Component]
   753   C0027882:Neurons [Cell]
   753   C0439083:>90 [Quantitative Concept]
   753   C0439087:<90 [Quantitative Concept]

Phrase: "are"

Phrase: "considered"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750591:considered [Idea or Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "silent,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0443304:Silent [Qualitative Concept]
   928 E C0858952:silence [Mental or Behavioral Dysfunction]

Phrase: "whereas"

Phrase: "almost"

Phrase: "all of the inhibitory interneurons"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0682694:Inhibitory interneuron [Cell]
   760   C0021792:Interneurons [Cell]
   760   C0444868:All [Quantitative Concept]
   760   C3463820:Inhibitory [Activity]
   760   C3539085:All [Idea or Concept]

Phrase: "are"

Phrase: "active"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205177:Active [Functional Concept]

Phrase: "(Freund"

Phrase: "and"

Phrase: "Buzsaki,"

Phrase: "1996"

Phrase: "; Henze et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.14: These results suggest that the firings of excitatory principal neurons are strictly suppressed in vivo. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the firings of excitatory principal neurons"

Phrase: "are"

Phrase: "strictly"

Phrase: "suppressed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260953:Suppressed [Functional Concept]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.15: In most types of GABAergic neurons, a single inhibitory neuron usually has thousands of target excitatory neurons (Freund and Buzsaki, 1996). 

Phrase: "In most types"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0332307:Types [Qualitative Concept]
   966 E C1547052:*Type [Quantitative Concept]

Phrase: "of GABAergic neurons,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0815002:GABAergic Neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "a single inhibitory neuron usually"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neuron [Cell]
   741 E C0521390:Neuronal [Immunologic Factor]

Phrase: "has"

Phrase: "thousands of target excitatory neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1883310:Thousand [Quantitative Concept]

Phrase: "(Freund"

Phrase: "and"

Phrase: "Buzsaki,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.16: Therefore, if inhibitory transmission takes on a role in information processing that goes beyond simple inhibition, selective modulation of the different inhibitory synapses appears to be required. 

Phrase: "Therefore,"

Phrase: "if"

Phrase: "inhibitory transmission"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0040722:transmission [Idea or Concept]
   861   C0242781:Transmission [Pathologic Function]
   861   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "takes on a role"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0035820:Role [Social Behavior]
   770   C1515187:Take [Health Care Activity]
   770   C1705810:Role [Conceptual Entity]

Phrase: "in information"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1533716:Information [Idea or Concept]
   928 E C3242430:informational [Idea or Concept]

Phrase: "processing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C1709694:Processing [Activity]
   966 E C1184743:Process [Body Part, Organ, or Organ Component]
   966 E C1522240:Process [Phenomenon or Process]

Phrase: "that goes beyond simple inhibition,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1947959:Goes [Eukaryote]

Phrase: "selective modulation of the different inhibitory synapses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0443264:Modulation [Spatial Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "required."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]
Processing 00000000.tx.17: However, little is known about the target selectivity in inhibitory augmentation, especially with respect to the long-term effects. 

Phrase: "However,"

Phrase: "little"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023882:Little NOS [Congenital Abnormality,Disease or Syndrome]
  1000   C0700321:Little [Quantitative Concept]
  1000   C2700395:Little [Quantitative Concept]

Phrase: "is"

Phrase: "known about the target selectivity"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205309:Known [Qualitative Concept]
   760   C1521840:Target [Functional Concept]
   760   C2986546:TARGET [Diagnostic Procedure]

Phrase: "in inhibitory augmentation,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1293122:Augmentation [Therapeutic or Preventive Procedure]

Phrase: "especially with respect to the long-term effects."
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   800   C0023983:Long-Term Effects [Phenomenon or Process]
   770   C0443252:Long-term [Temporal Concept]
   744   C0205166:Long [Qualitative Concept]
   744   C0679133:respect [Social Behavior]
   744   C1280500:effects [Qualitative Concept]
   744   C1515273:Term [Temporal Concept]
   744   C1705313:Term [Idea or Concept]
   744   C1706317:Long [Qualitative Concept]
   744   C2826302:TERM [Intellectual Product]
   711 E C2348382:Effect [Qualitative Concept]
Processing 00000000.tx.18: Brain-derived neurotrophic factor (BDNF) is a homo-dimer of a 15 kDa secretory protein, which is predominantly expressed in the CNS (Lewin and Barde, 1996). 

Phrase: "Brain-derived neurotrophic factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "(BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: ")"

Phrase: "is"

Phrase: "a homo-dimer of a 15 kDa secretory protein,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0596448:dimer [Chemical Viewed Structurally]
   742   C1300203:Homo [Mammal]
   742   C3245470:HOMO [Finding]

Phrase: "which"

Phrase: "is"

Phrase: "predominantly"

Phrase: "expressed in the CNS"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   833   C0927232:Central Nervous System [Body System]
   833   C1269563:Central nervous system [Body System]
   790   C0027763:Nervous System [Body System]
   790   C0422837:NERVOUS SYSTEM [Finding]
   790   C1269560:Nervous system [Body System]
   753   C0027769:Nervous [Sign or Symptom]
   753   C0205099:Central [Spatial Concept]
   753   C0449913:System [Functional Concept]
   753   C0599851:Nervous [Functional Concept]
   753   C1553451:System [Manufactured Object]
   753   C1704459:System [Medical Device]
   753   C1879652:Central - [Laboratory Procedure]
   734 E C0205494:Neurologic [Qualitative Concept]

Phrase: "(Lewin"

Phrase: "and"

Phrase: "Barde,"

Phrase: "1996"

Phrase: ")."
Processing 00000000.tx.19: This protein is produced primarily by excitatory neurons such as pyramidal and granule cells in the hippocampus (Ernfors et al., 1990). 

Phrase: "This protein"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "produced"

Phrase: "primarily by excitatory neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0027882:Neurons [Cell]

Phrase: "such as pyramidal"

Phrase: "and"

Phrase: "granule cells in the hippocampus"
Meta Candidates (Total=9; Excluded=4; Pruned=0; Remaining=5)
   781   C0010837:Cell granule [Cell Component]
           Granule
   773 E C0596630:granule cell [Cell]
   760   C0007634:Cells [Cell]
   760   C0993609:Granule [Biomedical or Dental Material]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(Ernfors et al.,"

Phrase: "1990"

Phrase: ")."
Processing 00000000.tx.20: Recent experiments using genetically modified mice have suggested a number of functions of BDNF and its receptor, TrkB, after birth, including its involvement in memory and learning (Gorski et al., 2003; Linnarsson et al., 1997; Minichiello et al., 1999). 

Phrase: "Recent experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "genetically modified mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mice [Mammal]
   827   C0025929:mice [Mammal]
   827   C0026809:Mice [Mammal]

Phrase: "have"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "a number of functions of BDNF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0237753:*Number [Quantitative Concept]
   742   C0449788:Number [Quantitative Concept]

Phrase: "and"

Phrase: "its receptor,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "TrkB,"

Phrase: "after birth,"
Meta Candidates (Total=18; Excluded=13; Pruned=0; Remaining=5)
   861   C0005615:Birth [Organism Function]
   861   C0231290:After [Temporal Concept]
   861   C0687676:After [Temporal Concept]
   861   C1550722:birth [Idea or Concept]
   861   C3245487:birth [Intellectual Product]
   805 E C0017296:GENETIC [Therapeutic or Preventive Procedure]
   805 E C0314603:Genetic [Functional Concept]
   805 E C0454729:Natal [Geographic Area]
   777 E C0035150:Reproduction [Organism Function]
   777 E C0079946:origin [Classification]
   777 E C0439659:Origin [Temporal Concept]
   777 E C1550512:origin [Intellectual Product]
   761 E C0559522:Genital [Body System]
   761 E C1546649:Genital [Intellectual Product]
   761 E C1550642:Genital [Body Substance]
   755 E C0205313:Original [Idea or Concept]
   755 E C2347409:Original [Occupational Activity]
   742 E C0598240:originality [Mental Process]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "its involvement in memory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1314939:Involvement [Functional Concept]

Phrase: "and"

Phrase: "learning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013621:learning [Educational Activity]
  1000   C0023185:Learning [Mental Process]

Phrase: "(Gorski et al.,"

Phrase: "2003"

Phrase: "; Linnarsson et al.,"

Phrase: "1997"

Phrase: "; Minichiello et al.,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.21: The expression of BDNF is regulated by neuronal activity (Castren et al., 1992; Tabuchi et al., 2000), and the expression level varies extensively among the same type of neurons (Tokuyama et al., 2000). 

Phrase: "The expression of BDNF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "regulated by neuronal activity"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0205177:Activity [Functional Concept]
   770   C0439167:% activity [Quantitative Concept]
   770   C0441655:Activity [Activity]
   770   C0521390:Neuronal [Immunologic Factor]
   770   C0851285:Regulated [Governmental or Regulatory Activity]
   770   C1561536:*Activity [Idea or Concept]

Phrase: "(Castren et al.,"

Phrase: "1992"

Phrase: "; Tabuchi et al.,"

Phrase: "2000"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the expression level"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C3244092:expression level [Idea or Concept]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
   861   C0441889:Level [Qualitative Concept]
   861   C0456079:Level [Classification]
   861   C1547707:Level [Geographic Area]
   861   C2946261:Level [Pharmacologic Substance]

Phrase: "varies"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1548673:Varies [Intellectual Product]

Phrase: "extensively among the same type of neurons"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   757   C0682689:neuron type [Cell]
   748   C0027882:Neurons [Cell]
   748   C0332307:Type [Qualitative Concept]
   748   C0445247:Same [Qualitative Concept]
   748   C1547052:*Type [Quantitative Concept]

Phrase: "(Tokuyama et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.22: The distribution patterns of BDNF and TrkB (Aoki et al., 2000; Klein et al., 1990; Marty et al., 1996) in neurons suggest that BDNF can behave both as an autocrine factor (Kokaia et al., 1993; Zakharenko et al., 2003) as well as a retrograde/anterograde trans-synaptic messenger (Drake et al., 1999; Gartner et al., 2000). 

Phrase: "The distribution patterns of BDNF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0449775:distribution patterns [Spatial Concept]
   744   C0449774:Patterns [Spatial Concept]

Phrase: "and"

Phrase: "TrkB"

Phrase: "(Aoki et al.,"

Phrase: "2000"

Phrase: "; Klein et al.,"

Phrase: "1990"

Phrase: "; Marty et al.,"

Phrase: "1996"

Phrase: ")"

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "can"

Phrase: "behave"

Phrase: "both as an autocrine factor"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0238767:Both [Spatial Concept]
   760   C0596138:Autocrine [Organ or Tissue Function]
   760   C1521761:Factor [Functional Concept]
   760   C1706086:Both [Qualitative Concept]
   760   C2827422:Factor [Conceptual Entity]

Phrase: "(Kokaia et al.,"

Phrase: "1993"

Phrase: "; Zakharenko et al.,"

Phrase: "2003"

Phrase: ")"

Phrase: "as well as"

Phrase: "a retrograde/anterograde trans-synaptic messenger"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0335218:Messenger [Professional or Occupational Group]

Phrase: "(Drake et al.,"

Phrase: "1999"

Phrase: "; Gartner et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.23: Taken together, these findings suggest that BDNF acts locally around activated neurons. 

Phrase: "Taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "together,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883357:Together [Qualitative Concept]

Phrase: "these findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "acts"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "locally around activated neurons."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0027882:Neurons [Cell]
   770   C1517927:Locally [Spatial Concept]
   770   C1879547:Activated [Activity]
   737 E C1515877:Activate [Functional Concept]
Processing 00000000.tx.24: The long-term effects of BDNF on the formation and functional activation of inhibitory GABAergic synapses have been well documented (Baldelli et al., 2002; Rutherford et al., 1997; Seil and Drake-Baumann, 2000; Vicario-Abejon et al., 1998). 

Phrase: "The long-term effects of BDNF"
Meta Candidates (Total=9; Excluded=1; Pruned=0; Remaining=8)
   790   C0023983:Long-Term Effects [Phenomenon or Process]
   764   C0443252:Long-term [Temporal Concept]
   742   C0205166:Long [Qualitative Concept]
   742   C1280500:effects [Qualitative Concept]
   742   C1515273:Term [Temporal Concept]
   742   C1705313:Term [Idea or Concept]
   742   C1706317:Long [Qualitative Concept]
   742   C2826302:TERM [Intellectual Product]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "on the formation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0220781:formation [Biologic Function]
  1000   C0439634:formation [Spatial Concept]
  1000   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "functional activation of inhibitory GABAergic synapses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1879547:Activation [Activity]

Phrase: "have"

Phrase: "been"

Phrase: "well documented"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0205170:Well [Qualitative Concept]
   861   C1301725:Documented [Health Care Activity]
   861   C1609436:documented [Idea or Concept]
   861   C3146287:Well [Manufactured Object]
   827 E C1301746:document [Intellectual Product]
   827 E C1547673:Document [Intellectual Product]

Phrase: "(Baldelli et al.,"

Phrase: "2002"

Phrase: "; Rutherford et al.,"

Phrase: "1997"

Phrase: "; Seil"

Phrase: "and"

Phrase: "Drake-Baumann,"

Phrase: "2000"

Phrase: "; Vicario-Abejon et al.,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.25: In particular, BDNF-induced maturation of GABAergic presynaptic functions has been demonstrated in many experimental systems, both in vivo and in vitro (Huang et al., 1999; Marty et al., 2000; Mizuno et al., 1994; Yamada et al., 2002). 

Phrase: "In particular, BDNF-induced maturation"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   795   C0678723:Maturation [Organism Function]
   795   C0870861:maturation [Phenomenon or Process]
   795   C1254042:Maturation [Physiologic Function]
   710   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "of GABAergic presynaptic functions"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0542341:Functions [Functional Concept]
   793 E C0031843:function [Physiologic Function]
   793 E C0700205:FUNCTION [Classification]
   793 E C1705273:Function [Intellectual Product]
   743 E C0205245:Functional [Functional Concept]
   743 E C2700217:Functional [Conceptual Entity]

Phrase: "has"

Phrase: "been"

Phrase: "demonstrated in many experimental systems,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1517586:Experimental [Qualitative Concept]
   726   C0449913:System [Functional Concept]
   726   C1553451:System [Manufactured Object]
   726   C1704459:System [Medical Device]

Phrase: "both in vivo"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "and"

Phrase: "in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "(Huang et al.,"

Phrase: "1999"

Phrase: "; Marty et al.,"

Phrase: "2000"

Phrase: "; Mizuno et al.,"

Phrase: "1994"

Phrase: "; Yamada et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.26: This was assessed by the expression level of glutamic acid decarboxylase (GAD), maximal GABA release and other methods. 

Phrase: "This"

Phrase: "was"

Phrase: "assessed by the expression level of glutamic acid decarboxylase (GAD),"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   790   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   764   C0061472:Glutamic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   764   C0523665:Glutamic Acid [Laboratory Procedure]
   764   C3244092:expression level [Idea or Concept]
   742   C0001128:Acid [Chemical]
   742   C0007054:Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   742   C0185117:Expression [Therapeutic or Preventive Procedure]
   742   C0202406:Acid [Laboratory Procedure]
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1516048:Assessed [Activity]
   742   C1547707:Level [Geographic Area]
   742   C2946261:Level [Pharmacologic Substance]

Phrase: "maximal GABA release"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   827   C0016904:GABA [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0030685:Release [Health Care Activity]
   827   C0391871:Release [Functional Concept]
   827   C0439180:% release [Quantitative Concept]
   827   C0680255:release [Health Care Activity]
   827   C1283071:Release [Functional Concept]
   827   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "other methods."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]
Processing 00000000.tx.27: Thus, BDNF is a candidate molecule for mediating the selective enhancement of inhibitory inputs on some of the excitatory neurons expressing BDNF. 

Phrase: "Thus,"

Phrase: "BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "is"

Phrase: "a candidate molecule for"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0567416:Molecule [Substance]

Phrase: "mediating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediating [Social Behavior]

Phrase: "the selective enhancement of inhibitory inputs"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   753   C2349975:Enhancement [Activity]

Phrase: "on some"

Phrase: "of the excitatory neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "expressing"

Phrase: "BDNF."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]
Processing 00000000.tx.28: To confirm this, we have developed methods for expressing BDNF and its dominant negative receptor in <1% of a population of neurons. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "this,"

Phrase: "we"

Phrase: "have"

Phrase: "developed methods for expressing BDNF"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   744   C0025663:Methods [Intellectual Product]
   744   C0025664:methods [Intellectual Product]
   744   C0449851:Methods [Functional Concept]
   711 E C0871511:METHOD [Intellectual Product]

Phrase: "and"

Phrase: "its dominant negative receptor in <1% of a population of neurons."
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   775   C1333312:Dominant Negative Receptor [Amino Acid, Peptide, or Protein,Receptor]
   756   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   738   C0027882:Neurons [Cell]
   738   C0032659:Population [Quantitative Concept]
   738   C0205160:Negative [Qualitative Concept]
   738   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   738   C1257890:Population [Population Group]
   738   C1513916:Negative [Finding]
   738   C1527180:Dominant [Functional Concept]
   738   C2825415:Negative [Conceptual Entity]
   738   C2825491:Negative [Qualitative Concept]
   712   C2325760:Neuronal receptor [Cell Component]
Processing 00000000.tx.29: We have also analyzed whether the changes in the properties of GABAergic synaptic machineries can distinguish the target.  

Phrase: "We"

Phrase: "have"

Phrase: "also"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "whether"

Phrase: "the changes in the properties of GABAergic synaptic machineries"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   748   C0025320:The change [Physiologic Function]
   742   C0392747:changes [Functional Concept]
   742   C0443172:changes [Quantitative Concept]
   708 E C1705241:Change [Quantitative Concept]

Phrase: "can"

Phrase: "distinguish"

Phrase: "the target."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1521840:Target [Functional Concept]
  1000   C2986546:TARGET [Diagnostic Procedure]
Processing 00000000.tx.30: Materials and Methods Top Abstract Introduction Materials and Methods Results Discussion References  Primary culture Cultured hippocampal neurons were prepared as previously described (Shitaka et al., 1996), with some modifications. 

Phrase: "Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Primary culture"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0010453:Culture [Idea or Concept]
   861   C0205225:Primary [Qualitative Concept]
   861   C0220814:culture [Functional Concept]
   861   C0430400:Culture [Laboratory Procedure]
   861   C0439631:Primary [Therapeutic or Preventive Procedure]
   861   C2242979:Culture [Laboratory Procedure]

Phrase: "Cultured"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   966   C0010453:Culture [Idea or Concept]
   966   C0220814:culture [Functional Concept]
   966   C0430400:Culture [Laboratory Procedure]
   966   C2242979:Culture [Laboratory Procedure]

Phrase: "hippocampal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "prepared as previously"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1521827:Prepare [Functional Concept]

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Shitaka et al.,"

Phrase: "1996"

Phrase: ")"

Phrase: ","

Phrase: "with some modifications."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0392747:Modification [Functional Concept]
   966   C1554963:modification [Qualitative Concept]
Processing 00000000.tx.31: Briefly, whole brains were isolated from embryonic day 18 Wistar rats (SLC, Shizuoka, Japan), and the hippocampi were dissected out and treated with 0.25% trypsin (Difco Laboratories, Detroit, MI) and 0.01% deoxyribonuclease I (Sigma, St Louis, MO) at 37C for 30 min. 

Phrase: "Briefly,"

Phrase: "whole brains"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0006104:Brains [Body Part, Organ, or Organ Component]
   827 E C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "isolated from embryonic day 18 Wistar rats"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   778   C0034716:Rats, Wistar [Mammal]
   748   C0013935:Embryonic [Embryonic Structure]
   748   C0034693:rats [Mammal]
   748   C0034721:Rats [Mammal]
   748   C0205409:Isolated [Functional Concept]
   748   C0332173:/day [Temporal Concept]
   748   C0439228:day [Temporal Concept]
   748   C0439505:/day [Temporal Concept]
   748   C1548221:Isolated [Idea or Concept]
   748   C2700262:Wistar [Mammal]
   714 E C0370215:Isolate [Substance]
   714 E C1875400:ISOLATE [Pharmacologic Substance]

Phrase: "(SLC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1332684:SLC [Gene or Genome]
  1000   C1705075:SLC [Gene or Genome]

Phrase: "Shizuoka,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the hippocampi"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "were"

Phrase: "dissected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205239:dissected [Functional Concept]

Phrase: "out"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "and"

Phrase: "treated with 0.25% trypsin"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   806   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   760   C0041236:TRYPSIN [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   760   C1522326:Treated [Functional Concept]
   726 E C1292734:TREAT [Functional Concept]

Phrase: "(Difco Laboratories,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0022877:Laboratories [Manufactured Object,Organization]
   861   C1619828:Laboratories [Intellectual Product]
   827 E C3244292:laboratory [Functional Concept]

Phrase: "Detroit,"

Phrase: "MI)"

Phrase: "and"

Phrase: "0.01% deoxyribonuclease I"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C0011519:Deoxyribonuclease I [Amino Acid, Peptide, or Protein,Enzyme]
   861   C1414107:DEOXYRIBONUCLEASE I [Gene or Genome]
   812   C0011522:DESOXYRIBONUCLEASE [Amino Acid, Peptide, or Protein,Enzyme,Pharmacologic Substance]
   812   C0021966:I- [Inorganic Chemical]
   812   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "(Sigma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: "St Louis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3272372:ST [Intellectual Product]

Phrase: "MO) at 37C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C3538743:MO [Idea or Concept]

Phrase: "for 30 min."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]
Processing 00000000.tx.32: The cells were suspended in Neurobasal medium (Invitrogen, San Diego, CA) containing 10% fetal bovine serum (Sanko-junyaku, Tokyo, Japan), and were plated at a density of 50 000 cells/cm2 on polyethyleneimine (Sigma)-coated glass coverslips (Matunami Glass Ind. Ltd, Japan), each equipped with a flexiPERM (Sartorius, Gttingen, Germany) that created eight wells of 0.7 x 1.0 cm2. 

Phrase: "The cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "suspended in Neurobasal medium"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   770   C0009458:Medium [Intellectual Product]
   770   C0439536:Medium [Quantitative Concept]
   770   C1553389:suspended [Idea or Concept]
   770   C1553403:suspended [Idea or Concept]
   770   C1705217:Medium [Substance]
   770   C1705537:Suspended [Functional Concept]
   770   C3244283:medium [Intellectual Product]

Phrase: "(Invitrogen,"

Phrase: "San Diego,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1826357:San [Gene or Genome]

Phrase: "CA)"

Phrase: "containing"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332256:Containing [Functional Concept]
  1000   C2700400:Containing [Activity]

Phrase: "10% fetal bovine serum"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   812   C0007452:Bovine [Mammal]
   812   C0015965:Fetal [Embryonic Structure]
   812   C0229671:Serum [Body Substance]
   812   C0521457:Fetal [Functional Concept]
   812   C1140701:bovine [Mammal]
   812   C1546774:Serum [Intellectual Product]
   812   C1550100:Serum [Body Substance]

Phrase: "(Sanko-junyaku,"

Phrase: "Tokyo,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040371:Tokyo [Geographic Area]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "were"

Phrase: "plated at a density of 50 000 cells/cm2"
Meta Candidates (Total=13; Excluded=3; Pruned=0; Remaining=10)
   745   C0162339:Cell Density [Quantitative Concept]
   745   C1166718:cells plate [Cell Component]
   742   C0007634:Cells [Cell]
   742   C0178587:density [Quantitative Concept]
   742   C0439479:cm2 [Quantitative Concept]
   742   C0555206:CM2 [Congenital Abnormality]
   742   C3282337:Cells [Cell]
   708   C0005971:Plate [Medical Device]
   708   C1139930:plate [Medical Device]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]
   708   C3537155:Plate [Manufactured Object]

Phrase: "on polyethyleneimine"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0032486:Polyethyleneimine [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")-"

Phrase: "coated glass coverslips"

Phrase: "(Matunami Glass Ind. Ltd,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C1136140:LTD [Organ or Tissue Function]

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: ","

Phrase: "each"

Phrase: "equipped with a flexiPERM"

Phrase: "(Sartorius,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0224434:Sartorius [Body Part, Organ, or Organ Component]
  1000   C1305055:Sartorius [Body Part, Organ, or Organ Component]

Phrase: "Gttingen,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "that created eight wells of 0.7 x 1.0 cm2."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   704   C0205170:Well [Qualitative Concept]
   704   C3146287:Well [Manufactured Object]
Processing 00000000.tx.33: Twenty-four hours after plating, the medium was changed to serum-free Neurobasal medium supplemented with 2% B27 (Invitrogen). 

Phrase: "Twenty-four hours after plating,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0439227:hours [Temporal Concept]
   726 E C0564385:/hour [Quantitative Concept]

Phrase: "the medium"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0009458:Medium [Intellectual Product]
  1000   C0439536:Medium [Quantitative Concept]
  1000   C1705217:Medium [Substance]
  1000   C3244283:medium [Intellectual Product]

Phrase: "was"

Phrase: "changed to serum-free Neurobasal medium"
Meta Candidates (Total=13; Excluded=1; Pruned=0; Remaining=12)
   753   C0009458:Medium [Intellectual Product]
   753   C0229671:Serum [Body Substance]
   753   C0332296:free [Functional Concept]
   753   C0392747:Changed [Functional Concept]
   753   C0439536:Medium [Quantitative Concept]
   753   C0443172:Changed [Quantitative Concept]
   753   C1546774:Serum [Intellectual Product]
   753   C1550100:Serum [Body Substance]
   753   C1705217:Medium [Substance]
   753   C1880497:Free [Qualitative Concept]
   753   C1996904:Free [Qualitative Concept]
   753   C3244283:medium [Intellectual Product]
   719 E C1705241:Change [Quantitative Concept]

Phrase: "supplemented with 2% B27"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C1537935:B27 [Gene or Genome]
   737   C0242295:Supplement [Food]
   737   C1947943:Supplement [Intellectual Product]
   737   C2348609:Supplement [Functional Concept]

Phrase: "(Invitrogen"

Phrase: ")."
Processing 00000000.tx.34: Transfection Truncated TrkB (tTrkB, mouse trkB.t1 11428, which lacks the kinase domain), control -galactosidase (both gifts from Dr Rita J. Balice-Gordon), and pre-pro BDNF (a gift from Dr Masami Kojima) were each subcloned into the pIRES-hrGFP expression vector (Stratagene, La Jolla, CA) that carries the CMV promoter upstream and an internal ribosomal entry site (IRES)-humanized Renilla reniformis green fluorescence protein (hrGFP) downstream. 

Phrase: "Transfection"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "Truncated"

Phrase: "TrkB"

Phrase: "(tTrkB,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]

Phrase: "mouse trkB.t1 11428,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0025914:Mouse [Mammal]
   812   C0025929:mouse [Mammal]
   812   C0026809:Mouse [Mammal]
   812   C1413227:T1 [Gene or Genome]

Phrase: "which"

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "the kinase domain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1880389:Domain [Functional Concept]
   861   C1883221:Domain [Conceptual Entity]
   861   C3541951:Domain [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "control -galactosidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016955:Galactosidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "("

Phrase: "both gifts from Dr Rita J. Balice-Gordon"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1136188:Gifts [Entity]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "pre-pro BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   901   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   799   C0006104:Brain [Body Part, Organ, or Organ Component]
   799   C1269537:Brain [Body Part, Organ, or Organ Component]
   799   C1441547:Derived [Qualitative Concept]
   799   C1521761:Factor [Functional Concept]
   799   C2827422:Factor [Conceptual Entity]
   799   C3245521:derived [Idea or Concept]

Phrase: "("

Phrase: "a gift from Dr Masami Kojima"

Phrase: ")"

Phrase: "were"

Phrase: "each subcloned into the pIRES-hrGFP expression vector"

Phrase: "(Stratagene,"

Phrase: "La Jolla,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1555265:La Jolla [Population Group]

Phrase: "CA)"

Phrase: "that"

Phrase: "carries"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0206243:Carry [Activity]
  1000   C0699809:Carries [Finding]

Phrase: "the CMV promoter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0086860:Promoter [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "upstream"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522505:Upstream [Spatial Concept]

Phrase: "and"

Phrase: "an internal ribosomal entry site (IRES)-humanized Renilla reniformis green fluorescence protein (hrGFP)"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   880   C0035552:Ribosomal Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   880   C1622856:ribosomal protein [Genetic Function]
   797   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   790   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "downstream."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522506:Downstream [Spatial Concept]
Processing 00000000.tx.35: Each gene of interest and hrGFP are thus transcribed as a single mRNA and then translated into separate proteins. 

Phrase: "Each gene of interest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0017337:Gene [Gene or Genome]

Phrase: "and"

Phrase: "hrGFP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   837   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "are"

Phrase: "thus"

Phrase: "transcribed as a single mRNA"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
   760   C0037179:Single [Population Group]
   760   C0087136:single [Finding]
   760   C0205171:Single [Quantitative Concept]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "translated into separate proteins."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0040710:translated [Occupational Activity]
   770   C0443299:Separate [Spatial Concept]
Processing 00000000.tx.36: DNA purified on a QIA filter (Plasmid Midi Kit; QIAGEN, Hilden, Germany) was used to transfect cells. 

Phrase: "DNA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0012854:DNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "purified on a QIA filter"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   760   C0180860:Filter [Manufactured Object]
   760   C0581406:Filter [Medical Device]
   760   C1522664:Filter [Intellectual Product]
   760   C1704449:Filter [Conceptual Entity]
   760   C1704684:Filter [Medical Device]
   760   C1875155:FILTER [Medical Device]
   760   C1998793:Purified [Functional Concept]

Phrase: "(Plasmid Midi Kit"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   827   C0812225:KIT [Medical Device]
   827   C1150635:KIT [Molecular Function]
   827   C1705212:Kit [Medical Device]
   827   C1705213:KIT [Medical Device]
   827   C3273202:Kit [Manufactured Object]

Phrase: "; QIAGEN,"

Phrase: "Hilden,"

Phrase: "Germany"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0017480:Germany [Geographic Area]

Phrase: ")"

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "transfect"

Phrase: "cells."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.37: A calcium phosphate precipitation method was used for transfecting cells after 5 (for tTrkB) or 7 (for BDNF) days in culture. 

Phrase: "A calcium phosphate precipitation method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0025663:Method [Intellectual Product]
   812   C0449851:Method [Functional Concept]
   812   C0871511:METHOD [Intellectual Product]

Phrase: "was"

Phrase: "used for transfecting cells"
Meta Candidates (Total=9; Excluded=6; Pruned=0; Remaining=3)
   770   C0007634:Cells [Cell]
   770   C1273517:used [Finding]
   770   C3282337:Cells [Cell]
   737 E C0042153:use [Functional Concept]
   737 E C0457083:Use [Functional Concept]
   737 E C1269647:Cell [Cell]
   737 E C1704653:Cell [Medical Device]
   737 E C1947944:Use [Intellectual Product]
   737 E C1948049:Cell [Spatial Concept]

Phrase: "after 5"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439084:>5 [Quantitative Concept]
  1000   C0728893:+5 [Quantitative Concept]

Phrase: "("

Phrase: "for tTrkB"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0348078:Form [Qualitative Concept]
   804   C0376315:Form [Manufactured Object]
   804   C0521125:For [Qualitative Concept]
   804   C1522492:Form [Functional Concept]

Phrase: ")"

Phrase: "or"

Phrase: "7"

Phrase: "("

Phrase: "for BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: ")"

Phrase: "days in culture."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   790   C0439228:days [Temporal Concept]
   756 E C0332173:/day [Temporal Concept]
   756 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.38: We defined cDNA-expressing cells as those with green fluorescence intensity >50, in 8-bit images, taken with a 0.5 s exposure. 

Phrase: "We"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "cDNA-expressing cells as those with green fluorescence intensity"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   742   C0007634:Cells [Cell]
   742   C3282337:Cells [Cell]
   708 E C1269647:Cell [Cell]
   708 E C1704653:Cell [Medical Device]
   708 E C1948049:Cell [Spatial Concept]

Phrase: ">50,"

Phrase: "in 8-bit images,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1704254:Image [Intellectual Product]
   793   C1704922:Image [Entity]
   793   C3542466:Image [Intellectual Product]

Phrase: "taken with a 0.5 s exposure."
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   778   C0444499:0/5 [Quantitative Concept]
   748   C0274281:Exposure, NOS [Injury or Poisoning]
   748   C0332157:Exposure [Clinical Attribute]
   748   C1883727:Taken [Conceptual Entity]
   714 E C1515187:Take [Health Care Activity]
Processing 00000000.tx.39: Under these conditions, morphological changes in neurons expressing tTrkB or BDNF were not apparent, and there were no significant differences in the average numbers of primary neurites or soma sizes in comparison with control-transfected neurons (some of the data is presented in the Results section). 

Phrase: "Under these conditions,"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   966   C0012634:condition [Disease or Syndrome]
   966   C0348080:Condition [Qualitative Concept]
   966   C1705253:Condition [Conceptual Entity]
   916 E C0009647:Conditioned [Mental Process]
   916 E C1701901:Conditional [Qualitative Concept]
   916 E C1963686:Conditional [Functional Concept]
   893 E C1519605:Conditionality [Conceptual Entity]

Phrase: "morphological changes in neurons"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0392747:changes [Functional Concept]
   770   C0443172:changes [Quantitative Concept]
   770   C0543482:morphological [Spatial Concept]
   766   C1260954:Morphologic change [Anatomical Abnormality]
   737 E C1705241:Change [Quantitative Concept]

Phrase: "expressing"

Phrase: "tTrkB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]

Phrase: "or"

Phrase: "BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "were"

Phrase: "not apparent,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0750489:apparent [Idea or Concept]

Phrase: "and"

Phrase: "there"

Phrase: "were"

Phrase: "no significant differences in the average numbers of primary neurites"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   741   C1879649:Average Difference [Research Activity]
   706   C1705241:*Difference [Quantitative Concept]
   706   C1705242:Difference [Qualitative Concept]

Phrase: "or"

Phrase: "soma"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0599444:soma [Cell Component]
  1000   C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   944 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]
   907 E C2986476:Somatic [Qualitative Concept]

Phrase: "sizes in comparison"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0456389:SIZES [Spatial Concept]
   790   C1707455:Comparison [Activity]

Phrase: "with control-transfected neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "("

Phrase: "some of the data"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0205392:Some [Quantitative Concept]
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]
   770   C3540770:Some [Intellectual Product]

Phrase: "is"

Phrase: "presented in the Results"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   770   C0449450:Presented [Idea or Concept]
   737 E C0150312:Present [Quantitative Concept]
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "section"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0205155:Section [Spatial Concept]
  1000   C1293097:Section, NOS [Therapeutic or Preventive Procedure]
  1000   C1522472:Section [Substance]
  1000   C1552923:Section [Quantitative Concept]
  1000   C1705191:Section [Physical Object]

Phrase: ")."
Processing 00000000.tx.40: The number of neurites passing through the circles was counted and used for quantification. 

Phrase: "The number of neurites"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0237753:*Number [Quantitative Concept]
   770   C0449788:Number [Quantitative Concept]

Phrase: "passing through the circles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1282913:Circle [Spatial Concept]
   737   C1551714:Circle [Population Group]
   737   C2828386:Pass [Finding]

Phrase: "was"

Phrase: "counted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0750480:Count [Activity]
   966   C1705566:Count [Quantitative Concept]

Phrase: "and"

Phrase: "used for quantification."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   790   C1273517:used [Finding]
   790   C1709793:Quantification [Quantitative Concept]
   756 E C0042153:use [Functional Concept]
   756 E C0457083:Use [Functional Concept]
   756 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.41: Cell Treatment For all experiments except those involving BDNF expression, 10 ng/ml of recombinant human BDNF (a gift from Sumitomo Pharmaceuticals, Osaka, Japan.) was added to the culture medium for 1 h in the case of Fos induction or 48 h in the case of other experiments. 

Phrase: "Cell Treatment For all experiments"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0039798:treatment [Functional Concept]
   760   C0087111:Treatment [Therapeutic or Preventive Procedure]
   760   C1522326:Treatment [Functional Concept]
   760   C1533734:Treatment [Therapeutic or Preventive Procedure]
   760   C1705169:Treatment [Conceptual Entity]
   760   C3538994:TREATMENT [Research Activity]

Phrase: "except those"

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "BDNF expression,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   771   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "10 ng/ml of recombinant human BDNF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0439275:ng/mL [Quantitative Concept]
   739   C0439526:/mL [Quantitative Concept]

Phrase: "("

Phrase: "a gift from Sumitomo Pharmaceuticals,"

Phrase: "Osaka,"

Phrase: "Japan."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")"

Phrase: "was"

Phrase: "added to the culture medium"
Meta Candidates (Total=11; Excluded=1; Pruned=0; Remaining=10)
   806   C0010454:Culture medium [Indicator, Reagent, or Diagnostic Aid]
   760   C0009458:Medium [Intellectual Product]
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C0439536:Medium [Quantitative Concept]
   760   C1524062:Added [Functional Concept]
   760   C1705217:Medium [Substance]
   760   C2242979:Culture [Laboratory Procedure]
   760   C3244283:medium [Intellectual Product]
   726 E C1883712:Add [Functional Concept]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "in the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of Fos induction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0205263:Induction [Functional Concept]
   861   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "48 h in the case of other experiments."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   744   C0033727:H+ [Element, Ion, or Isotope]
   744   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441932:H+ [Classification]
   744   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.42: The addition was made after 7 days of in vitro growth and 48 h after cDNA transfection. 

Phrase: "The addition"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883712:Addition [Functional Concept]
   928 E C1524062:Additional [Functional Concept]

Phrase: "was"

Phrase: "made after 7 days of in vitro growth"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   770   C0021135:In Vitro [Intellectual Product]
   770   C1533691:in vitro [Qualitative Concept]
           vitro
   770   C2827718:In Vitro [Functional Concept]
   744   C0018270:'growth' NOS [Organism Function]
   744   C0220844:growth [Physiologic Function]
   744   C0439228:days [Temporal Concept]
   744   C1621966:Growth [Organ or Tissue Function]
   744   C2911660:Growth [Activity]
   711 E C0332173:/day [Temporal Concept]
   711 E C0439505:/day [Temporal Concept]
   711   C1881534:Make [Functional Concept]

Phrase: "and"

Phrase: "48 h after cDNA transfection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0033727:H+ [Element, Ion, or Isotope]
   760   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441932:H+ [Classification]
   760   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.43: In the case of drug treatment, the following drugs were added 30 min prior to the treatment with BDNF: 50 M picrotoxin (Sigma), 200 M saclofen (Tocris, Bristol, UK), 2 M tetrodotoxin (TTX; Wako Chemicals), 1 mM N-nitro-L-arginine methyl ester (L-NAME; Sigma), 3 M AM281 (Tocris) or a mixture of 100 M 2-amino-5-phosphonovaleric acid (APV; Sigma), 30 M 6-cyano-7-nitroquinoxaline (CNQX; Sigma) and 150 M (R,S)--methyl-4-carboxyphenyl-glycine (MCPG; Tocris). 

Phrase: "In the case"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "of drug treatment,"
Meta Candidates (Total=11; Excluded=3; Pruned=0; Remaining=8)
   861   C0013227:Drug [Pharmacologic Substance]
   861   C0039798:treatment [Functional Concept]
   861   C0087111:Treatment [Therapeutic or Preventive Procedure]
   861   C1254351:Drug [Pharmacologic Substance]
   861   C1522326:Treatment [Functional Concept]
   861   C1533734:Treatment [Therapeutic or Preventive Procedure]
   861   C1705169:Treatment [Conceptual Entity]
   861   C3538994:TREATMENT [Research Activity]
   805 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   805 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   768 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "the following drugs"
Meta Candidates (Total=5; Excluded=4; Pruned=0; Remaining=1)
   861   C0013227:Drugs [Pharmacologic Substance]
   827 E C1254351:Drug [Pharmacologic Substance]
   789 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   789 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]
   761 E C0456386:Medicament [Pharmacologic Substance]

Phrase: "were"

Phrase: "added"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1524062:Added [Functional Concept]
   966 E C1883712:Add [Functional Concept]

Phrase: "30 min prior to the treatment"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0456693:/30 min [Temporal Concept]
   790   C1442458:30 min [Temporal Concept]
   753   C0702093:/min [Temporal Concept]

Phrase: "with BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: ":"

Phrase: "50 M picrotoxin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031890:Picrotoxin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "200 M saclofen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0215145:saclofen [Organic Chemical,Pharmacologic Substance]

Phrase: "(Tocris,"

Phrase: "Bristol,"

Phrase: "UK"

Phrase: ")"

Phrase: ","

Phrase: "2 M tetrodotoxin"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0039705:Tetrodotoxin [Biologically Active Substance,Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "(TTX"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039705:Tetrodotoxin [Biologically Active Substance,Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "; Wako Chemicals"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0220806:Chemicals [Chemical]
   827 E C3272558:Chemical [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "1 mM N-nitro-L-arginine methyl ester"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   835   C0052335:arginine methyl ester [Amino Acid, Peptide, or Protein]
   793   C0003765:Arginine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   793   C0014898:Ester [Organic Chemical]

Phrase: "(L-NAME"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0083536:L-NAME [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0027365:Name [Intellectual Product]
   861   C1547383:Name [Intellectual Product]

Phrase: "; Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "3 M AM281"

Phrase: "(Tocris"

Phrase: ")"

Phrase: "or"

Phrase: "a mixture of 100 M 2-amino-5-phosphonovaleric acid"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0439962:Mixture [Substance]

Phrase: "(APV"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0754188:APV [Organic Chemical,Pharmacologic Substance]

Phrase: "; Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "30 M 6-cyano-7-nitroquinoxaline"

Phrase: "(CNQX"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0099122:CNQX [Organic Chemical,Pharmacologic Substance]

Phrase: "; Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "150"

Phrase: "M ("

Phrase: "R,S"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: "--"

Phrase: "methyl-4-carboxyphenyl-glycine"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1258918:methyl-(4-carboxyphenyl)glycine [Organic Chemical]
   812   C0017890:Glycine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0522461:Glycine [Plant]

Phrase: "(MCPG"

Phrase: "; Tocris"

Phrase: ")."
Processing 00000000.tx.44: The effects of all the drugs other than MCPG and saclofen were confirmed electrophysiologically. 

Phrase: "The effects of all"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   770   C1280500:effects [Qualitative Concept]
   737 E C2348382:Effect [Qualitative Concept]

Phrase: "the drugs other than MCPG"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0013227:Drugs [Pharmacologic Substance]
   726 E C1254351:Drug [Pharmacologic Substance]

Phrase: "and"

Phrase: "saclofen"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0215145:saclofen [Organic Chemical,Pharmacologic Substance]

Phrase: "were"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "electrophysiologically."
Processing 00000000.tx.45: Immunocytochemistry Cells were treated sequentially with 4% paraformaldehyde at 4C for 30 min, 0.1% Triton X-100 for 15 min, 2% goat serum/PBS for 1 h, and then with primary antibody, overnight, at 4C. 

Phrase: "Immunocytochemistry Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0007634:Cells [Cell]
   861   C3282337:Cells [Cell]
   827 E C1269647:Cell [Cell]
   827 E C1704653:Cell [Medical Device]
   827 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "treated"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0332293:treated [Therapeutic or Preventive Procedure]
  1000   C1522326:Treated [Functional Concept]
   966 E C1292734:TREAT [Functional Concept]

Phrase: "sequentially with 4% paraformaldehyde"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0070066:Paraformaldehyde [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]

Phrase: "at 4C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]

Phrase: "for 30 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "0.1% Triton X-100 for 15 min,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   800   C0146951:Triton X-100 [Biomedical or Dental Material,Organic Chemical,Pharmacologic Substance]
   770   C0133689:Triton X [Organic Chemical,Pharmacologic Substance]
   744   C0242759:Triton [Geographic Area]

Phrase: "2% goat serum/PBS for 1 h,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1720830:PBS [Disease or Syndrome]
   748   C1823521:PBS [Gene or Genome]

Phrase: "and"

Phrase: "then with primary antibody,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   770   C0205225:Primary [Qualitative Concept]
   770   C0439631:Primary [Therapeutic or Preventive Procedure]
   770   C1883708:Then [Temporal Concept]

Phrase: "overnight,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439583:Overnight [Temporal Concept]

Phrase: "at 4C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0450376:4c [Intellectual Product]
Processing 00000000.tx.46: The primary antibodies used were anti-GAD65 (mouse monoclonal GAD-6, 1:500 dilution; 

Phrase: "The primary antibodies"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   827 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "anti-GAD65"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   937   C2825893:Glutamic Acid Decarboxylase 65 [Laboratory Procedure]
   884   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0061472:Glutamic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0523665:Glutamic Acid [Laboratory Procedure]
   804   C0001128:Acid [Chemical]
   804   C0007054:Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0202406:Acid [Laboratory Procedure]
   804   C0450385:65 [Intellectual Product]

Phrase: "(mouse monoclonal GAD-6,"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   861   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0061472:Glutamic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   827   C0523665:Glutamic Acid [Laboratory Procedure]
   799   C0001128:Acid [Chemical]
   799   C0007054:Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   799   C0025914:Mouse [Mammal]
   799   C0025929:mouse [Mammal]
   799   C0026809:Mouse [Mammal]
   799   C0202406:Acid [Laboratory Procedure]
   799   C0746619:monoclonal [Finding]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: ";"
Processing 00000000.tx.47: Developmental Studies Hybridoma Bank, University of Iowa, IA), anti-MAP2 (rabbit, 1:1000 dilution; 

Phrase: "Developmental Studies Hybridoma Bank,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0442598:Bank [Manufactured Object]
   812   C0872261:Bank [Manufactured Object]

Phrase: "University of Iowa,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0022037:Iowa [Geographic Area]
   827   C0041740:University [Manufactured Object,Organization]
   827   C1555231:Iowa [Population Group]

Phrase: "IA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1947960:Ia [Mammal]

Phrase: ")"

Phrase: ","

Phrase: "anti-MAP2"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1417006:MAP2 [Gene or Genome]
   861   C1424480:MAP2 [Gene or Genome]

Phrase: "(rabbit,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034493:Rabbit [Mammal]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "1000 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: ";"
Processing 00000000.tx.48: Biogenesis, UK), anti-TrkB (rabbit, 1:300 dilution, recognizes the intracellular domain of gp145; 

Phrase: "Biogenesis,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0005495:Biogenesis [Natural Phenomenon or Process]
  1000   C0220781:Biogenesis [Biologic Function]

Phrase: "UK"

Phrase: ")"

Phrase: ","

Phrase: "anti-TrkB"

Phrase: "(rabbit,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034493:Rabbit [Mammal]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "300 dilution,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: "recognizes"

Phrase: "the intracellular domain of gp145"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0175996:intracellular [Cell Component]
   760   C0178719:Intracellular [Spatial Concept]
   760   C1880389:Domain [Functional Concept]
   760   C1883221:Domain [Conceptual Entity]
   760   C3541951:Domain [Intellectual Product]

Phrase: ";"
Processing 00000000.tx.49: Santa Cruz Biotechnology, Santa Cruz, CA), anti-HA (mouse, 1:500 dilution; 

Phrase: "Santa Cruz Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "Santa Cruz,"

Phrase: "CA),"

Phrase: "anti-HA (mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0025914:Mouse [Mammal]
   827   C0025929:mouse [Mammal]
   827   C0026809:Mouse [Mammal]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "500 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: ";"
Processing 00000000.tx.50: Roche Diagnostics Corp.), anti-dystrophin (mouse, DY2, a gift from Dr F. Saito at Teikyo University), anti-GABAA receptor 2/3 (mouse, 1:200 dilution; 

Phrase: "Roche Diagnostics Corp."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0683758:Corp. [Organization]

Phrase: ")"

Phrase: ","

Phrase: "anti-dystrophin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079259:Dystrophin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C1414083:DYSTROPHIN [Gene or Genome]

Phrase: "(mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "DY2,"

Phrase: "a gift from Dr F. Saito"

Phrase: "at Teikyo University"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0041740:University [Manufactured Object,Organization]

Phrase: ")"

Phrase: ","

Phrase: "anti-GABAA receptor 2/3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   840   C0034807:GABA(A) Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "(mouse,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025914:Mouse [Mammal]
  1000   C0025929:mouse [Mammal]
  1000   C0026809:Mouse [Mammal]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "200 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: ";"
Processing 00000000.tx.51: 623G1, Upstate Biotechnology, NY) and anti-Fos (rabbit, 1:300 dilution; 

Phrase: "623G1,"

Phrase: "Upstate Biotechnology,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0005574:Biotechnology [Biomedical Occupation or Discipline]

Phrase: "NY"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0027976:NY [Geographic Area]
  1000   C1879958:NY [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "anti-Fos (rabbit,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0034493:Rabbit [Mammal]

Phrase: "1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C2827734:1+ [Quantitative Concept]
  1000   C2981698:1+ [Classification]

Phrase: ":"

Phrase: "300 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: ";"
Processing 00000000.tx.52: Oncogene Research Products). 

Phrase: "Oncogene Research Products"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   913   C0029005:Oncogene Products [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C1514468:Products [Entity]
   793 E C1704444:Product [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.53: After washing, the cells were incubated with a fluorochrome-conjugated secondary antibody (Alexa 350-, 568- or 594-conjugated anti-rabbit IgG; 

Phrase: "After washing,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0441648:Washing [Activity]

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "incubated with a fluorochrome-conjugated secondary antibody"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   748   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   748   C0025397:Fluorochrome [Organic Chemical,Pharmacologic Substance]
   748   C0027627:secondary [Neoplastic Process]
   748   C0175668:Secondary [Temporal Concept]
   748   C0205436:Secondary [Quantitative Concept]
   748   C0522529:Conjugated [Spatial Concept]
   748   C1439852:Incubated [Laboratory Procedure]

Phrase: "(Alexa 350-,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0893629:Alexa 350 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C1071616:Alexa [Plant]

Phrase: "568-"

Phrase: "or"

Phrase: "594-conjugated anti-rabbit IgG"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   853   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]
   804   C0034493:Rabbit [Mammal]

Phrase: ";"
Processing 00000000.tx.54: Alexa 350- or 594-conjugated anti-mouse IgG; 

Phrase: "Alexa 350-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0893629:Alexa 350 [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   861   C1071616:Alexa [Plant]

Phrase: "or"

Phrase: "594-conjugated anti-mouse IgG"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   853   C0051979:anti-IgG [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: ";"
Processing 00000000.tx.55: all at 1:400 dilution; 

Phrase: "all at 1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1412113:AT-1 [Gene or Genome]
   861   C1516077:At [Spatial Concept]

Phrase: ":"

Phrase: "400 dilution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0079240:Dilution [Laboratory Procedure]
   861   C1948037:Dilution [Functional Concept]

Phrase: ";"
Processing 00000000.tx.56: Molecular Probes, Eugene, OR) for 1 h at room temperature. 

Phrase: "Molecular Probes,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0026381:Molecular Probes [Indicator, Reagent, or Diagnostic Aid]
   861   C0182400:Probes [Medical Device]
   827 E C1704681:Probe [Gene or Genome]
   827 E C2347609:Probe [Chemical Viewed Functionally]
   827 E C3536729:Probe [Manufactured Object]

Phrase: "Eugene,"

Phrase: "OR) for 1 h"

Phrase: "at room temperature."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C2348236:ROOM TEMPERATURE [Qualitative Concept]
   861   C0005903:temperature [Organism Attribute]
   861   C0039476:*Temperature [Quantitative Concept]
   861   C1547703:Room [Spatial Concept]
Processing 00000000.tx.57: The specificity of GAD-6 for GAD65 among mixtures of brain proteins has been well characterized (Chang and Gottlieb, 1988). 

Phrase: "The specificity of GAD-6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0037791:Specificity [Quantitative Concept]
   748   C1511884:Specificity [Quantitative Concept]

Phrase: "for GAD65"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C2825893:Glutamic Acid Decarboxylase 65 [Laboratory Procedure]
   923   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0061472:Glutamic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0523665:Glutamic Acid [Laboratory Procedure]
   812   C0001128:Acid [Chemical]
   812   C0007054:Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0202406:Acid [Laboratory Procedure]
   812   C0450385:65 [Intellectual Product]

Phrase: "among mixtures"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0439962:mixtures [Substance]

Phrase: "of brain proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0033684:Proteins [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "has"

Phrase: "been"

Phrase: "well characterized"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205170:Well [Qualitative Concept]
   861   C1880022:Characterized [Activity]
   861   C3146287:Well [Manufactured Object]

Phrase: "(Chang"

Phrase: "and"

Phrase: "Gottlieb,"

Phrase: "1988"

Phrase: ")."
Processing 00000000.tx.58: The rabbit anti-MAP2 antibody appears to have cross-immunoreactivity in the nucleus (as shown in Fig. 1A, blue), but we confirmed that it could safely be used as a neuronal marker, using another mouse monoclonal antibody from Chemicon. 

Phrase: "The rabbit anti-MAP2 antibody"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   902   C1979003:Rabbit Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   875   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   812   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "cross-immunoreactivity in the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0597879:immunoreactivity [Molecular Function]

Phrase: "("

Phrase: "as"

Phrase: "shown in Fig. 1A,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0349966:Fig [Food]
   770   C0450344:1A [Intellectual Product]
   770   C1337208:FIG [Food]
   770   C1553633:1a [Medical Device]
   737   C1547282:Show [Intellectual Product]

Phrase: "blue"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260957:Blue [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "we"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "it"

Phrase: "could"

Phrase: "safely"

Phrase: "be"

Phrase: "used as a neuronal marker,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0005516:Marker [Clinical Attribute]
   760   C0521390:Neuronal [Immunologic Factor]
   760   C1273517:used [Finding]
   726 E C0042153:use [Functional Concept]
   726 E C0457083:Use [Functional Concept]
   726 E C1947944:Use [Intellectual Product]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "another mouse monoclonal antibody from Chemicon."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0359168:Mouse monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   790   C0003250:Monoclonal antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]
   753   C0746619:monoclonal [Finding]
Processing 00000000.tx.59: View larger version (28K): [in this window] [in a new window]  Figure 1. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(28K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 1."
Processing 00000000.tx.60: Increases in GAD65 signals around BDNF-overexpressing neurons. 

Phrase: "Increases in GAD65 signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:increases [Functional Concept]

Phrase: "around BDNF-overexpressing neurons."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0027882:Neurons [Cell]
   734   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   716 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.61: (A) Immunofluorescent signals for GAD65 (red, upper and lower panels) are clearly augmented around a BDNF-overexpressing neuron (BDNF-OE) visualized with coexpressed hrGFP (green, upper panel). 

Phrase: "(A) Immunofluorescent signals for GAD65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   711   C1710082:Signal [Phenomenon or Process]

Phrase: "(red,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "upper"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1282910:Upper [Spatial Concept]

Phrase: "and"

Phrase: "lower panels"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "are"

Phrase: "clearly"

Phrase: "augmented around a BDNF-overexpressing neuron"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   818   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   810   C1826397:NEURON-DERIVED NEUROTROPHIC FACTOR [Gene or Genome]
   810   C3472710:neuron-derived neurotrophic factor [Gene or Genome]
   764   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   764   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   762   C0960756:factor A [Organic Chemical]
   742   C0006104:Brain [Body Part, Organ, or Organ Component]
   742   C0027882:Neuron [Cell]
   742   C0205217:Augmented [Quantitative Concept]
   742   C1269537:Brain [Body Part, Organ, or Organ Component]
   742   C1441547:Derived [Qualitative Concept]
   742   C1521761:Factor [Functional Concept]
   742   C2827422:Factor [Conceptual Entity]
   742   C3245521:derived [Idea or Concept]
   708   C1514559:overexpress [Genetic Function]

Phrase: "(BDNF-OE)"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   937   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   840   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   840   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]
   804   C1441547:Derived [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C1551089:Oe [Quantitative Concept]
   804   C2827422:Factor [Conceptual Entity]
   804   C3245521:derived [Idea or Concept]

Phrase: "visualized with coexpressed hrGFP"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   766   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   764   C0997916:Renilla reniformis [Eukaryote]
   742   C0016315:Fluorescence [Natural Phenomenon or Process]
   742   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   742   C0234621:Visualized [Functional Concept]
   742   C0332583:Green [Qualitative Concept]
   742   C1093003:Renilla [Eukaryote]

Phrase: "(green,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: "upper panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0441833:Panel [Idea or Concept]
   861   C1999270:Panel [Intellectual Product]
   861   C3537156:Panel [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.62: Such signals are not apparent around neurons interposed between the BDNF-overexpressing neuron and inhibitory neurons. 

Phrase: "Such signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710082:Signal [Phenomenon or Process]

Phrase: "are"

Phrase: "not apparent around neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0750489:apparent [Idea or Concept]

Phrase: "interposed between the BDNF-overexpressing neuron"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   818   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   810   C1826397:NEURON-DERIVED NEUROTROPHIC FACTOR [Gene or Genome]
   810   C3472710:neuron-derived neurotrophic factor [Gene or Genome]
   764   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   764   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   742   C0006104:Brain [Body Part, Organ, or Organ Component]
   742   C0027882:Neuron [Cell]
   742   C1269537:Brain [Body Part, Organ, or Organ Component]
   742   C1441547:Derived [Qualitative Concept]
   742   C1521761:Factor [Functional Concept]
   742   C2827422:Factor [Conceptual Entity]
   742   C3245521:derived [Idea or Concept]
   708   C1514559:overexpress [Genetic Function]

Phrase: "and"

Phrase: "inhibitory neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.63: The interposed neurons used to gather the data shown in C are defined as MAP2-positive cells (blue, lower panel) whose soma are localized approximately within 60120 rhombuses drawn between BDNF-overexpressing neurons and GAD65-positive cell bodies (presumably inhibitory neurons). 

Phrase: "The interposed neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "gather"

Phrase: "the data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "shown in C"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]

Phrase: "are"

Phrase: "defined as MAP2-positive cells"
Meta Candidates (Total=14; Excluded=3; Pruned=0; Remaining=11)
   806   C0439178:% positive cells [Quantitative Concept]
           % Positive
   760   C0007634:Cells [Cell]
   760   C1417006:MAP2 [Gene or Genome]
   760   C1424480:MAP2 [Gene or Genome]
   760   C1446409:Positive [Qualitative Concept]
   760   C1514241:Positive [Finding]
   760   C1704788:Defined [Conceptual Entity]
   760   C2825490:Positive [Qualitative Concept]
   760   C3282337:Cells [Cell]
   760   C3539106:Defined [Intellectual Product]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "(blue,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1260957:Blue [Qualitative Concept]

Phrase: "lower"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441994:Lower [Spatial Concept]
  1000   C1548802:Lower [Body Location or Region]
  1000   C2003888:Lower [Activity]

Phrase: "panel"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0441833:Panel [Idea or Concept]
  1000   C1999270:Panel [Intellectual Product]
  1000   C3537156:Panel [Manufactured Object]

Phrase: ")"

Phrase: "whose soma"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0599444:soma [Cell Component]
  1000   C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   944 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]
   907 E C2986476:Somatic [Qualitative Concept]

Phrase: "are"

Phrase: "localized"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0392752:Localized [Spatial Concept]

Phrase: "approximately within 60120 rhombuses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332232:Approximately [Qualitative Concept]

Phrase: "drawn"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0013113:Draw [Intellectual Product]

Phrase: "between BDNF-overexpressing neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   795   C0027882:Neurons [Cell]
   712 E C0521390:Neuronal [Immunologic Factor]
   710   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "GAD65-positive cell bodies"
Meta Candidates (Total=12; Excluded=2; Pruned=0; Remaining=10)
   818   C0439178:positive cell [Quantitative Concept]
   795   C0007634:Cell [Cell]
   795   C0242821:bodies [Human]
   795   C1269647:Cell [Cell]
   795   C1704653:Cell [Medical Device]
   795   C1948049:Cell [Spatial Concept]
   795   C1995017:Bodies [Cell Component]
   785   C0599444:Cell body [Cell Component]
   785   C2752549:cell body [Cell Component]
   762 E C0460148:Body [Anatomical Structure]
   762 E C1268086:Body [Anatomical Structure]
   710   C2825893:Glutamic Acid Decarboxylase 65 [Laboratory Procedure]

Phrase: "(presumably inhibitory neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.64: The circles (r = 17.5 m) represent the areas in which GAD65 was quantified for the data shown in C. 

Phrase: "The circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1282913:Circle [Spatial Concept]
   966   C1551714:Circle [Population Group]

Phrase: "(r = 17.5"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: "m)"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "the areas in which GAD65"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0205146:areas [Spatial Concept]
   711 E C0017446:Area [Geographic Area]

Phrase: "was"

Phrase: "quantified for the data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C1511726:Data [Idea or Concept]
   770   C3245479:data [Medical Device]
   737   C1709793:Quantify [Quantitative Concept]

Phrase: "shown in C."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.65: Scale bar, 20 m. 

Phrase: "Scale bar,"

Phrase: "20 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.66: (B) GAD65 puncta around an interposed neuron 1 in A become distinct when the red intensity in the image is artificially enhanced, suggesting that other synaptic contacts exist besides the intense puncta shown in A. 

Phrase: "(B) GAD65 puncta around an interposed neuron 1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   704   C1500338:Punctum [Eukaryote]

Phrase: "in A"

Phrase: "become"

Phrase: "distinct"

Phrase: "when"

Phrase: "the red intensity in the image"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0522510:Intensity [Qualitative Concept]

Phrase: "is"

Phrase: "artificially"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: ","

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "other synaptic contacts"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0332158:contact [Functional Concept]
   827   C0337611:Contact [Population Group]
   827   C1705415:Contact [Idea or Concept]

Phrase: "exist besides the intense puncta"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0522510:Intense [Qualitative Concept]
   760   C2987476:Exist [Conceptual Entity]
   726   C1500338:Punctum [Eukaryote]

Phrase: "shown in A."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1547282:Show [Intellectual Product]
Processing 00000000.tx.67: (C) The average intensities of GAD65 immunofluorescence around BDNF-overexpressing neurons (BDNF-OE, n = 120) and interposed neurons (n = 259) show a clear difference (**P < 0.01, Student's t-test).  

Phrase: "(C)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1553033:[c] [Quantitative Concept]

Phrase: "The average intensities of GAD65 immunofluorescence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0522510:intensities [Qualitative Concept]

Phrase: "around BDNF-overexpressing neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0027882:Neurons [Cell]
   734   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   716 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(BDNF-OE,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1551089:Oe [Quantitative Concept]
   771   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "n = 120"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "and"

Phrase: "interposed neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(n = 259"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "a clear difference"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "("

Phrase: "*"

Phrase: "*P < 0.01,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "Student's t-test"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.68: Fluorescent images were acquired with an Orca II cooled CCD camera (Hamamatsu Photonics, Shizuoka, Japan). 

Phrase: "Fluorescent images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "acquired with an Orca II"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   760   C0439661:Acquired [Temporal Concept]
   760   C0995158:Orca [Mammal]
   760   C2239659:ORCA [Gene or Genome]
   760   C2986646:ORCA [Gene or Genome]
   760   C3245488:acquired [Intellectual Product]
   726 E C1706701:Acquire [Activity]

Phrase: "cooled"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1548792:Cool [Qualitative Concept]

Phrase: "CCD camera"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0598124:CCD camera [Manufactured Object]
   861   C0179533:Camera [Medical Device]
   861   C1654607:Camera [Eukaryote]
   861   C1706254:CAMERA [Medical Device]

Phrase: "(Hamamatsu Photonics,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1328817:Photonics [Classification]

Phrase: "Shizuoka,"

Phrase: "Japan"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022341:Japan [Geographic Area]

Phrase: ")."
Processing 00000000.tx.69: Quantitative Fluorescence Image Analysis Eight-bit digitized images were taken with a fixed exposure time that was carefully determined so as not to include pixels saturated in intensity. 

Phrase: "Quantitative Fluorescence Image Analysis Eight-bit digitized images"

Phrase: "were"

Phrase: "taken with a fixed exposure time"
Meta Candidates (Total=10; Excluded=1; Pruned=0; Remaining=9)
   790   C2348485:Exposure Time [Quantitative Concept]
   753   C0040223:Time [Temporal Concept]
   753   C0231441:Fixed [Finding]
   753   C0274281:Exposure, NOS [Injury or Poisoning]
   753   C0332157:Exposure [Clinical Attribute]
   753   C0443218:Fixed [Qualitative Concept]
   753   C1883727:Taken [Conceptual Entity]
   753   C2827483:Fixed [Body Substance]
   753   C3541383:Time [Temporal Concept]
   719 E C1515187:Take [Health Care Activity]

Phrase: "that"

Phrase: "was"

Phrase: "carefully"

Phrase: "determined"

Phrase: "so"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0037640:SO [Geographic Area]

Phrase: "as"

Phrase: "not to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "include"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332257:include [Functional Concept]
  1000   C1552866:include [Idea or Concept]
  1000   C2700399:Include [Activity]

Phrase: "pixels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1709558:Pixel [Conceptual Entity]

Phrase: "saturated in intensity."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0522510:Intensity [Qualitative Concept]
   790   C0522534:Saturated [Phenomenon or Process]
   790   C1705188:SATURATED [Quantitative Concept]
Processing 00000000.tx.70: A linear relationship of fluorescence with intensity in the images was confirmed in the range used. 

Phrase: "A linear relationship of fluorescence"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0439849:Relationship [Qualitative Concept]
   760   C1705630:Relationship [Idea or Concept]
   760   C1706279:Relationship [Idea or Concept]
   760   C3540605:Relationship [Intellectual Product]

Phrase: "with intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522510:Intensity [Qualitative Concept]

Phrase: "in the images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "was"

Phrase: "confirmed in the range"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0521093:confirmed [Qualitative Concept]
   770   C0750484:Confirmed [Idea or Concept]
   770   C1514721:Range [Quantitative Concept]
   770   C2348147:Range [Quantitative Concept]
   770   C3542016:Range [Intellectual Product]
   737 E C1456348:Confirm [Qualitative Concept]

Phrase: "used."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]
Processing 00000000.tx.71: Images were analyzed using Scion Image software (Scion Corp., Frederick, MD) and Metamorph (Universal Imaging Co.). 

Phrase: "Images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "Scion Image software"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0037585:Software [Intellectual Product,Manufactured Object]

Phrase: "(Scion Corp.,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0683758:Corp. [Organization]

Phrase: "Frederick,"

Phrase: "MD)"

Phrase: "and"

Phrase: "Metamorph"

Phrase: "(Universal Imaging Co."

Phrase: ")."
Processing 00000000.tx.72: For all images, the backgrounds were automatically subtracted prior to analysis using the rolling ball method in Scion Image, but no other modifications were applied to the intensity values. 

Phrase: "For all images,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1704254:Image [Intellectual Product]
   966   C1704922:Image [Entity]
   966   C3542466:Image [Intellectual Product]

Phrase: "the backgrounds"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1706907:Background [Conceptual Entity]

Phrase: "were"

Phrase: "automatically"

Phrase: "subtracted prior to analysis"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   833   C0332152:Prior to [Temporal Concept]
           Prior
   770   C0002778:Analysis [Laboratory Procedure]
   770   C0936012:Analysis [Research Activity]
   770   C1524024:analysis [Functional Concept]
   770   C2826257:PRIOR [Event]
   737   C1719767:Subtract [Intellectual Product]
   737   C2348589:Subtract [Phenomenon or Process]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the rolling ball method in Scion Image,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0025663:Method [Intellectual Product]
   748   C0449851:Method [Functional Concept]
   748   C0871511:METHOD [Intellectual Product]

Phrase: "but"

Phrase: "no other modifications"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0392747:Modification [Functional Concept]
   966   C1554963:modification [Qualitative Concept]

Phrase: "were"

Phrase: "applied to the intensity values."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   760   C0042295:Values [Qualitative Concept]
   760   C0185125:Applied [Health Care Activity]
   760   C0522510:Intensity [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]
   726 E C1632850:Apply [Functional Concept]
   726 E C1879355:Apply [Functional Concept]
Processing 00000000.tx.73: To quantify the expression level of GAD65, three methods were applied as follows. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "quantify"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709793:Quantify [Quantitative Concept]

Phrase: "the expression level of GAD65,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C3244092:expression level [Idea or Concept]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "three methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "were"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "as"

Phrase: "follows."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332283:follow [Temporal Concept]
  1000   C1719822:Follow [Intellectual Product]
Processing 00000000.tx.74: First, to control the analyses, we defined interposed neurons as those within rhombuses, composed of two regular triangles that connected the somas of BDNF-expressing neurons and inhibitory neurons as shown in Figure 1A. 

Phrase: "First,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0243148:control [Qualitative Concept]
  1000   C1550141:Control [Substance]
  1000   C1882979:Control [Conceptual Entity]
  1000   C2587213:Control [Functional Concept]
  1000   C3274648:Control [Qualitative Concept]

Phrase: "the analyses,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "we"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "interposed neurons as those within rhombuses,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0027882:Neurons [Cell]

Phrase: "composed of two regular triangles"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0205119:triangles [Conceptual Entity]
   760   C0205272:Regular [Qualitative Concept]
   760   C0205448:Two [Quantitative Concept]

Phrase: "that"

Phrase: "connected"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C2986575:Connect [Activity]

Phrase: "the somas of BDNF-expressing neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   762   C0599444:Soma of neuron [Cell Component]
           somas
   708 E C0702216:Soma [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "inhibitory neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "as"

Phrase: "shown in Figure 1A."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0450344:1A [Intellectual Product]
   770   C1553633:1a [Medical Device]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.75: To compare the GAD level around BDNF-expressing neurons and interposed neurons, we used the average intensity of GAD staining in a circle of radius 17.5 m around the center of the soma. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "compare"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707455:Compare [Activity]

Phrase: "the GAD level around BDNF-expressing neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   736   C0441889:Level [Qualitative Concept]
   736   C0456079:Level [Classification]
   736   C1547707:Level [Geographic Area]
   736   C2946261:Level [Pharmacologic Substance]

Phrase: "and"

Phrase: "interposed neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "the average intensity of GAD staining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0522510:Intensity [Qualitative Concept]

Phrase: "in a circle"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1282913:Circle [Spatial Concept]
  1000   C1551714:Circle [Population Group]

Phrase: "of radius 17.5 m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   812   C0441923:M+ [Intellectual Product]

Phrase: "around the center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205099:Center [Spatial Concept]

Phrase: "of the soma."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0599444:soma [Cell Component]
  1000   C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   944 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]
   907 E C2986476:Somatic [Qualitative Concept]
Processing 00000000.tx.76: This radius was determined as being approximately twice the average soma radius, and such circles included the largest soma and many of the GAD-puncta seen on thin neurites around the soma. 

Phrase: "This radius"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034627:Radius [Body Part, Organ, or Organ Component]
  1000   C1279083:Radius [Body Part, Organ, or Organ Component]
  1000   C1306504:Radius [Quantitative Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "as"

Phrase: "being"

Phrase: "approximately twice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0332232:Approximately [Qualitative Concept]
   861   C1720725:Twice [Intellectual Product]
   861   C1948050:Twice [Quantitative Concept]

Phrase: "the average soma radius,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0034627:Radius [Body Part, Organ, or Organ Component]
   827   C1279083:Radius [Body Part, Organ, or Organ Component]
   827   C1306504:Radius [Quantitative Concept]

Phrase: "and"

Phrase: "such circles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1282913:Circle [Spatial Concept]
   966   C1551714:Circle [Population Group]

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the largest soma"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   861   C0599444:soma [Cell Component]
   861   C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   805 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]
   768 E C2986476:Somatic [Qualitative Concept]

Phrase: "and"

Phrase: "many of the GAD-puncta"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   814   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   778   C0061472:Glutamic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   778   C0523665:Glutamic Acid [Laboratory Procedure]
   748   C0001128:Acid [Chemical]
   748   C0007054:Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   748   C0202406:Acid [Laboratory Procedure]
   748   C0439064:Many [Quantitative Concept]
   748   C0747726:many [Conceptual Entity]
   714   C1500338:Punctum [Eukaryote]

Phrase: "seen on thin neurites"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   770   C0085103:Neurites [Cell Component]
   770   C0205168:Thin [Qualitative Concept]
   770   C0205397:Seen [Qualitative Concept]
   737 E C0042789:see [Organism Function]
   737 E C1947903:See [Activity]

Phrase: "around the soma."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0599444:soma [Cell Component]
  1000   C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   944 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]
   907 E C2986476:Somatic [Qualitative Concept]
Processing 00000000.tx.77: To normalize for bias in each image, the values were divided by the average value obtained from four non-transfected neurons that happened to be present at the corners of the image. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "normalize for bias"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0242568:Bias [Idea or Concept]
   790   C1504315:Bias [Bird]
   790   C1882115:Normalize [Research Activity]
   756 E C1061346:Bia [Eukaryote]
   756 E C1704746:BIA [Diagnostic Procedure]

Phrase: "in each image,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1704254:Image [Intellectual Product]
  1000   C1704922:Image [Entity]
  1000   C3542466:Image [Intellectual Product]

Phrase: "the values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0042295:Values [Qualitative Concept]
   966 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "divided by the average value"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0332849:Divided [Functional Concept]
   760   C1510992:Average [Quantitative Concept]
   760   C1522609:Value [Quantitative Concept]
   760   C2825518:AVERAGE [Quantitative Concept]

Phrase: "obtained from four non-transfected neurons"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0027882:Neurons [Cell]
   753   C0205450:Four [Quantitative Concept]
   753   C1301820:Obtained [Functional Concept]
   753   C1518422:Non [Functional Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "that"

Phrase: "happened"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1709305:Happened [Activity]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "present at the corners of the image."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]
Processing 00000000.tx.78: This method represented our best possible strategy for analyzing the terminals innervating neurons with no hrGFP, partly because we had previously confirmed that soma size and GAD level had no correlation (r2 = 0.03 for BDNF neurons and 0.09 for interposed neurons). 

Phrase: "This method"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0025663:Method [Intellectual Product]
  1000   C0449851:Method [Functional Concept]
  1000   C0871511:METHOD [Intellectual Product]

Phrase: "represented"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1882932:Represent [Activity]

Phrase: "our best possible strategy for analyzing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0679199:strategy [Mental Process]

Phrase: "the terminals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0205088:Terminal [Temporal Concept]
   966   C1705314:Terminal [Manufactured Object]
   966   C1705315:Terminal [Spatial Concept]

Phrase: "innervating"

Phrase: "neurons with no hrGFP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0027882:Neurons [Cell]

Phrase: "partly"

Phrase: "because"

Phrase: "we"

Phrase: "had"

Phrase: "previously"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that soma size"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0456389:size [Spatial Concept]

Phrase: "and"

Phrase: "GAD level"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   812   C0441889:Level [Qualitative Concept]
   812   C0456079:Level [Classification]
   812   C1547707:Level [Geographic Area]
   812   C2946261:Level [Pharmacologic Substance]
   756   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "had"

Phrase: "no correlation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707520:Correlation [Qualitative Concept]

Phrase: "(r2"

Phrase: "= 0.03 for BDNF neurons"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   833   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   811   C1826397:NEURON-DERIVED NEUROTROPHIC FACTOR [Gene or Genome]
   811   C3472710:neuron-derived neurotrophic factor [Gene or Genome]
   770   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   770   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   744   C0006104:Brain [Body Part, Organ, or Organ Component]
   744   C0027882:Neurons [Cell]
   744   C1269537:Brain [Body Part, Organ, or Organ Component]
   744   C1441547:Derived [Qualitative Concept]
   744   C1521761:Factor [Functional Concept]
   744   C2827422:Factor [Conceptual Entity]
   744   C3245521:derived [Idea or Concept]

Phrase: "and"

Phrase: "0.09 for interposed neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027882:Neurons [Cell]

Phrase: ")."
Processing 00000000.tx.79: Secondly, to determine the effects of bath-applied BDNF with or without drug treatments, the average overall fluorescence intensity (0255) of 10 randomly selected fields (10 x 0.34 x 0.34 mm2) in each well (as in Fig. 3B) was normalized with respect to the values of sister cultures that were not treated with BDNF. 

Phrase: "Secondly,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205436:Secondly [Quantitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the effects of bath-applied BDNF"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "with"

Phrase: "or without drug treatments,"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   770   C0013227:Drug [Pharmacologic Substance]
   770   C0087111:Treatments [Therapeutic or Preventive Procedure]
   770   C1254351:Drug [Pharmacologic Substance]
   737 E C0039798:treatment [Functional Concept]
   737 E C1522326:Treatment [Functional Concept]
   737 E C1533734:Treatment [Therapeutic or Preventive Procedure]
   737 E C1705169:Treatment [Conceptual Entity]
   737 E C3538994:TREATMENT [Research Activity]
   715 E C0031336:Pharmaceutical [Biomedical Occupation or Discipline]
   715 E C1135440:pharmaceutical [Therapeutic or Preventive Procedure]

Phrase: "the average overall fluorescence intensity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0016315:Fluorescence [Natural Phenomenon or Process]
   812   C0522510:Intensity [Qualitative Concept]
   741 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(0255"

Phrase: ")"

Phrase: "of 10 randomly selected fields"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   779   C0440042:Field's [Indicator, Reagent, or Diagnostic Aid]
   779   C1521738:Field [Conceptual Entity]
   779   C2346620:Field [Conceptual Entity]
   779   C2349184:Field [Conceptual Entity]
   779   C3539073:FIELD [Spatial Concept]

Phrase: "(10 x 0.34 x 0.34 mm2)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C0456786:mm2 [Quantitative Concept]

Phrase: "in each well"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205170:Well [Qualitative Concept]
  1000   C3146287:Well [Manufactured Object]

Phrase: "("

Phrase: "as in Fig. 3B"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0349966:Fig [Food]
   770   C0450365:3b [Intellectual Product]
   770   C1337208:FIG [Food]
   770   C1706097:3B [Research Activity]

Phrase: ")"

Phrase: "was"

Phrase: "normalized with respect to the values of sister"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   744   C0042295:Values [Qualitative Concept]
   744   C0337514:Sister [Family Group]
   744   C0679133:respect [Social Behavior]
   744   C1882115:Normalized [Research Activity]
   711 E C1522609:Value [Quantitative Concept]

Phrase: "cultures"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "that"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "treated with BDNF."
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   882   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   882   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   790   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   790   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   790   C0332293:Treated with [Therapeutic or Preventive Procedure]
           treated
   790   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   753   C0006104:Brain [Body Part, Organ, or Organ Component]
   753   C1269537:Brain [Body Part, Organ, or Organ Component]
   753   C1441547:Derived [Qualitative Concept]
   753   C1521761:Factor [Functional Concept]
   753   C1522326:Treated [Functional Concept]
   753   C2827422:Factor [Conceptual Entity]
   753   C3245521:derived [Idea or Concept]
   719 E C1292734:TREAT [Functional Concept]
Processing 00000000.tx.80: For each experiment, we obtained results from 69 wells, and each experiment was performed at least in triplicate. 

Phrase: "For each experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "we"

Phrase: "obtained"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C1301820:Obtained [Functional Concept]
   966 E C1706701:Obtain [Activity]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442805:Increase [Functional Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "results from 69 wells,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   737   C1274040:Result [Functional Concept]
   737   C1546471:Result [Idea or Concept]
   737   C2825142:Result [Finding]

Phrase: "and"

Phrase: "each experiment"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "was"

Phrase: "performed at least"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0884358:Performed [Functional Concept]
   756 E C2947996:Perform [Pharmacologic Substance]

Phrase: "in triplicate."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205174:Triplicate [Quantitative Concept]
Processing 00000000.tx.81: View larger version (42K): [in this window] [in a new window]  Figure 3. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(42K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 3."
Processing 00000000.tx.82: Exogenous BDNF increases the GAD65 level independently of neurotransmission. 

Phrase: "Exogenous BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   937   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   840   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   840   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]
   804   C1441547:Derived [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   804   C3245521:derived [Idea or Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the GAD65 level independently of neurotransmission."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0441889:Level [Qualitative Concept]
   742   C0456079:Level [Classification]
   742   C1547707:Level [Geographic Area]
   742   C2946261:Level [Pharmacologic Substance]
Processing 00000000.tx.83: (A) The BDNF-induced increase in GAD65 immunofluorescence intensity was quantified and is shown as a ratio to the value from cultures without BDNF. 

Phrase: "(A)"

Phrase: "The BDNF-induced increase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0442805:Increase [Functional Concept]
   734   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "in GAD65 immunofluorescence intensity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C0522510:Intensity [Qualitative Concept]
   734   C2825893:Glutamic Acid Decarboxylase 65 [Laboratory Procedure]

Phrase: "was"

Phrase: "quantified"

Phrase: "and"

Phrase: "is"

Phrase: "shown as a ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0456603:Ratio [Quantitative Concept]
   770   C1547037:Ratio [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: "to the value"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522609:Value [Quantitative Concept]

Phrase: "from cultures"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0010453:Cultures [Idea or Concept]
   966 E C0220814:culture [Functional Concept]
   966 E C0430400:Culture [Laboratory Procedure]
   966 E C2242979:Culture [Laboratory Procedure]

Phrase: "without BDNF."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]
Processing 00000000.tx.84: The level was not influenced by treatment with: tetrodotoxin (TTX), which blocks action potentials; 

Phrase: "The level"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0441889:Level [Qualitative Concept]
  1000   C0456079:Level [Classification]
  1000   C1547707:Level [Geographic Area]
  1000   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "influenced by treatment"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "with"

Phrase: ":"

Phrase: "tetrodotoxin (TTX),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039705:Tetrodotoxin [Biologically Active Substance,Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "which"

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "action potentials"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0001272:Action Potentials [Cell Function]
   861   C0441472:Action [Functional Concept]
   861   C3245505:potentials [Qualitative Concept]
   861   C3266814:Action [Activity]

Phrase: ";"
Processing 00000000.tx.85: a mixture of the glutamate receptor antagonists AP5, CNQX and MCPG (GluRs antagonists); 

Phrase: "a mixture of the glutamate receptor antagonists AP5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0439962:Mixture [Substance]

Phrase: "CNQX"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0099122:CNQX [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "MCPG"

Phrase: "(GluRs antagonists"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0243076:antagonists [Chemical Viewed Functionally]
   827 E C0231491:Antagonist [Organ or Tissue Function]
   755 E C0680242:antagonism [Social Behavior]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.86: the GABAA antagonist picrotoxin (Picro); 

Phrase: "the GABAA antagonist picrotoxin (Picro)"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0031890:Picrotoxin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: ";"
Processing 00000000.tx.87: or the GABAB antagonist saclofen (Sac), each applied 30 min prior to the BDNF treatment. 

Phrase: "or"

Phrase: "the GABAB antagonist saclofen (Sac),"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0215145:saclofen [Organic Chemical,Pharmacologic Substance]

Phrase: "each"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "30 min prior to the BDNF treatment."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0456693:/30 min [Temporal Concept]
   760   C1442458:30 min [Temporal Concept]
   739   C0702093:/min [Temporal Concept]
Processing 00000000.tx.88: The ratios are: BDNF only, 1.6  0.1 (n = 17 wells); 

Phrase: "The ratios"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0456603:Ratios [Quantitative Concept]
  1000   C1610540:*Ratios [Quantitative Concept]
   966 E C1547037:Ratio [Intellectual Product]

Phrase: "are"

Phrase: ":"

Phrase: "BDNF only,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   937   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   840   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   840   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]
   804   C1441547:Derived [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   804   C3245521:derived [Idea or Concept]

Phrase: "1.6  0.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "(n = 17 wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0205170:Well [Qualitative Concept]
   793   C3146287:Well [Manufactured Object]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.89: + TTX, 1.6  0.1 (n = 8); 

Phrase: "+ TTX,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039705:Tetrodotoxin [Biologically Active Substance,Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "1.6  0.1"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "(n = 8"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.90: + GluRs antagonists, 1.7  0.1 (n = 7); 

Phrase: "+ GluRs antagonists,"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0243076:antagonists [Chemical Viewed Functionally]
   827 E C0231491:Antagonist [Organ or Tissue Function]
   755 E C0680242:antagonism [Social Behavior]

Phrase: "1.7  0.1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C3541329:1-7 [Gene or Genome]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "(n = 7"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.91: + Pic, 1.7  0.1 (n = 6); 

Phrase: "+ Pic,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0014878:Pike [Fish]
  1000   C0522667:Pike [Manufactured Object]
  1000   C0730321:PIC [Disease or Syndrome]

Phrase: "1.7  0.1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C3541329:1-7 [Gene or Genome]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "(n = 6"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.92: and + Sac, 1.5  0.1 (n = 9). 

Phrase: "and +"

Phrase: "Sac,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0215145:saclofen [Organic Chemical,Pharmacologic Substance]

Phrase: "1.5  0.1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0450316:1/5 [Quantitative Concept]
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "(n = 9"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.93: There are no significant differences among these ratios. 

Phrase: "There"

Phrase: "are"

Phrase: "no significant differences among these ratios."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   719   C1705241:*Difference [Quantitative Concept]
   719   C1705242:Difference [Qualitative Concept]
Processing 00000000.tx.94: (B) DIC images and corresponding immunofluorescent images of GAD65 (green) on hippocampal neurons cultured in the absence or presence of 10 ng/ml BDNF for 48 h from 7 days in vitro. 

Phrase: "(B) DIC images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1704254:Image [Intellectual Product]
   793   C1704922:Image [Entity]
   793   C3542466:Image [Intellectual Product]

Phrase: "and"

Phrase: "corresponding immunofluorescent images of GAD65"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   711   C1704254:Image [Intellectual Product]
   711   C1704922:Image [Entity]
   711   C3542466:Image [Intellectual Product]

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")"

Phrase: "on hippocampal neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "cultured in the absence"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0332197:absence [Quantitative Concept]
   770   C1689985:Absence [Anatomical Abnormality]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "or"

Phrase: "presence of 10 ng/ml BDNF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0392148:Presence [Therapeutic or Preventive Procedure]

Phrase: "for 48 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "from 7 days in vitro."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0021135:In Vitro [Intellectual Product]
   861   C1533691:in vitro [Qualitative Concept]
           vitro
   861   C1547085:7 days [Temporal Concept]
   861   C2827718:In Vitro [Functional Concept]
   812   C0439228:days [Temporal Concept]
   779 E C0332173:/day [Temporal Concept]
   779 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.95: Scale bar, 40 m.  

Phrase: "Scale bar,"

Phrase: "40 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.96: Finally, during analyses on tTrkB-hrGFP- or control lacZ-hrGFP-expressing neurons, regions labeled with hrGFP (areas in images inside the cDNA-expressing neurons and very close surrounding regions) were clipped out, and the GAD image present inside was extracted. 

Phrase: "Finally,"

Phrase: "during analyses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0002778:Analysis [Laboratory Procedure]
   966   C0936012:Analysis [Research Activity]
   966   C1524024:analysis [Functional Concept]

Phrase: "on tTrkB-hrGFP-"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   801   C0997916:Renilla reniformis [Eukaryote]
   792   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   788   C0016315:Fluorescence [Natural Phenomenon or Process]
   788   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   788   C0332583:Green [Qualitative Concept]
   788   C0348078:Form [Qualitative Concept]
   788   C0376315:Form [Manufactured Object]
   788   C1093003:Renilla [Eukaryote]
   788   C1522492:Form [Functional Concept]
   788   C1720176:On [Functional Concept]
   788   C1720294:On [Intellectual Product]
   717 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "or"

Phrase: "control lacZ-hrGFP-expressing neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0027882:Neurons [Cell]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   966   C0017446:Region [Geographic Area]
   966   C0205147:Region [Spatial Concept]
   916 E C0205276:Regional [Spatial Concept]
   916 E C1947913:Regional [Spatial Concept]

Phrase: "labeled with hrGFP"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   776   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   770   C0997916:Renilla reniformis [Eukaryote]
   744   C0016315:Fluorescence [Natural Phenomenon or Process]
   744   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   744   C0332583:Green [Qualitative Concept]
   744   C1093003:Renilla [Eukaryote]
   744   C1708632:Labeled [Qualitative Concept]
   711 E C0181496:Label [Manufactured Object]
   711 E C2827499:Label [Governmental or Regulatory Activity]

Phrase: "(areas in images"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0205146:areas [Spatial Concept]
   756 E C0017446:Area [Geographic Area]

Phrase: "inside the cDNA-expressing neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "very close surrounding regions"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   779   C0017446:Region [Geographic Area]
   779   C0205147:Region [Spatial Concept]
   729 E C0205276:Regional [Spatial Concept]
   729 E C1947913:Regional [Spatial Concept]

Phrase: ")"

Phrase: "were"

Phrase: "clipped"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0175722:Clip [Medical Device]
   966   C1705205:Clip [Medical Device]

Phrase: "out,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0439787:Out [Spatial Concept]
  1000   C0849355:Out [Qualitative Concept]

Phrase: "and"

Phrase: "the GAD image present inside"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150312:Present [Quantitative Concept]
   748   C0449450:Present [Idea or Concept]

Phrase: "was"

Phrase: "extracted."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0185115:Extracted [Therapeutic or Preventive Procedure]
  1000   C3541890:EXTRACTED [Finding]
   966 E C2828366:Extract [Substance]
Processing 00000000.tx.97: For the clipping, pixels with intensity over 50 in 8-bit hrGFP images (taken with an 8 s exposure) were assigned as 1, while the remainder were assigned as 0, and the resultant digitized images were then multiplied to the GAD65 image. 

Phrase: "For the clipping, pixels"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1709558:Pixel [Conceptual Entity]

Phrase: "with intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0522510:Intensity [Qualitative Concept]

Phrase: "over 50"

Phrase: "in 8-bit hrGFP images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   758   C1704254:Image [Intellectual Product]
   758   C1704922:Image [Entity]
   758   C3542466:Image [Intellectual Product]

Phrase: "("

Phrase: "taken with an 8 s exposure"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   753   C0274281:Exposure, NOS [Injury or Poisoning]
   753   C0332157:Exposure [Clinical Attribute]
   753   C1883727:Taken [Conceptual Entity]
   719 E C1515187:Take [Health Care Activity]

Phrase: ")"

Phrase: "were"

Phrase: "assigned as 1,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1516050:Assigned [Functional Concept]
   790   C1552601:assigned [Intellectual Product]

Phrase: "while"

Phrase: "the remainder"

Phrase: "were"

Phrase: "assigned as 0,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C1516050:Assigned [Functional Concept]
   790   C1552601:assigned [Intellectual Product]

Phrase: "and"

Phrase: "the resultant digitized images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   793   C1704254:Image [Intellectual Product]
   793   C1704922:Image [Entity]
   793   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "multiplied to the GAD65 image."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C2825893:Glutamic Acid Decarboxylase 65 [Laboratory Procedure]
   800   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   770   C0061472:Glutamic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   770   C0523665:Glutamic Acid [Laboratory Procedure]
   744   C0001128:Acid [Chemical]
   744   C0007054:Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0202406:Acid [Laboratory Procedure]
   744   C0450385:65 [Intellectual Product]
   744   C1704254:Image [Intellectual Product]
   744   C1704922:Image [Entity]
   744   C3542466:Image [Intellectual Product]
   711   C1719797:Multiply [Functional Concept]
   711   C2911648:Multiply [Quantitative Concept]
Processing 00000000.tx.98: The extracted GAD signals were quantified as the average intensity. 

Phrase: "The extracted GAD signals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C1710082:Signal [Phenomenon or Process]
   717   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "quantified as the average intensity."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0522510:Intensity [Qualitative Concept]
   760   C1510992:Average [Quantitative Concept]
   760   C2825518:AVERAGE [Quantitative Concept]
   726   C1709793:Quantify [Quantitative Concept]
Processing 00000000.tx.99: Nuclear Fos immunoreactivity was measured by drawing a circle of radius 2.5 m at the center of the nuclei (Hoechst-stained areas). 

Phrase: "Nuclear Fos immunoreactivity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0597879:immunoreactivity [Molecular Function]

Phrase: "was"

Phrase: "measured by drawing"
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
   790   C0013113:drawing [Intellectual Product]
   790   C0444706:Measured [Qualitative Concept]
   790   C3541902:MEASURED [Diagnostic Procedure]
   756 E C0079809:Measure [Quantitative Concept]
   756 E C0242485:Measure [Functional Concept]

Phrase: "a circle of radius 2.5 m"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1282913:Circle [Spatial Concept]
   748   C1551714:Circle [Population Group]

Phrase: "at the center"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205099:Center [Spatial Concept]

Phrase: "of the nuclei"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0007610:Nucleus [Cell Component]

Phrase: "(Hoechst-stained areas"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   827   C0205146:areas [Spatial Concept]
   793 E C0017446:Area [Geographic Area]
   717   C1441607:Hoechst stain [Laboratory Procedure]

Phrase: ")."
Processing 00000000.tx.100: This radius was determined to be half of the average radius of the nucleus. 

Phrase: "This radius"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0034627:Radius [Body Part, Organ, or Organ Component]
  1000   C1279083:Radius [Body Part, Organ, or Organ Component]
  1000   C1306504:Radius [Quantitative Concept]

Phrase: "was"

Phrase: "determined"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "half of the average radius of the nucleus."
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   744   C0007610:Nucleus [Cell Component]
   744   C0034627:Radius [Body Part, Organ, or Organ Component]
   744   C1279083:Radius [Body Part, Organ, or Organ Component]
   744   C1306504:Radius [Quantitative Concept]
   744   C1510992:Average [Quantitative Concept]
   744   C2825407:Half [Quantitative Concept]
   744   C2825518:AVERAGE [Quantitative Concept]
Processing 00000000.tx.101: It was large enough to obtain stable values for any part of the nucleus and still small enough to be included in the smallest nucleus. 

Phrase: "It"

Phrase: "was"

Phrase: "large enough to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0549177:Large [Quantitative Concept]

Phrase: "obtain"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C1301820:Obtain [Functional Concept]
  1000   C1706701:Obtain [Activity]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442805:Increase [Functional Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "stable values for any part of the nucleus"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0042295:Values [Qualitative Concept]
   711 E C1522609:Value [Quantitative Concept]

Phrase: "and"

Phrase: "still small enough to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0700321:Small [Quantitative Concept]

Phrase: "be"

Phrase: "included in the smallest nucleus."
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   760   C0007610:Nucleus [Cell Component]
   760   C0332257:included [Functional Concept]
   760   C2700395:Smallest [Quantitative Concept]
   760   C3538986:INCLUDED [Gene or Genome]
   726 E C0700321:Small [Quantitative Concept]
   726 E C1552866:include [Idea or Concept]
   726 E C2700399:Include [Activity]
Processing 00000000.tx.102: Electrophysiology Whole cell patch-clamp recordings were performed in transfected neurons as previously described (Bolton et al., 2000). 

Phrase: "Electrophysiology Whole cell patch-clamp recordings"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   885   C0242624:Whole-Cell Recordings [Research Activity]

Phrase: "were"

Phrase: "performed in transfected neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   770   C0027882:Neurons [Cell]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]

Phrase: "as"

Phrase: "previously"

Phrase: "described"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1552738:described [Idea or Concept]

Phrase: "(Bolton et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.103: HrGFP-expressing cells were selected under an Olympus BX50WI fluorescence microscope. 

Phrase: "HrGFP-expressing cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   827   C0007634:Cells [Cell]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "selected under an Olympus BX50WI fluorescence microscope."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0016315:Fluorescence [Natural Phenomenon or Process]
   748   C0181839:Microscope [Medical Device]
   748   C1706379:Microscope [Medical Device]
   714   C1707391:Select [Activity]
Processing 00000000.tx.104: For recording GABAA receptor-mediated synaptic currents, we used an extracellular solution consisting of 137 mM NaCl, 5.4 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 5 mM HEPES (pH 7.4), 20 M CNQX (Sigma) and 50 M AP5 (Sigma), with or without 2 M TTX, as well as an intracellular solution consisting of 140 mM CsCl, 0.2 mM CaCl2, 2 mM EGTA, 4 mM MgATP, 5 mM QX314 and 5 mM HEPES (pH 7.2). 

Phrase: "For recording GABAA receptor-mediated synaptic currents,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   799   C0521116:currents [Temporal Concept]
   766 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "we"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "an extracellular solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "consisting of 137 mM NaCl,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0037494:NaCl [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   760   C1959973:% NaCl [Quantitative Concept]
   726   C0332529:CONSIST [Qualitative Concept]

Phrase: "5.4 mM KCl,"

Phrase: "1.8 mM CaCl2,"

Phrase: "1 mM MgCl2,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024472:MgCl2 [Inorganic Chemical,Pharmacologic Substance]

Phrase: "5 mM HEPES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(pH 7.4"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   913   C2678549:PH-4 [Gene or Genome]
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")"

Phrase: ","

Phrase: "20 M CNQX"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0099122:CNQX [Organic Chemical,Pharmacologic Substance]

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: "and"

Phrase: "50 M AP5"

Phrase: "(Sigma"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1719918:Sigma [Intellectual Product]

Phrase: ")"

Phrase: ","

Phrase: "with"

Phrase: "or without 2 M TTX,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0039705:Tetrodotoxin [Biologically Active Substance,Hazardous or Poisonous Substance,Organic Chemical]
   760   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   760   C0441923:M+ [Intellectual Product]

Phrase: "as well as"

Phrase: "an intracellular solution"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037633:Solution [Substance]
   861   C0525069:Solution [Biomedical or Dental Material]

Phrase: "consisting of 140 mM CsCl,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0055134:CsCl [Inorganic Chemical,Pharmacologic Substance]
   726   C0332529:CONSIST [Qualitative Concept]

Phrase: "0.2 mM CaCl2,"

Phrase: "2 mM EGTA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0013714:EGTA [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "4 mM MgATP,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0024471:MgATP [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "5 mM QX314"

Phrase: "and"

Phrase: "5 mM HEPES"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0019215:HEPES [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]

Phrase: "(pH 7.2"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C1882074:pH 7 [Qualitative Concept]
   827   C0020283:[pH] [Quantitative Concept]
   827   C0450407:ph+ [Finding]
   827   C0450408:ph++ [Finding]
   827   C0450409:ph+++ [Finding]

Phrase: ")."
Processing 00000000.tx.105: Cells were held in a voltage clamp mode at a potential of 70 mV. 

Phrase: "Cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "were"

Phrase: "held in a voltage clamp mode"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   790   C0872303:voltage clamp [Research Activity]
   753   C0175721:Clamp [Medical Device]
   753   C0598352:Voltage [Quantitative Concept]
   753   C1513371:Mode [Functional Concept]
   753   C1705738:Mode [Quantitative Concept]
   753   C1705942:Clamp [Manufactured Object]
   753   C1883710:Clamp [Functional Concept]
   753   C1948036:held [Idea or Concept]
   753   C2347637:Mode [Quantitative Concept]
   753   C2348146:Mode [Quantitative Concept]
   753   C2987518:hELD [Amino Acid, Peptide, or Protein]
   719 E C1553387:Hold [Idea or Concept]
   719 E C1948035:Hold [Activity]

Phrase: "at a potential"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3245505:Potential [Qualitative Concept]

Phrase: "of 70 mV."
Processing 00000000.tx.106: Signals were recorded with an AXOPATCH 200B amplifier (Axon Instruments) with clamp-ex and clamp-fit, digitized by a DIGIDATA 1321A (Axon Instruments) at 10 kHz sampling frequency, filtered at 1 kHz and then analyzed with Igor software (Wave Metric Inc.).  

Phrase: "Signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1710082:Signal [Phenomenon or Process]

Phrase: "were"

Phrase: "recorded with an AXOPATCH 200B amplifier"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0002684:amplifier [Manufactured Object]
   753   C1706099:Amplifier [Manufactured Object]
   719   C0034869:Record [Intellectual Product]

Phrase: "(Axon Instruments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0348000:instruments [Medical Device]

Phrase: ")"

Phrase: "with clamp-ex"

Phrase: "and"

Phrase: "clamp-fit,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0036572:Fit [Sign or Symptom]
   861   C0424576:Fit [Finding]
   861   C2349186:Fit [Activity]

Phrase: "digitized by a DIGIDATA 1321A"

Phrase: "(Axon Instruments"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0348000:instruments [Medical Device]

Phrase: ")"

Phrase: "at 10 kHz sampling frequency,"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0376249:frequency [Quantitative Concept]
   812   C0439603:Frequency [Temporal Concept]
   812   C0871396:Frequency [Quantitative Concept]
   812   C1561548:Frequency [Qualitative Concept]
   812   C1705502:Frequency [Quantitative Concept]
   741 E C0332183:Frequent [Temporal Concept]

Phrase: "filtered"
Meta Candidates (Total=11; Excluded=5; Pruned=0; Remaining=6)
   966   C0180860:Filter [Manufactured Object]
   966   C0581406:Filter [Medical Device]
   966   C1522664:Filter [Intellectual Product]
   966   C1704449:Filter [Conceptual Entity]
   966   C1704684:Filter [Medical Device]
   966   C1875155:FILTER [Medical Device]
   928 E C0080194:Strain [Injury or Poisoning]
   928 E C0442694:Straining [Physiologic Function]
   928 E C0456178:strain [Intellectual Product]
   928 E C1518614:Strain [Organism]
   928 E C2987481:Strain [Mental Process]

Phrase: "at 1 kHz"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0556965:kHz [Quantitative Concept]
   734   C1412113:AT-1 [Gene or Genome]

Phrase: "and"

Phrase: "then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "analyzed with Igor software"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0037585:Software [Intellectual Product,Manufactured Object]
   770   C0936012:Analyzed [Research Activity]

Phrase: "(Wave Metric"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0699680:Metric [Organic Chemical,Pharmacologic Substance]

Phrase: "Inc."

Phrase: ")."
Processing 00000000.tx.107: Results Top Abstract Introduction Materials and Methods Results Discussion References  Selective Increases in GAD65 in Terminals on BDNF-overexpressing Neurons BDNF has been shown to have highly reproducible effects, both in vitro and in vivo, on increasing the expression level of GAD, which is the rate-limiting enzyme in the synthesis of GABA (Huang et al., 1999; Marty et al., 2000; Yamada et al., 2002). 

Phrase: "Results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Selective Increases in GAD65"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:increases [Functional Concept]

Phrase: "in Terminals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0205088:Terminal [Temporal Concept]
   966   C1705314:Terminal [Manufactured Object]
   966   C1705315:Terminal [Spatial Concept]

Phrase: "on BDNF-overexpressing Neurons BDNF"

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "have"

Phrase: "highly reproducible effects,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C1280500:effects [Qualitative Concept]
   793 E C2348382:Effect [Qualitative Concept]

Phrase: "both in vitro"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]

Phrase: "and"

Phrase: "in vivo,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo

Phrase: "on increasing"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442808:Increasing [Functional Concept]
   966 E C0442805:Increase [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0205217:Increased [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the expression level of GAD,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   778   C3244092:expression level [Idea or Concept]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "which"

Phrase: "is"

Phrase: "the rate-limiting enzyme in the synthesis of GABA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0014442:Enzyme [Enzyme,Organic Chemical]
   726   C0597548:synthetic enzyme [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(Huang et al.,"

Phrase: "1999"

Phrase: "; Marty et al.,"

Phrase: "2000"

Phrase: "; Yamada et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.108: However, it is unclear whether this effect is selective among the target neurons. 

Phrase: "However,"

Phrase: "it"

Phrase: "is"

Phrase: "unclear"

Phrase: "whether"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "is"

Phrase: "selective among the target neurons."
Processing 00000000.tx.109: We analyzed this issue by detecting GAD65, a major subtype of GAD distributed predominantly in the presynaptic terminals of GABAergic synapses (Kaufman et al., 1991). 

Phrase: "We"

Phrase: "analyzed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]

Phrase: "this issue by detecting GAD65,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0033213:Issue [Finding]
   744   C1706387:Issue [Intellectual Product]

Phrase: "a major subtype of GAD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0449560:Subtype [Classification]

Phrase: "distributed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1704711:Distributed [Functional Concept]

Phrase: "predominantly in the presynaptic terminals of GABAergic synapses"
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   770   C0206181:Presynaptic Terminals [Cell Component]
           Synaptic Terminals
   744   C0039062:Synapses [Body Space or Junction]
   711   C0205088:Terminal [Temporal Concept]
   711 E C0598501:Synapsis [Cell Function]
   711 E C1633000:Synapsis [Plant]
   711   C1705314:Terminal [Manufactured Object]
   711   C1705315:Terminal [Spatial Concept]

Phrase: "(Kaufman et al.,"

Phrase: "1991"

Phrase: ")."
Processing 00000000.tx.110: In order to develop a model for neurons that strongly express BDNF, we transfected hippocampal cells with BDNF cDNA. 

Phrase: "In order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "develop"

Phrase: "a model for neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C3161035:Model [Intellectual Product]

Phrase: "that strongly"

Phrase: "express"

Phrase: "BDNF,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "we"

Phrase: "transfected"

Phrase: "hippocampal cells with BDNF cDNA."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   767   C0596208:brain cells [Cell]
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.111: The rate of expression was intentionally lowered to <1% of the population of neurons in order to mimic the activity-dependent expression of BDNF in vivo. 

Phrase: "The rate of expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0871208:Rate [Activity]
   770   C1521828:Rate [Quantitative Concept]

Phrase: "was"

Phrase: "intentionally"

Phrase: "lowered"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0441994:lowered [Spatial Concept]
  1000   C1272755:Lowered [Quantitative Concept]
  1000   C2003888:Lowered [Activity]
   966 E C1548802:Lower [Body Location or Region]

Phrase: "to <1% of the population of neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0027882:Neurons [Cell]
   748   C0032659:Population [Quantitative Concept]
   748   C1257890:Population [Population Group]
   748   C1883351:To [Qualitative Concept]

Phrase: "in order to"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   861   C1705175:Order [Intellectual Product]
   861   C1705176:Order [Qualitative Concept]
   861   C1705177:Order [Classification]
   861   C1705178:Order [Activity]
   861   C1882348:Order [Qualitative Concept]

Phrase: "mimic"

Phrase: "the activity-dependent expression of BDNF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.112: This was done because it has been reported that the increased expression of BDNF during learning has been detected in only 5% of the population of neurons in a part of the monkey cortex (Tokuyama et al., 2000). 

Phrase: "This"

Phrase: "was"

Phrase: "done"

Phrase: "because"

Phrase: "it"

Phrase: "has"

Phrase: "been"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "that"

Phrase: "the increased expression of BDNF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "during learning"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013621:learning [Educational Activity]
  1000   C0023185:Learning [Mental Process]

Phrase: "has"

Phrase: "been"

Phrase: "detected in only 5% of the population of neurons"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   742   C0027882:Neurons [Cell]
   742   C0032659:Population [Quantitative Concept]
   742   C0205171:Only [Quantitative Concept]
   742   C0442726:Detected [Finding]
   742   C1257890:Population [Population Group]
   742   C1511790:Detected [Therapeutic or Preventive Procedure]
   742   C1720467:Only [Intellectual Product]

Phrase: "in a part"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0449719:Part [Spatial Concept]
  1000   C1709471:Part [Quantitative Concept]

Phrase: "of the monkey cortex"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0007776:Cortex [Body Part, Organ, or Organ Component]
   861   C1176472:Cortex [Body Part, Organ, or Organ Component]
   861   C2700441:Cortex [Plant]

Phrase: "(Tokuyama et al.,"

Phrase: "2000"

Phrase: ")."
Processing 00000000.tx.113: As a result, 48 h after transfection, the immunocytochemical punctate stainings of GAD65 were selectively larger and brighter around the BDNF-overexpressing neurons (Fig. 1A, red). 

Phrase: "As a result,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "48 h after transfection,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]

Phrase: "the immunocytochemical punctate stainings of GAD65"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0487602:Stainings [Laboratory Procedure]
   708 E C1704680:Staining [Finding]

Phrase: "were"

Phrase: "selectively larger"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0443228:larger [Quantitative Concept]
   861   C0549177:Larger [Quantitative Concept]
   861   C1704243:Larger [Quantitative Concept]

Phrase: "and"

Phrase: "brighter around the BDNF-overexpressing neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   708   C0423899:Bright [Finding]
   708   C3539536:BRIGHT [Gene or Genome]

Phrase: "(Fig. 1A,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: "red"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.114: This enhancement was indistinct in the case of the other neighboring neurons. 

Phrase: "This enhancement"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1627358:Enhancement [Therapeutic or Preventive Procedure]
  1000   C2349975:Enhancement [Activity]

Phrase: "was"

Phrase: "indistinct in the case of the"

Phrase: "other neighboring neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.115: To evaluate the difference quantitatively, we defined control neurons as those neurons interposed between BDNF-overexpressing neurons and inhibitory neurons, within the same images. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the difference quantitatively,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C1705241:*Difference [Quantitative Concept]
   861   C1705242:Difference [Qualitative Concept]
   789 E C0443199:Differential [Qualitative Concept]

Phrase: "we"

Phrase: "defined"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1704788:Defined [Conceptual Entity]
  1000   C3539106:Defined [Intellectual Product]

Phrase: "control neurons as those neurons"

Phrase: "interposed"

Phrase: "between BDNF-overexpressing neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   795   C0027882:Neurons [Cell]
   712 E C0521390:Neuronal [Immunologic Factor]
   710   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "inhibitory neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "within the same images."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]
Processing 00000000.tx.116: While evaluating the analytical methods, we found that although they were not observed in the original image (Fig. 1A), several GAD puncta were present around the interposed neurons when the GAD intensity in the image was artificially enhanced (Fig. 1B). 

Phrase: "While"

Phrase: "evaluating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0220825:Evaluate [Functional Concept]

Phrase: "the analytical methods,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
  1000   C0178476:analytical methods [Intellectual Product]
   861   C0025663:Methods [Intellectual Product]
   861   C0025664:methods [Intellectual Product]
   861   C0449851:Methods [Functional Concept]
   827 E C0871511:METHOD [Intellectual Product]

Phrase: "we"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "that"

Phrase: "although"

Phrase: "they"

Phrase: "were"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "observed in the original image"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0205313:Original [Idea or Concept]
   760   C1441672:Observed [Functional Concept]
   760   C1704254:Image [Intellectual Product]
   760   C1704922:Image [Entity]
   760   C2347409:Original [Occupational Activity]
   760   C3542466:Image [Intellectual Product]

Phrase: "(Fig. 1A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450344:1A [Intellectual Product]
   861   C1553633:1a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "several GAD puncta"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C1500338:Punctum [Eukaryote]
   717   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "were"

Phrase: "present around the interposed neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0150312:Present [Quantitative Concept]
   760   C0449450:Present [Idea or Concept]

Phrase: "when"

Phrase: "the GAD intensity in the image"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0522510:Intensity [Qualitative Concept]

Phrase: "was"

Phrase: "artificially"

Phrase: "enhanced"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhanced [Activity]

Phrase: "(Fig. 1B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450345:1B [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.117: Thus, we decided to avoid methods that required setting a threshold value so as to ensure that the information from lower intensity staining was not neglected. 

Phrase: "Thus,"

Phrase: "we"

Phrase: "decided"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "avoid"

Phrase: "methods"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0025663:Methods [Intellectual Product]
  1000   C0025664:methods [Intellectual Product]
  1000   C0449851:Methods [Functional Concept]
   966 E C0871511:METHOD [Intellectual Product]

Phrase: "that"

Phrase: "required"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514873:Required [Functional Concept]

Phrase: "setting"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0542559:setting [Functional Concept]
  1000   C1318139:{Setting} [Quantitative Concept]
   966 E C0036849:Set [Mental Process]
   966 E C1442518:Set [Functional Concept]
   966 E C1705195:Set [Conceptual Entity]

Phrase: "a threshold value so as to"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0449864:Threshold [Qualitative Concept]
   753   C1522609:Value [Quantitative Concept]

Phrase: "ensure"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0218063:Ensure [Food]

Phrase: "that"

Phrase: "the information from lower intensity staining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1533716:Information [Idea or Concept]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "neglected."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0521874:neglected [Finding]
Processing 00000000.tx.118: Instead, the overall average intensity of GAD staining in an area was taken as an indicator of the amount of GAD in this study. 

Phrase: "Instead,"

Phrase: "the overall average intensity of GAD staining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0522510:Intensity [Qualitative Concept]

Phrase: "in an area"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0017446:Area [Geographic Area]
  1000   C0205146:Area [Spatial Concept]

Phrase: "was"

Phrase: "taken as an indicator of the amount of GAD"
Meta Candidates (Total=12; Excluded=1; Pruned=0; Remaining=11)
   775   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   756   C0061472:Glutamic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   756   C0523665:Glutamic Acid [Laboratory Procedure]
   738   C0001128:Acid [Chemical]
   738   C0007054:Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   738   C0021212:indicator [Indicator, Reagent, or Diagnostic Aid]
   738   C0202406:Acid [Laboratory Procedure]
   738   C1235732:Indicator [Bird]
   738   C1265611:Amount [Quantitative Concept]
   738   C1522602:Indicator [Functional Concept]
   738   C1883727:Taken [Conceptual Entity]
   704 E C1515187:Take [Health Care Activity]

Phrase: "in this study."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]
Processing 00000000.tx.119: GAD signals around neurons were enclosed by a circle of radius 17.5 m, as shown in Figure 1A, and the average intensities inside the circle were normalized by the average value obtained from four non-transfected neurons at the corners of the image. 

Phrase: "GAD"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0061472:Glutamic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0523665:Glutamic Acid [Laboratory Procedure]
   827   C0001128:Acid [Chemical]
   827   C0007054:Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "signals around neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0027882:Neurons [Cell]
   790   C1710082:Signal [Phenomenon or Process]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "were"

Phrase: "enclosed by a circle of radius 17.5 m,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   762   C1440942:M-5 [Immunologic Factor]
   742   C0034627:Radius [Body Part, Organ, or Organ Component]
   742   C0205380:Enclosed [Spatial Concept]
   742   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   742   C0441923:M+ [Intellectual Product]
   742   C1279083:Radius [Body Part, Organ, or Organ Component]
   742   C1282913:Circle [Spatial Concept]
   742   C1306504:Radius [Quantitative Concept]
   742   C1551714:Circle [Population Group]

Phrase: "as"

Phrase: "shown in Figure 1A,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0450344:1A [Intellectual Product]
   770   C1553633:1a [Medical Device]
   737   C1547282:Show [Intellectual Product]

Phrase: "and"

Phrase: "the average intensities inside the circle"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0522510:intensities [Qualitative Concept]

Phrase: "were"

Phrase: "normalized by the average value"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C1510992:Average [Quantitative Concept]
   760   C1522609:Value [Quantitative Concept]
   760   C1882115:Normalized [Research Activity]
   760   C2825518:AVERAGE [Quantitative Concept]

Phrase: "obtained from four non-transfected neurons"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   753   C0027882:Neurons [Cell]
   753   C0205450:Four [Quantitative Concept]
   753   C1301820:Obtained [Functional Concept]
   753   C1518422:Non [Functional Concept]
   719 E C1706701:Obtain [Activity]

Phrase: "at the corners"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C1879655:Corner - [Laboratory Procedure]
   966   C1879656:Corner + [Laboratory Procedure]

Phrase: "of the image."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1704254:Image [Intellectual Product]
  1000   C1704922:Image [Entity]
  1000   C3542466:Image [Intellectual Product]
Processing 00000000.tx.120: As a result, the level of GAD staining around BDNF-overexpressing neurons was increased to 2.08  0.13 (n = 120 neurons, P < 0.01), while that around the interposed neurons was 1.05  0.04 (n = 259) (Fig. 1C). 

Phrase: "As a result,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1274040:Result [Functional Concept]
  1000   C1546471:Result [Idea or Concept]
  1000   C2825142:Result [Finding]

Phrase: "the level of GAD staining"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "around BDNF-overexpressing neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0027882:Neurons [Cell]
   734   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   716 E C0521390:Neuronal [Immunologic Factor]

Phrase: "was"

Phrase: "increased to 2.08  0.13"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205217:Increased [Quantitative Concept]
   753   C0442805:Increased [Functional Concept]

Phrase: "(n = 120 neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: ")"

Phrase: ","

Phrase: "while"

Phrase: "that around the interposed neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027882:Neurons [Cell]

Phrase: "was"

Phrase: "1.05  0.04"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "(n = 259"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")"

Phrase: "(Fig. 1C"

Phrase: ")."
Processing 00000000.tx.121: Another control for transfection was taken using neurons carrying a larger plasmid, which included lacZ in the same vector, and these neurons showed no increase in GAD staining (1.02  0.11, n = 11). 

Phrase: "Another control for transfection"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "was"

Phrase: "taken"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1883727:Taken [Conceptual Entity]
   966 E C1515187:Take [Health Care Activity]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "carrying"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0206243:Carrying [Activity]
   966 E C0699809:carry [Finding]

Phrase: "a larger plasmid,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0032136:Plasmid [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "which"

Phrase: "included"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0332257:included [Functional Concept]
  1000   C3538986:INCLUDED [Gene or Genome]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "lacZ in the same vector,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0022959:LacZ [Gene or Genome]

Phrase: "and"

Phrase: "these neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "no increase in GAD staining"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "(1.02  0.11,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: "n = 11"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.122: This effect of BDNF-expression was completely inhibited by an inhibitor of TrkB receptor kinase, K252a (0.99  0.04 of control value, n = 51). 

Phrase: "This effect of BDNF-expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "completely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205197:Completely [Qualitative Concept]

Phrase: "inhibited by an inhibitor of TrkB receptor kinase,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0084873:Receptor, trkB [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   767   C1171350:Kinase Inhibitor [Pharmacologic Substance]
   767   C3537023:kinase inhibitor [Molecular Function]
   767   C3537035:kinase inhibitor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0311403:Inhibited [Qualitative Concept]
   744   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   744   C1999216:Inhibitor [Qualitative Concept]

Phrase: "K252a"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0124355:K252a [Organic Chemical,Pharmacologic Substance]

Phrase: "(0.99  0.04 of control value,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   748   C0243148:control [Qualitative Concept]
   748   C1522609:Value [Quantitative Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "n = 51"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.123: This increase cannot be attributed to the number of major neurites, because the average values are not significantly changed. 

Phrase: "This increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "cannot"

Phrase: "be"

Phrase: "attributed to the number of major neurites,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   748   C0085103:Neurites [Cell Component]
   748   C0205164:Major [Qualitative Concept]
   748   C0237753:*Number [Quantitative Concept]
   748   C0449788:Number [Quantitative Concept]
   714   C0449234:Attribute [Idea or Concept]
   714   C1704772:Attribute [Conceptual Entity]
   714   C1882133:Attribute [Qualitative Concept]

Phrase: "because"

Phrase: "the average values"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0042295:Values [Qualitative Concept]
   827 E C1522609:Value [Quantitative Concept]

Phrase: "are"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "changed."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392747:Changed [Functional Concept]
  1000   C0443172:Changed [Quantitative Concept]
   966 E C1705241:Change [Quantitative Concept]
Processing 00000000.tx.124: The values for primary neurites were 11  0.7 and 9.9  0.5, and those for secondary neurites were 3.6  0.2 and 3.1  0.7, for BDNF-overexpressing neurons and control neurons, respectively (n = 36). 

Phrase: "The values for primary neurites"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0042295:Values [Qualitative Concept]
   726 E C1522609:Value [Quantitative Concept]

Phrase: "were"

Phrase: "11  0.7"

Phrase: "and"

Phrase: "9.9  0.5,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0444499:0/5 [Quantitative Concept]

Phrase: "and"

Phrase: "those for secondary neurites"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0027627:secondary [Neoplastic Process]
   770   C0085103:Neurites [Cell Component]
   770   C0175668:Secondary [Temporal Concept]
   770   C0205436:Secondary [Quantitative Concept]

Phrase: "were"

Phrase: "3.6  0.2"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0442759:3 6 [Finding]
   812   C0439086:<3 [Quantitative Concept]
   812   C2827736:3+ [Quantitative Concept]
   812   C2981702:3+ [Classification]

Phrase: "and"

Phrase: "3.1  0.7,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0439086:<3 [Quantitative Concept]
   812   C2827736:3+ [Quantitative Concept]
   812   C2981702:3+ [Classification]

Phrase: "for BDNF-overexpressing neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0027882:Neurons [Cell]
   734   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   716 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "control neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "respectively"

Phrase: "(n = 36"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0369718:N NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441922:N+ [Intellectual Product]
   861   C1553036:[n] [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.125: It is most probable that the level of GAD enzyme present in the presynaptic terminals innervating the BDNF-overexpressing neurons was increased. 

Phrase: "It"

Phrase: "is"

Phrase: "most probable"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0033204:Probable [Quantitative Concept]
   861   C0332148:Probable [Qualitative Concept]

Phrase: "that"

Phrase: "the level of GAD enzyme present"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0014440:enzyme level [Laboratory Procedure]
   767   C1287349:Enzyme level [Laboratory or Test Result]
   744   C0441889:Level [Qualitative Concept]
   744   C0456079:Level [Classification]
   744   C1547707:Level [Geographic Area]
   744   C2946261:Level [Pharmacologic Substance]

Phrase: "in the presynaptic terminals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0206181:Presynaptic Terminals [Cell Component]
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]

Phrase: "innervating"

Phrase: "the BDNF-overexpressing neurons"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   799   C0027882:Neurons [Cell]
   734   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   716 E C0521390:Neuronal [Immunologic Factor]

Phrase: "was"

Phrase: "increased."
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.126: The BDNF-induced Increase in Presynaptic GAD65 is Significantly Attenuated by the Expression of Kinase-defective TrkB in the Postsynaptic Neurons The effect of BDNF on the GAD65 level was so local that there were two possible mechanisms: either BDNF acted directly on the GABAergic presynaptic terminals or it acted as an autocrine regulator of postsynaptic neurons, thereby activating GABAergic presynaptic terminals via another trans-synaptic retrograde signal. 

Phrase: "The BDNF-induced Increase"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   799   C0442805:Increase [Functional Concept]
   734   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "in Presynaptic GAD65"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   937   C2825893:Glutamic Acid Decarboxylase 65 [Laboratory Procedure]
   884   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0061472:Glutamic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0523665:Glutamic Acid [Laboratory Procedure]
   804   C0001128:Acid [Chemical]
   804   C0007054:Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0202406:Acid [Laboratory Procedure]
   804   C0450385:65 [Intellectual Product]

Phrase: "is"

Phrase: "Significantly"

Phrase: "Attenuated by the Expression of Kinase-defective TrkB"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]
   744   C0332161:Attenuated [Qualitative Concept]
   744   C0332452:Defective [Functional Concept]
   744   C0599946:Attenuated [Activity]

Phrase: "in the Postsynaptic Neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "The effect of BDNF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on the GAD65 level"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0441889:Level [Qualitative Concept]
   804   C0456079:Level [Classification]
   804   C1547707:Level [Geographic Area]
   804   C2946261:Level [Pharmacologic Substance]
   771   C2825893:Glutamic Acid Decarboxylase 65 [Laboratory Procedure]
   717   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "was"

Phrase: "so local"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205276:Local [Spatial Concept]

Phrase: "that there"

Phrase: "were"

Phrase: "two possible mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0441712:Mechanisms [Functional Concept]
   793 E C1706376:Mechanism [Manufactured Object]

Phrase: ":"

Phrase: "either BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   937   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   840   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   840   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]
   804   C1441547:Derived [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   804   C3245521:derived [Idea or Concept]

Phrase: "acted"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "directly on the GABAergic presynaptic terminals"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   790   C0206181:Presynaptic Terminals [Cell Component]
   753   C1947931:Directly [Qualitative Concept]
   719   C0205088:Terminal [Temporal Concept]
   719   C1705314:Terminal [Manufactured Object]
   719   C1705315:Terminal [Spatial Concept]

Phrase: "or"

Phrase: "it"

Phrase: "acted as an autocrine regulator of postsynaptic neurons,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   744   C0027882:Neurons [Cell]
   744   C0182953:REGULATOR [Medical Device]
   744   C0596138:Autocrine [Organ or Tissue Function]
   744   C1704734:Regulator [Medical Device]
   744   C1704735:Regulator [Conceptual Entity]
   711   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "thereby"

Phrase: "activating"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C1879547:activating [Activity]
   966 E C1515877:Activate [Functional Concept]

Phrase: "GABAergic presynaptic terminals via another trans-synaptic retrograde signal."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0206181:Presynaptic Terminals [Cell Component]
           Synaptic Terminals
   708   C0205088:Terminal [Temporal Concept]
   708   C1705314:Terminal [Manufactured Object]
   708   C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.127: To determine the contributions of pre- or postsynaptic neurons to the enhancement of GABAergic presynaptic terminals, we inhibited TrkB which is the BDNF receptor, in the neurons on just one side of the synapse, in the presence of BDNF. 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "determine"

Phrase: "the contributions of pre-"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   737   C1880177:Contribution [Activity]

Phrase: "or"

Phrase: "postsynaptic neurons to the enhancement of GABAergic presynaptic terminals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   762   C0815002:GABAergic Neurons [Cell]
   742   C0027882:Neurons [Cell]

Phrase: "we"

Phrase: "inhibited"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
  1000   C0311403:Inhibited [Qualitative Concept]
   928 E C0018790:arrested [Disease or Syndrome]
   928 E C0237477:Arrest [Temporal Concept]
   928 E C0392351:arrest [Governmental or Regulatory Activity]
   928 E C0521111:Retarded [Qualitative Concept]
   907 E C3463820:Inhibiting [Activity]

Phrase: "TrkB"

Phrase: "which"

Phrase: "is"

Phrase: "the BDNF receptor,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0084873:Brain Derived Neurotrophic Factor Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   884   C0132173:Neurotrophic Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   804   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   771   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "in the neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "on just one side"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0205092:one side [Spatial Concept]
   827   C0441987:Side [Spatial Concept]

Phrase: "of the synapse,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039062:Synapse [Body Space or Junction]

Phrase: "in the presence"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0392148:Presence [Therapeutic or Preventive Procedure]
   928 E C0150312:Present [Quantitative Concept]
   928 E C0449450:Present [Idea or Concept]

Phrase: "of BDNF."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]
Processing 00000000.tx.128: A truncated form of TrkB (tTrkB), which lacks the intracellular tyrosine kinase domain, has been shown to act as a dominant negative receptor for BDNF (Castren et al., 1992; Gonzalez et al., 1999; Haapasalo et al., 2001). 

Phrase: "A truncated form of TrkB (tTrkB),"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0348078:Form [Qualitative Concept]
   760   C0376315:Form [Manufactured Object]
   760   C1522492:Form [Functional Concept]

Phrase: "which"

Phrase: "lacks"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:lack [Qualitative Concept]

Phrase: "the intracellular tyrosine kinase domain,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C1519724:Tyrosine Kinase Domain [Amino Acid Sequence]
   861   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C1880389:Domain [Functional Concept]
   812   C1883221:Domain [Conceptual Entity]
   812   C3541951:Domain [Intellectual Product]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "act as a dominant negative receptor"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   833   C1333312:Dominant Negative Receptor [Amino Acid, Peptide, or Protein,Receptor]
   790   C1512032:Dominant Negative [Cell or Molecular Dysfunction]
   753   C0079613:ACT [Therapeutic or Preventive Procedure]
   753   C0205160:Negative [Qualitative Concept]
   753   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   753   C1513916:Negative [Finding]
   753   C1527180:Dominant [Functional Concept]
   753   C2825415:Negative [Conceptual Entity]
   753   C2825491:Negative [Qualitative Concept]

Phrase: "for BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "(Castren et al.,"

Phrase: "1992"

Phrase: "; Gonzalez et al.,"

Phrase: "1999"

Phrase: "; Haapasalo et al.,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.129: We transfected cells with the tTrkB cDNA tagged with HA-antigen, and also transfected -galactosidase (lacZ) cDNA as a negative control for gene expression. 

Phrase: "We"

Phrase: "transfected"

Phrase: "cells with the tTrkB cDNA"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   744   C0007634:Cells [Cell]
   744   C3282337:Cells [Cell]
   711 E C1269647:Cell [Cell]
   711 E C1704653:Cell [Medical Device]
   711 E C1948049:Cell [Spatial Concept]

Phrase: "tagged with HA-antigen,"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   770   C0003320:Antigen [Immunologic Factor]
   770   C1522485:Tagged [Indicator, Reagent, or Diagnostic Aid]
   770   C1708632:Tagged [Qualitative Concept]
   737 E C0037293:Tag [Neoplastic Process]
   737 E C0181496:Tag [Manufactured Object]
   737 E C1710492:TAG [Gene or Genome]

Phrase: "and"

Phrase: "also"

Phrase: "transfected -"

Phrase: "galactosidase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016955:Galactosidase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "(lacZ"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0022959:LacZ [Gene or Genome]

Phrase: ")"

Phrase: "cDNA as a negative control"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]

Phrase: "for gene expression."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0017262:Gene Expression [Genetic Function]
   861   C0017337:Gene [Gene or Genome]
   861   C0185117:Expression [Therapeutic or Preventive Procedure]
Processing 00000000.tx.130: In this paper, the contribution of only postsynaptic excitatory neurons was examined, because, to our surprise, the transfection of inhibitory neurons was minimal. 

Phrase: "In this paper,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0030351:Paper [Manufactured Object]
  1000   C1547566:Paper [Idea or Concept]

Phrase: "the contribution of only postsynaptic excitatory neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1880177:Contribution [Activity]

Phrase: "was"

Phrase: "examined"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332128:Examined [Finding]

Phrase: ","

Phrase: "because"

Phrase: ","

Phrase: "to our surprise,"

Phrase: "the transfection of inhibitory neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]

Phrase: "was"

Phrase: "minimal."
Meta Candidates (Total=5; Excluded=2; Pruned=0; Remaining=3)
  1000   C0547040:Minimal [Qualitative Concept]
  1000   C1524031:MINIMAL [Qualitative Concept]
  1000   C2945599:Minimal [Qualitative Concept]
   928 E C1552614:minimum [Idea or Concept]
   928 E C2826545:MINIMUM [Quantitative Concept]
Processing 00000000.tx.131: Even when the control vector was used, almost all (>95%) the cells expressing hrGFP were non-GABAergic neurons, defined as MAP2-positive and somatic-GAD65-negative. 

Phrase: "Even"

Phrase: "when"

Phrase: "the control vector"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0031249:control vector [Occupational Activity]
   861   C0086022:Vector [Nucleic Acid, Nucleoside, or Nucleotide]
   861   C0442335:Vector [Spatial Concept]
   861   C1705099:Vector [Idea or Concept]

Phrase: "was"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: ","

Phrase: "almost"

Phrase: "all (>95%"

Phrase: ")"

Phrase: "the cells"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0007634:Cells [Cell]
  1000   C3282337:Cells [Cell]
   966 E C1269647:Cell [Cell]
   966 E C1704653:Cell [Medical Device]
   966 E C1948049:Cell [Spatial Concept]

Phrase: "expressing"

Phrase: "hrGFP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   837   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "were"

Phrase: "non-GABAergic neurons,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0815002:GABAergic Neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "defined as MAP2-positive"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   770   C0439178:% Positive [Quantitative Concept]
   770   C1417006:MAP2 [Gene or Genome]
   770   C1424480:MAP2 [Gene or Genome]
   770   C1446409:Positive [Qualitative Concept]
   770   C1514241:Positive [Finding]
   770   C1704788:Defined [Conceptual Entity]
   770   C2825490:Positive [Qualitative Concept]
   770   C3539106:Defined [Intellectual Product]

Phrase: "and"

Phrase: "somatic-GAD65-negative."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   799   C0205160:Negative [Qualitative Concept]
   799   C1513916:Negative [Finding]
   799   C2825415:Negative [Conceptual Entity]
   799   C2825491:Negative [Qualitative Concept]
   734   C2825893:Glutamic Acid Decarboxylase 65 [Laboratory Procedure]
Processing 00000000.tx.132: This was not due to a difference in viability, since the ratio of the two types of neurons was not affected by the transfection (data not shown). 

Phrase: "This"

Phrase: "was"

Phrase: "not due to a difference"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0678226:Due to [Functional Concept]
           due
   760   C1518422:Not [Functional Concept]
   760   C1705241:*Difference [Quantitative Concept]
   760   C1705242:Difference [Qualitative Concept]
   760   C3146286:Due [Idea or Concept]

Phrase: "in viability,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443348:viability [Qualitative Concept]

Phrase: "since"

Phrase: "the ratio of the two types of neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0456603:Ratio [Quantitative Concept]
   744   C1547037:Ratio [Intellectual Product]

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "affected by the transfection"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   770   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
   770   C0392760:Affected [Functional Concept]
   770   C1314939:Affected [Functional Concept]
   737 E C0001721:Affect [Mental Process]

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.133: The tTrkB-expression was first determined immunocytochemically with an anti-HA antibody, 48 h after transfection. 

Phrase: "The tTrkB-expression"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]
   748   C1554102:Formal Expression [Idea or Concept]

Phrase: "was"

Phrase: "first"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205435:First [Quantitative Concept]
  1000   C1279901:First [Qualitative Concept]

Phrase: "determined"

Phrase: "immunocytochemically with an anti-HA antibody,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   783   C0003242:anti antibody [Amino Acid, Peptide, or Protein,Immunologic Factor]
   753   C0003241:Antibody [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   753   C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "48 h after transfection."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
Processing 00000000.tx.134: We confirmed that all the hrGFP-expressing neurons expressed HA (data not shown). 

Phrase: "We"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "all the hrGFP-expressing neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0027882:Neurons [Cell]
   710 E C0521390:Neuronal [Immunologic Factor]

Phrase: "expressed"

Phrase: "HA (data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.135: To confirm that the tTrkB-expressing neurons had lost their responsiveness to BDNF, we assayed the induction of nuclear Fos by BDNF using immunofluorescence, since the c-fos protein has been shown to be induced via the activation of TrkB in NIH-3T3 cells (McCarty and Feinstein, 1999). 

Phrase: "To"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "confirm"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0521093:confirm [Qualitative Concept]
  1000   C0750484:confirm [Idea or Concept]
  1000   C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the tTrkB-expressing neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "had"

Phrase: "lost"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0745777:Lost [Functional Concept]

Phrase: "their responsiveness to BDNF,"

Phrase: "we"

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "the induction of nuclear Fos"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0205263:Induction [Functional Concept]
   760   C0857127:induction [Therapeutic or Preventive Procedure]

Phrase: "by BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "using"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1524063:Using [Functional Concept]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "immunofluorescence,"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0016318:Immunofluorescence [Laboratory Procedure]
  1000   C0079603:Immunofluorescence [Laboratory Procedure]
   944 E C0282648:Direct immunofluorescence [Laboratory Procedure]
   928 E C0183489:Immunofluorescent [Indicator, Reagent, or Diagnostic Aid]

Phrase: "since"

Phrase: "the c-fos protein"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C0085301:c fos protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           c fos
  1000   C0596588:c-fos Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
           FOS Protein
   913   C0055817:c protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   734   C0085940:c fos [Gene or Genome]
   734   C0087140:c-fos [Gene or Genome]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "induced via the activation of TrkB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0205263:Induced [Functional Concept]
   753   C1879547:Activation [Activity]

Phrase: "in NIH-3T3 cells"
Meta Candidates (Total=9; Excluded=3; Pruned=0; Remaining=6)
  1000   C1257739:NIH 3T3 Cells [Cell]
           NIH/3T3
   901   C0085087:3T3 Cells [Cell]
   827   C0007634:Cells [Cell]
   827   C0027468:NIH [Health Care Related Organization]
   827   C3282337:Cells [Cell]
   793 E C1269647:Cell [Cell]
   793 E C1704653:Cell [Medical Device]
   793 E C1948049:Cell [Spatial Concept]

Phrase: "(McCarty"

Phrase: "and"

Phrase: "Feinstein,"

Phrase: "1999"

Phrase: ")."
Processing 00000000.tx.136: Exogenously applied BDNF did not increase the Fos expression in the tTrkB + hrGFP-expressing neurons (Fig. 2B), whereas it did increase the Fos levels in the control lacZ + hrGFP-expressing neurons (Fig. 2A, yellow signal in the nucleus in the merged image). 

Phrase: "Exogenously applied BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   901   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   799   C0006104:Brain [Body Part, Organ, or Organ Component]
   799   C1269537:Brain [Body Part, Organ, or Organ Component]
   799   C1441547:Derived [Qualitative Concept]
   799   C1521761:Factor [Functional Concept]
   799   C2827422:Factor [Conceptual Entity]
   799   C3245521:derived [Idea or Concept]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the Fos expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in the tTrkB + hrGFP-expressing neurons"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   795   C0997916:Renilla reniformis [Eukaryote]
   786   C0016315:Fluorescence [Natural Phenomenon or Process]
   786   C0027882:Neurons [Cell]
   786   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   786   C0150312:In [Quantitative Concept]
   786   C0332285:In [Spatial Concept]
   786   C0332583:Green [Qualitative Concept]
   786   C0348078:Form [Qualitative Concept]
   786   C0376315:Form [Manufactured Object]
   786   C1093003:Renilla [Eukaryote]
   786   C1522492:Form [Functional Concept]
   782   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   714 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   702 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(Fig. 2B"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450354:2b [Intellectual Product]
   861   C1706096:2B [Research Activity]

Phrase: ")"

Phrase: ","

Phrase: "whereas"

Phrase: "it"

Phrase: "did"

Phrase: "increase"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the Fos levels"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0441889:Levels [Qualitative Concept]
   827 E C0456079:Level [Classification]
   827 E C1547707:Level [Geographic Area]
   827 E C2946261:Level [Pharmacologic Substance]

Phrase: "in the control lacZ + hrGFP-expressing neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0027882:Neurons [Cell]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(Fig. 2A,"

Phrase: "yellow signal in the nucleus"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1710082:Signal [Phenomenon or Process]

Phrase: "in the merged image"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1704254:Image [Intellectual Product]
   861   C1704922:Image [Entity]
   861   C3542466:Image [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.137: These data (Fig. 2C) demonstrate that the tTrkB-expressing neurons were unresponsive to BDNF. 

Phrase: "These data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "(Fig. 2C"

Phrase: ")"

Phrase: "demonstrate"

Phrase: "that"

Phrase: "the tTrkB-expressing neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   748   C0348078:Form [Qualitative Concept]
   748   C0376315:Form [Manufactured Object]
   748   C1522492:Form [Functional Concept]

Phrase: "were"

Phrase: "unresponsive to BDNF."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0205269:Unresponsive [Functional Concept]
   753   C0237284:Unresponsive [Finding]
   716   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   716   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
Processing 00000000.tx.138: View larger version (11K): [in this window] [in a new window]  Figure 2. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(11K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 2."
Processing 00000000.tx.139: Confirmation of the lack of BDNF-induced response by nuclear Fos expression in neurons expressing tTrkB, a kinase-defective receptor for BDNF. 

Phrase: "Confirmation of the lack of BDNF-induced response"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   756   C0521091:Confirmation of [Qualitative Concept]
           confirmation
   738   C0750484:Confirmation [Idea or Concept]

Phrase: "by nuclear Fos expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "expressing"

Phrase: "tTrkB,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]

Phrase: "a kinase-defective receptor for BDNF."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   838   C0084873:Brain Derived Neurotrophic Factor Receptor [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   784   C0132173:Neurotrophic Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   781   C1566952:A-Factor Receptor [Amino Acid, Peptide, or Protein,Receptor]
   742   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.140: (A, B) Treatment with 10 ng/ml BDNF for 1 h induces expression of nuclear Fos (red) in control lacZ + hrGFP-expressing neurons (A, yellow in the merged image), but not in tTrkB + hrGFP-expressing neurons (B). 

Phrase: "(A,"

Phrase: "B) Treatment with 10 ng/ml BDNF"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   757   C0679853:Treatment Factor [Intellectual Product]
   739   C0039798:treatment [Functional Concept]
   739   C0087111:Treatment [Therapeutic or Preventive Procedure]
   739   C1522326:Treatment [Functional Concept]
   739   C1533734:Treatment [Therapeutic or Preventive Procedure]
   739   C1705169:Treatment [Conceptual Entity]
   739   C3538994:TREATMENT [Research Activity]

Phrase: "for 1 h"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0700308:1 H [Element, Ion, or Isotope]
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "expression of nuclear Fos ("
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "red)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "in control lacZ + hrGFP-expressing neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0027882:Neurons [Cell]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(A,"

Phrase: "yellow in the merged image"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0221205:Yellow [Qualitative Concept]

Phrase: ")"

Phrase: ","

Phrase: "but"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "in tTrkB + hrGFP-expressing neurons"
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   797   C0997916:Renilla reniformis [Eukaryote]
   786   C0016315:Fluorescence [Natural Phenomenon or Process]
   786   C0027882:Neurons [Cell]
   786   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   786   C0150312:In [Quantitative Concept]
   786   C0332285:In [Spatial Concept]
   786   C0332583:Green [Qualitative Concept]
   786   C0348078:Form [Qualitative Concept]
   786   C0376315:Form [Manufactured Object]
   786   C1093003:Renilla [Eukaryote]
   786   C1522492:Form [Functional Concept]
   785   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   715 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   703 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.141: Scale bar, 20 m. 

Phrase: "Scale bar,"

Phrase: "20 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.142: (C) Treatment with 10 ng/ml BDNF induces a significant increase in nuclear Fos expression in lacZ-expressing neurons, which is suppressed in tTrkB-expressing neurons (**P < 0.01 as compared with the lacZ-expressing neurons, Mann-Whitney U-test, n = 116341 neurons). 

Phrase: "(C) Treatment with 10 ng/ml BDNF"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   757   C0679853:Treatment Factor [Intellectual Product]
   739   C0039798:treatment [Functional Concept]
   739   C0087111:Treatment [Therapeutic or Preventive Procedure]
   739   C1522326:Treatment [Functional Concept]
   739   C1533734:Treatment [Therapeutic or Preventive Procedure]
   739   C1705169:Treatment [Conceptual Entity]
   739   C3538994:TREATMENT [Research Activity]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "a significant increase in nuclear Fos expression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0442805:Increase [Functional Concept]

Phrase: "in lacZ-expressing neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "which"

Phrase: "is"

Phrase: "suppressed in tTrkB-expressing neurons"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0027882:Neurons [Cell]
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1260953:Suppressed [Functional Concept]
   744   C1522492:Form [Functional Concept]

Phrase: "("

Phrase: "*"

Phrase: "*P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "as"

Phrase: "compared with the lacZ-expressing neurons,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0022959:LacZ [Gene or Genome]
   753   C0027882:Neurons [Cell]
   753   C1707455:Compared [Activity]

Phrase: "Mann-Whitney U-test,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242927:Mann-Whitney U Test [Quantitative Concept]
   923   C1708930:Mann-Whitney Test [Intellectual Product]
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]

Phrase: "n = 116341 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.143: The increase in Fos fluorescent intensity in neurons expressing hrGFP is expressed as a percentage of the increase observed in the lacZ-expressing neurons.  

Phrase: "The increase in Fos fluorescent intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "in neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "expressing"

Phrase: "hrGFP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   837   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   799   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "is"

Phrase: "expressed as a percentage of the increase"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0439165:Percentage [Quantitative Concept]
   748   C0442805:Increase [Functional Concept]
   748   C1549488:Percentage [Idea or Concept]
   748   C1561533:Percentage [Idea or Concept]

Phrase: "observed in the lacZ-expressing neurons."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0022959:LacZ [Gene or Genome]
   753   C0027882:Neurons [Cell]
   753   C1441672:Observed [Functional Concept]
Processing 00000000.tx.144: Since we applied BDNF in the medium at a 100-fold higher concentration than the Kd of Trk and neurotrophin, it is logical to suppose that the inhibition by tTrkB should be confined to the expressing neurons. 

Phrase: "Since"

Phrase: "we"

Phrase: "applied"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0185125:Applied [Health Care Activity]
   966 E C1632850:Apply [Functional Concept]
   966 E C1879355:Apply [Functional Concept]

Phrase: "BDNF in the medium"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   853   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   778   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   778   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1441547:Derived [Qualitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]
   748   C3245521:derived [Idea or Concept]

Phrase: "at a 100-fold higher concentration"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   812   C0086045:Concentration [Mental Process]
   812   C1446561:Concentration [Quantitative Concept]
   741 E C1880165:Concentrated [Biomedical or Dental Material]

Phrase: "than the Kd"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0026691:KD [Disease or Syndrome]
  1000   C1705240:KD [Gene or Genome]
  1000   C1839259:KD [Disease or Syndrome]

Phrase: "of Trk"

Phrase: "and"

Phrase: "neurotrophin,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0132298:Neurotrophin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
  1000   C1323315:neurotrophin [Molecular Function]
  1000   C1332408:neurotrophin [Gene or Genome]

Phrase: "it"

Phrase: "is"

Phrase: "logical to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   789   C0023963:Logic [Idea or Concept]

Phrase: "suppose"

Phrase: "that"

Phrase: "the inhibition by tTrkB"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0021467:Inhibition [Mental Process]
   748   C0021469:Inhibition [Molecular Function]
   748   C1628982:% inhibition [Quantitative Concept]
   748   C3463820:Inhibition [Activity]

Phrase: "should"

Phrase: "be"

Phrase: "confined to the expressing neurons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027882:Neurons [Cell]
Processing 00000000.tx.145: Even pumping out of the excess ligand from the synaptic clefts appears to be impossible, partly because tTrkB is believed to be defective in the internalization with the ligand (Du et al., 2000), and also because the synaptic clefts in cultured neurons are exposed to a volume of medium that is >1000-fold larger than the volume of the tTrkB-expressing neurons. 

Phrase: "Even pumping out of the excess ligand"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0182537:pumping [Medical Device]
   714 E C1706421:Pump [Manufactured Object]

Phrase: "from the synaptic clefts"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0682685:Synaptic cleft [Cell Component]
   827   C0205242:Cleft [Spatial Concept]

Phrase: "appears"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700364:APPEAR [Qualitative Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "impossible, partly"

Phrase: "because"

Phrase: "tTrkB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0348078:Form [Qualitative Concept]
   770   C0376315:Form [Manufactured Object]
   770   C1522492:Form [Functional Concept]

Phrase: "is"

Phrase: "believed"

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "be"

Phrase: "defective in the internalization"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0332452:Defective [Functional Concept]

Phrase: "with the ligand"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0023688:Ligand [Chemical]

Phrase: "(Du et al.,"

Phrase: "2000"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "also"

Phrase: "because"

Phrase: "the synaptic clefts in cultured neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   756   C0682685:Synaptic cleft [Cell Component]
   719   C0205242:Cleft [Spatial Concept]

Phrase: "are"

Phrase: "exposed to a volume of medium"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   790   C0332157:Exposed to [Clinical Attribute]
           Exposed
   753   C0009458:Medium [Intellectual Product]
   753   C0439536:Medium [Quantitative Concept]
   753   C0449468:*Volume [Quantitative Concept]
   753   C1690016:% volume [Qualitative Concept]
   753   C1705102:Volume [Intellectual Product]
   753   C1705217:Medium [Substance]
   753   C2700258:Volume [Laboratory Procedure]
   753   C3244283:medium [Intellectual Product]

Phrase: "that is >1000-fold"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0332462:Fold [Spatial Concept]
   827   C1880834:FOLD [Phenomenon or Process]

Phrase: "larger than the volume of the tTrkB-expressing neurons."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   736   C0443228:larger [Quantitative Concept]
   736   C0549177:Larger [Quantitative Concept]
   736   C1704243:Larger [Quantitative Concept]
   718   C0228072:Large neuron [Cell]
Processing 00000000.tx.146: In fact, we confirmed that the average Fos response of other cells in the same well as the tTrkB-expressing neurons, remained unaltered in this system (as shown in Fig. 2B, red, plus data not shown). 

Phrase: "In fact,"

Phrase: "we"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that"

Phrase: "the average Fos response of other cells"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0871261:Response [Organism Attribute]
   748   C1704632:Response [Finding]
   748   C1706817:Response [Intellectual Product]
   748   C2911692:Response [Mental Process]

Phrase: "in the same well"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205170:Well [Qualitative Concept]
   861   C0445247:Same [Qualitative Concept]
   861   C3146287:Well [Manufactured Object]

Phrase: "as the tTrkB-expressing neurons,"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   793   C0027882:Neurons [Cell]
   793   C0348078:Form [Qualitative Concept]
   793   C0376315:Form [Manufactured Object]
   793   C1522492:Form [Functional Concept]
   710 E C0521390:Neuronal [Immunologic Factor]

Phrase: "remained"

Phrase: "unaltered in this system"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1709843:Unaltered [Qualitative Concept]

Phrase: "("

Phrase: "as"

Phrase: "shown in Fig. 2B,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0349966:Fig [Food]
   770   C0450354:2b [Intellectual Product]
   770   C1337208:FIG [Food]
   770   C1706096:2B [Research Activity]
   737   C1547282:Show [Intellectual Product]

Phrase: "red,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "plus data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1511726:Data [Idea or Concept]
   861   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.147: Thus, we confirmed the establishment of an experimental system in which only a small number of neurons lost their TrkB function, while most of the surrounding neurons showed normal responses to exogenously applied BDNF. 

Phrase: "Thus,"

Phrase: "we"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "the establishment of an experimental system"

Phrase: "in which only"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0205171:Only [Quantitative Concept]
  1000   C1720467:Only [Intellectual Product]

Phrase: "a small number of neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0237753:*Number [Quantitative Concept]
   760   C0449788:Number [Quantitative Concept]

Phrase: "lost"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0745777:Lost [Functional Concept]

Phrase: "their TrkB function,"
Meta Candidates (Total=6; Excluded=2; Pruned=0; Remaining=4)
   861   C0031843:function [Physiologic Function]
   861   C0542341:Function [Functional Concept]
   861   C0700205:FUNCTION [Classification]
   861   C1705273:Function [Intellectual Product]
   789 E C0205245:Functional [Functional Concept]
   789 E C2700217:Functional [Conceptual Entity]

Phrase: "while"

Phrase: "most of the surrounding neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0027882:Neurons [Cell]
   760   C0205393:Most [Quantitative Concept]
   760   C1282914:Surrounding [Spatial Concept]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "normal responses to exogenously applied BDNF."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   742   C0871261:responses [Organism Attribute]
   708 E C1704632:Response [Finding]
   708 E C1706817:Response [Intellectual Product]
   708 E C2911692:Response [Mental Process]
Processing 00000000.tx.148: Next, we confirmed that treatment with 10 ng/ml BDNF increased the immunofluorescence signal of GAD65. 

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "we"

Phrase: "confirmed"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0521093:confirmed [Qualitative Concept]
  1000   C0750484:Confirmed [Idea or Concept]
   966 E C1456348:Confirm [Qualitative Concept]

Phrase: "that treatment with 10 ng/ml BDNF"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   757   C0679853:Treatment Factor [Intellectual Product]
   739   C0039798:treatment [Functional Concept]
   739   C0087111:Treatment [Therapeutic or Preventive Procedure]
   739   C1522326:Treatment [Functional Concept]
   739   C1533734:Treatment [Therapeutic or Preventive Procedure]
   739   C1705169:Treatment [Conceptual Entity]
   739   C3538994:TREATMENT [Research Activity]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "the immunofluorescence signal of GAD65."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.149: This is in agreement with previously reported similar results of in vivo, slice and culture experiments (Huang et al., 1999; Marty et al., 2000; Yamada et al., 2002). 

Phrase: "This"

Phrase: "is in agreement"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0680240:Agreement [Social Behavior]

Phrase: "with previously"

Phrase: "reported"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0684224:Reported [Intellectual Product]
  1000   C0700287:Reported [Health Care Activity]
  1000   C3496591:Reported [Clinical Attribute]
   966 E C3273238:Report [Intellectual Product]

Phrase: "similar results of in vivo, slice"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1517589:In Vivo Result [Conceptual Entity]
   719   C1274040:Result [Functional Concept]
   719   C1546471:Result [Idea or Concept]
   719   C2825142:Result [Finding]

Phrase: "and"

Phrase: "culture experiments"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0681814:Experiments [Research Activity]
   827 E C1706386:Experiment [Conceptual Entity]
   777 E C1517586:Experimental [Qualitative Concept]

Phrase: "(Huang et al.,"

Phrase: "1999"

Phrase: "; Marty et al.,"

Phrase: "2000"

Phrase: "; Yamada et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.150: Regarding the time course, 612 h were required for significant changes to be observed and 4872 h were necessary for stable changes (data not shown); 

Phrase: "Regarding"

Phrase: "the time course,"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
  1000   C0449247:Time course [Temporal Concept]
   861   C0040223:Time [Temporal Concept]
   861   C0750729:Course [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "612 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "were"

Phrase: "required for significant changes to"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   760   C0237881:significant [Quantitative Concept]
   760   C0392747:changes [Functional Concept]
   760   C0443172:changes [Quantitative Concept]
   760   C0750502:Significant [Idea or Concept]
   760   C1514873:Required [Functional Concept]
   760   C1546944:Significant [Qualitative Concept]
   726 E C1705241:Change [Quantitative Concept]

Phrase: "be"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "and"

Phrase: "4872 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "were"

Phrase: "necessary for stable changes"

Phrase: "(data"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1511726:Data [Idea or Concept]
  1000   C3245479:data [Medical Device]

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: ")"

Phrase: ";"
Processing 00000000.tx.151: thus, BDNF treatment was performed for 48 h. 

Phrase: "thus,"

Phrase: "BDNF treatment"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   840   C0679853:factor treatment [Intellectual Product]
   804   C0039798:treatment [Functional Concept]
   804   C0087111:Treatment [Therapeutic or Preventive Procedure]
   804   C1522326:Treatment [Functional Concept]
   804   C1533734:Treatment [Therapeutic or Preventive Procedure]
   804   C1705169:Treatment [Conceptual Entity]
   804   C3538994:TREATMENT [Research Activity]
   771   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "was"

Phrase: "performed for 48 h."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   770   C0033727:H+ [Element, Ion, or Isotope]
   770   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0441932:H+ [Classification]
   770   C0564385:/h [Quantitative Concept]
   770   C0884358:Performed [Functional Concept]
   737 E C2947996:Perform [Pharmacologic Substance]
Processing 00000000.tx.152: There was a 1.6-fold overall increase in GAD (Fig. 3, black column). 

Phrase: "There"

Phrase: "was"

Phrase: "a 1.6-fold overall"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   804   C0332462:Fold [Spatial Concept]
   804   C1880834:FOLD [Phenomenon or Process]

Phrase: "increase in GAD"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   862   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   806   C0061472:Glutamic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   806   C0523665:Glutamic Acid [Laboratory Procedure]
   760   C0001128:Acid [Chemical]
   760   C0007054:Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0202406:Acid [Laboratory Procedure]
   760   C0442805:Increase [Functional Concept]
   704 E C1517378:Gain [Quantitative Concept]

Phrase: "(Fig. 3,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "black column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.153: Next, we determined whether the effect of BDNF on GAD65 was mediated by neurotransmission. 

Phrase: "Next,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0205117:next [Spatial Concept]
  1000   C0332282:Next [Temporal Concept]
  1000   C1883708:Next [Temporal Concept]

Phrase: "we"

Phrase: "determined"

Phrase: "whether"

Phrase: "the effect of BDNF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C1280500:Effect [Qualitative Concept]
   748   C2348382:Effect [Qualitative Concept]

Phrase: "on GAD65"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
  1000   C2825893:Glutamic Acid Decarboxylase 65 [Laboratory Procedure]
   923   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0061472:Glutamic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0523665:Glutamic Acid [Laboratory Procedure]
   812   C0001128:Acid [Chemical]
   812   C0007054:Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0202406:Acid [Laboratory Procedure]
   812   C0450385:65 [Intellectual Product]

Phrase: "was"

Phrase: "mediated by neurotransmission."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0027793:Neurotransmission [Cell Function]
   790   C0086597:mediated [Social Behavior]
   790   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
Processing 00000000.tx.154: This is because BDNF has been shown to acutely alter neurotransmission by increasing neurotransmitter release (Zakharenko et al., 2003), causing a form of long-term potentiation (Kang and Schuman, 1995) and decreasing inhibitory inputs (Tanaka et al., 1997) at postsynaptic sites. 

Phrase: "This"

Phrase: "is"

Phrase: "because"

Phrase: "BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to acutely"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1883351:To [Qualitative Concept]

Phrase: "alter"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   916   C0392747:Altered [Functional Concept]

Phrase: "neurotransmission by increasing neurotransmitter release"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027793:Neurotransmission [Cell Function]

Phrase: "(Zakharenko et al.,"

Phrase: "2003"

Phrase: ")"

Phrase: ","

Phrase: "causing"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0678227:Causing [Functional Concept]
   966 E C0015127:cause [Functional Concept]
   966 E C1524003:Cause [Conceptual Entity]

Phrase: "a form of long-term potentiation"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "(Kang"

Phrase: "and"

Phrase: "Schuman,"

Phrase: "1995"

Phrase: ")"

Phrase: "and"

Phrase: "decreasing inhibitory inputs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708517:Input [Conceptual Entity]

Phrase: "(Tanaka et al.,"

Phrase: "1997"

Phrase: ")"

Phrase: "at postsynaptic sites."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0205145:Sites [Spatial Concept]
   827 E C1515974:Site [Body Location or Region]
   827 E C2825164:Site [Spatial Concept]
Processing 00000000.tx.155: As the results show, treatment of cells for 30 min prior to and during BDNF treatment with the following reagents did not have any significant effects on the BDNF-induced increases in the GAD65 level. 

Phrase: "As the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: ","

Phrase: "treatment of cells"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   790   C0039798:treatment [Functional Concept]
   790   C0087111:Treatment [Therapeutic or Preventive Procedure]
   790   C1522326:Treatment [Functional Concept]
   790   C1533734:Treatment [Therapeutic or Preventive Procedure]
   790   C1705169:Treatment [Conceptual Entity]
   790   C3538994:TREATMENT [Research Activity]

Phrase: "for 30 min"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0456693:/30 min [Temporal Concept]
  1000   C1442458:30 min [Temporal Concept]
   861   C0702093:/min [Temporal Concept]

Phrase: "prior to"

Phrase: "and during BDNF treatment"
Meta Candidates (Total=19; Excluded=0; Pruned=0; Remaining=19)
   853   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   778   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   778   C0679853:factor treatment [Intellectual Product]
   778   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0039798:treatment [Functional Concept]
   748   C0087111:Treatment [Therapeutic or Preventive Procedure]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1441547:Derived [Qualitative Concept]
   748   C1515981:And [Idea or Concept]
   748   C1521761:Factor [Functional Concept]
   748   C1522326:Treatment [Functional Concept]
   748   C1533734:Treatment [Therapeutic or Preventive Procedure]
   748   C1705169:Treatment [Conceptual Entity]
   748   C2827422:Factor [Conceptual Entity]
   748   C3245521:derived [Idea or Concept]
   748   C3538994:TREATMENT [Research Activity]

Phrase: "with the following reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "did"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "have"

Phrase: "any significant effects on the BDNF-induced increases"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C1280500:effects [Qualitative Concept]
   704 E C2348382:Effect [Qualitative Concept]

Phrase: "in the GAD65 level."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   804   C0441889:Level [Qualitative Concept]
   804   C0456079:Level [Classification]
   804   C1547707:Level [Geographic Area]
   804   C2946261:Level [Pharmacologic Substance]
   771   C2825893:Glutamic Acid Decarboxylase 65 [Laboratory Procedure]
   717   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
Processing 00000000.tx.156: The reagents used were TTX, which blocks action potentials; 

Phrase: "The reagents"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0034760:Reagents [Indicator, Reagent, or Diagnostic Aid]

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "were"

Phrase: "TTX,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039705:Tetrodotoxin [Biologically Active Substance,Hazardous or Poisonous Substance,Organic Chemical]

Phrase: "which"

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "action potentials"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0001272:Action Potentials [Cell Function]
   861   C0441472:Action [Functional Concept]
   861   C3245505:potentials [Qualitative Concept]
   861   C3266814:Action [Activity]

Phrase: ";"
Processing 00000000.tx.157: a mixture of glutamate receptor antagonists; 

Phrase: "a mixture of glutamate receptor antagonists"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0439962:Mixture [Substance]

Phrase: ";"
Processing 00000000.tx.158: picrotoxin, a GABAA antagonist; 

Phrase: "picrotoxin,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0031890:Picrotoxin [Hazardous or Poisonous Substance,Organic Chemical,Pharmacologic Substance]

Phrase: "a GABAA antagonist"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0231491:Antagonist [Organ or Tissue Function]
   761 E C0680242:antagonism [Social Behavior]

Phrase: ";"
Processing 00000000.tx.159: and saclofen, a GABAB antagonist that blocks long-term potentiation of GABAergic synapses (Komatsu, 1996) (Fig. 3). 

Phrase: "and"

Phrase: "saclofen,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0215145:saclofen [Organic Chemical,Pharmacologic Substance]

Phrase: "a GABAB antagonist"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0231491:Antagonist [Organ or Tissue Function]
   761 E C0680242:antagonism [Social Behavior]

Phrase: "that"

Phrase: "blocks"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "long-term potentiation of GABAergic synapses"
Meta Candidates (Total=10; Excluded=0; Pruned=0; Remaining=10)
   833   C0206249:Long-Term Potentiation [Organ or Tissue Function]
           long-term synaptic potentiation
   833   C2984294:Long-term potentiation [Functional Concept]
   790   C0443252:Long-term [Temporal Concept]
   753   C0205166:Long [Qualitative Concept]
   753   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   753   C1515273:Term [Temporal Concept]
   753   C1705313:Term [Idea or Concept]
   753   C1706317:Long [Qualitative Concept]
   753   C2826302:TERM [Intellectual Product]

Phrase: "(Komatsu,"

Phrase: "1996"

Phrase: ")"

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")."
Processing 00000000.tx.160: We then assayed the GAD65 signals in the tTrkB-expressing neurons. 

Phrase: "We then"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883708:Then [Temporal Concept]

Phrase: "assayed"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C0005507:Assay [Laboratory Procedure]
   966   C0243073:assay [Qualitative Concept]
   966   C1510438:Assay [Laboratory Procedure]

Phrase: "the GAD65 signals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   771   C1710082:Signal [Phenomenon or Process]
   771   C2825893:Glutamic Acid Decarboxylase 65 [Laboratory Procedure]
   717   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "in the tTrkB-expressing neurons."
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   793   C0027882:Neurons [Cell]
   793   C0150312:In [Quantitative Concept]
   793   C0332285:In [Spatial Concept]
   793   C0348078:Form [Qualitative Concept]
   793   C0376315:Form [Manufactured Object]
   793   C1522492:Form [Functional Concept]
   710 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.161: In order to quantitatively analyze the GAD65 immunoreactive signals in the hrGFP-expressing neurons, GAD65 images inside the boundary line of hrGFP-fluorescence were clipped (Fig. 4A), and the overall GAD signals included in these clipped images were quantified (Fig. 4B). 

Phrase: "In order"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C1705175:Order [Intellectual Product]
  1000   C1705176:Order [Qualitative Concept]
  1000   C1705177:Order [Classification]
  1000   C1705178:Order [Activity]
  1000   C1882348:Order [Qualitative Concept]

Phrase: "to quantitatively"

Phrase: "analyze"

Phrase: "the GAD65 immunoreactive signals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   766   C1710082:Signal [Phenomenon or Process]
   734   C2825893:Glutamic Acid Decarboxylase 65 [Laboratory Procedure]

Phrase: "in the hrGFP-expressing neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   793   C0027882:Neurons [Cell]
   710 E C0521390:Neuronal [Immunologic Factor]

Phrase: "GAD65 images inside the boundary line"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   708   C1704254:Image [Intellectual Product]
   708   C1704922:Image [Entity]
   708   C3542466:Image [Intellectual Product]

Phrase: "of hrGFP-fluorescence"

Phrase: "were"

Phrase: "clipped"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0175722:Clip [Medical Device]
   966   C1705205:Clip [Medical Device]

Phrase: "(Fig. 4A"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0450373:4a [Intellectual Product]
   861   C1553636:4a [Medical Device]

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "the overall GAD signals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C1710082:Signal [Phenomenon or Process]
   717   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "included in these clipped images"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   760   C0332257:included [Functional Concept]
   760   C3538986:INCLUDED [Gene or Genome]
   726   C0175722:Clip [Medical Device]
   726 E C1552866:include [Idea or Concept]
   726   C1704254:Image [Intellectual Product]
   726   C1704922:Image [Entity]
   726   C1705205:Clip [Medical Device]
   726 E C2700399:Include [Activity]
   726   C3542466:Image [Intellectual Product]

Phrase: "were"

Phrase: "quantified"

Phrase: "(Fig. 4B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0450375:4b [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.162: Treatment for 48 h with 10 ng/ml BDNF increased GAD65 expression in lacZ-expressing neurons (Fig. 4, white column). 

Phrase: "Treatment for 48 h"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: "with 10 ng/ml BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   877   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   877   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   818   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   818   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   795   C0006104:Brain [Body Part, Organ, or Organ Component]
   795   C1269537:Brain [Body Part, Organ, or Organ Component]
   795   C1441547:Derived [Qualitative Concept]
   795   C1521761:Factor [Functional Concept]
   795   C2827422:Factor [Conceptual Entity]
   795   C3245521:derived [Idea or Concept]

Phrase: "increased"
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]

Phrase: "GAD65 expression in lacZ-expressing neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "(Fig. 4,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: "white column"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1185738:Column [Body Part, Organ, or Organ Component]
   861   C1706132:Column [Idea or Concept]

Phrase: ")."
Processing 00000000.tx.163: In tTrkB-expressing neurons, however, this increase was significantly attenuated (P < 0.01 as compared with the lacZ-expressing neurons). 

Phrase: "In tTrkB-expressing neurons,"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   795   C0027882:Neurons [Cell]
   795   C0150312:In [Quantitative Concept]
   795   C0332285:In [Spatial Concept]
   795   C0348078:Form [Qualitative Concept]
   795   C0376315:Form [Manufactured Object]
   795   C1522492:Form [Functional Concept]
   712 E C0521390:Neuronal [Immunologic Factor]

Phrase: "however,"

Phrase: "this increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "significantly"

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "(P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "as"

Phrase: "compared with the lacZ-expressing neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0022959:LacZ [Gene or Genome]
   753   C0027882:Neurons [Cell]
   753   C1707455:Compared [Activity]

Phrase: ")."
Processing 00000000.tx.164: This suggests that BDNF-TrkB signaling in postsynaptic neurons contributes to the BDNF-induced increase in GAD in presynaptic terminals. 

Phrase: "This"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that BDNF-TrkB signaling in postsynaptic neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0037083:Signaling [Cell Function]
   739   C3537152:signaling [Biologic Function]

Phrase: "contributes to the BDNF-induced increase"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   818   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   764   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   764   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   742   C0006104:Brain [Body Part, Organ, or Organ Component]
   742   C0205263:Induced [Functional Concept]
   742   C0442805:Increase [Functional Concept]
   742   C1269537:Brain [Body Part, Organ, or Organ Component]
   742   C1441547:Derived [Qualitative Concept]
   742   C1521761:Factor [Functional Concept]
   742   C1880177:Contribute [Activity]
   742   C2827422:Factor [Conceptual Entity]
   742   C3245521:derived [Idea or Concept]

Phrase: "in GAD"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0061472:Glutamic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0523665:Glutamic Acid [Laboratory Procedure]
   827   C0001128:Acid [Chemical]
   827   C0007054:Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0202406:Acid [Laboratory Procedure]

Phrase: "in presynaptic terminals."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0206181:Presynaptic Terminals [Cell Component]
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.165: View larger version (21K): [in this window] [in a new window]  Figure 4. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(21K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 4."
Processing 00000000.tx.166: Contribution of BDNF-TrkB signaling in postsynaptic neurons to the increase in presynaptic GAD65. 

Phrase: "Contribution of BDNF-TrkB signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880177:Contribution [Activity]

Phrase: "in postsynaptic neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "to the increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "in presynaptic GAD65."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   937   C2825893:Glutamic Acid Decarboxylase 65 [Laboratory Procedure]
   884   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   840   C0061472:Glutamic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   840   C0523665:Glutamic Acid [Laboratory Procedure]
   804   C0001128:Acid [Chemical]
   804   C0007054:Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   804   C0202406:Acid [Laboratory Procedure]
   804   C0450385:65 [Intellectual Product]
Processing 00000000.tx.167: (A) Top left: A fluorescent image of GAD65 staining (red) and a tTrkB + hrGFP-expressing neuron (green). 

Phrase: "(A) Top left"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0205091:Left [Spatial Concept]
   827   C1552822:left [Functional Concept]

Phrase: ":"

Phrase: "A fluorescent image of GAD65"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   744   C1704254:Image [Intellectual Product]
   744   C1704922:Image [Entity]
   744   C3542466:Image [Intellectual Product]

Phrase: "staining"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0487602:Staining [Laboratory Procedure]
  1000   C1704680:Staining [Finding]
   966 E C0038128:Stain [Indicator, Reagent, or Diagnostic Aid]

Phrase: "(red)"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "and"

Phrase: "a tTrkB + hrGFP-expressing neuron"
Meta Candidates (Total=13; Excluded=2; Pruned=0; Remaining=11)
   873   C0038164:a protein [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   797   C0997916:Renilla reniformis [Eukaryote]
   786   C0016315:Fluorescence [Natural Phenomenon or Process]
   786   C0027882:Neuron [Cell]
   786   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   786   C0332583:Green [Qualitative Concept]
   786   C0348078:Form [Qualitative Concept]
   786   C0376315:Form [Manufactured Object]
   786   C1093003:Renilla [Eukaryote]
   786   C1522492:Form [Functional Concept]
   785   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   715 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   715 E C0521390:Neuronal [Immunologic Factor]

Phrase: "(green"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332583:Green [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.168: Scale bar, 40 m. 

Phrase: "Scale bar,"

Phrase: "40 m."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.169: Middle: A clipped image of hrGFP (black) overlaid with that of GAD (red, intensified for clarity). 

Phrase: "Middle"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0444598:Middle [Spatial Concept]
  1000   C0549183:middle [Spatial Concept]
  1000   C1552826:middle [Idea or Concept]
   944 E C0205098:Medial [Spatial Concept]

Phrase: ":"

Phrase: "A clipped image of hrGFP"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   739   C1704254:Image [Intellectual Product]
   739   C1704922:Image [Entity]
   739   C3542466:Image [Intellectual Product]

Phrase: "(black"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0005680:Black [Population Group]
  1000   C0027567:Black [Population Group]
  1000   C0085756:Black [Population Group]
  1000   C0439541:Black [Qualitative Concept]

Phrase: ")"

Phrase: "overlaid with that of GAD"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   714   C0444456:Overlay [Spatial Concept]
   714   C1706359:Overlay [Medical Device]

Phrase: "(red,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332575:Red [Finding]
  1000   C1260956:Red [Qualitative Concept]

Phrase: "intensified for clarity"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0486588:Clarity [Clinical Attribute]
   790   C3272888:Clarity [Laboratory Procedure]
   718 E C2963144:Clear [Qualitative Concept]

Phrase: ")."
Processing 00000000.tx.170: Bottom right: A 3-fold magnification of part of the overlaid image. 

Phrase: "Bottom right"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0205090:Right [Spatial Concept]

Phrase: ":"

Phrase: "A 3-fold magnification of part of the overlaid image."
Processing 00000000.tx.171: (B) Attenuation of the BDNF-induced increase in GAD65 signal on tTrkB + hrGFP-expressing neurons. 

Phrase: "(B) Attenuation of the BDNF-induced increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   739   C0599946:Attenuation [Activity]

Phrase: "in GAD65 signal"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1710082:Signal [Phenomenon or Process]
   771   C2825893:Glutamic Acid Decarboxylase 65 [Laboratory Procedure]
   717   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "on tTrkB + hrGFP-expressing neurons."
Meta Candidates (Total=14; Excluded=2; Pruned=0; Remaining=12)
   797   C0997916:Renilla reniformis [Eukaryote]
   786   C0016315:Fluorescence [Natural Phenomenon or Process]
   786   C0027882:Neurons [Cell]
   786   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   786   C0332583:Green [Qualitative Concept]
   786   C0348078:Form [Qualitative Concept]
   786   C0376315:Form [Manufactured Object]
   786   C1093003:Renilla [Eukaryote]
   786   C1522492:Form [Functional Concept]
   786   C1720176:On [Functional Concept]
   786   C1720294:On [Intellectual Product]
   785   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   715 E C0303920:Fluorescent [Indicator, Reagent, or Diagnostic Aid,Organic Chemical]
   703 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.172: The average GAD65 signal intensities within the clipped images were measured, and the increase induced by 10 ng/ml BDNF treatment for 48 h is shown as a ratio to that obtained from control lacZ + hrGFP-expressing neurons (**P < 0.01 compared with the control, Student's t-test, n = 98175 neurons).  

Phrase: "The average GAD65 signal intensities within the clipped images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   736   C0522510:intensities [Qualitative Concept]
   736   C1710082:Signal [Phenomenon or Process]
   719   C0871362:signal intensity [Quantitative Concept]

Phrase: "were"

Phrase: "measured"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0444706:Measured [Qualitative Concept]
  1000   C3541902:MEASURED [Diagnostic Procedure]
   966 E C0079809:Measure [Quantitative Concept]
   966 E C0242485:Measure [Functional Concept]

Phrase: ","

Phrase: "and"

Phrase: "the increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]

Phrase: "induced by 10 ng/ml BDNF treatment"
Meta Candidates (Total=21; Excluded=0; Pruned=0; Remaining=21)
   806   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C0439275:ng/mL [Quantitative Concept]
   760   C0679853:factor treatment [Intellectual Product]
   760   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   739   C0006104:Brain [Body Part, Organ, or Organ Component]
   739   C0039798:treatment [Functional Concept]
   739   C0087111:Treatment [Therapeutic or Preventive Procedure]
   739   C0205263:Induced [Functional Concept]
   739   C0439526:/mL [Quantitative Concept]
   739   C1269537:Brain [Body Part, Organ, or Organ Component]
   739   C1441547:Derived [Qualitative Concept]
   739   C1521761:Factor [Functional Concept]
   739   C1522326:Treatment [Functional Concept]
   739   C1533734:Treatment [Therapeutic or Preventive Procedure]
   739   C1705169:Treatment [Conceptual Entity]
   739   C2827422:Factor [Conceptual Entity]
   739   C3245521:derived [Idea or Concept]
   739   C3538994:TREATMENT [Research Activity]

Phrase: "for 48 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "is"

Phrase: "shown as a ratio"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0456603:Ratio [Quantitative Concept]
   770   C1547037:Ratio [Intellectual Product]
   737   C1547282:Show [Intellectual Product]

Phrase: "to that"

Phrase: "obtained from control lacZ + hrGFP-expressing neurons"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   753   C0997916:Renilla reniformis [Eukaryote]
   747   C0120285:green fluorescent protein [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]
   736   C0016315:Fluorescence [Natural Phenomenon or Process]
   736   C0022959:LacZ [Gene or Genome]
   736   C0027882:Neurons [Cell]
   736   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   736   C0243148:control [Qualitative Concept]
   736   C0332583:Green [Qualitative Concept]
   736   C1093003:Renilla [Eukaryote]
   736   C1301820:Obtained [Functional Concept]
   736   C1550141:Control [Substance]
   736   C1882979:Control [Conceptual Entity]
   736   C2587213:Control [Functional Concept]
   736   C3274648:Control [Qualitative Concept]
   703 E C1706701:Obtain [Activity]

Phrase: "("

Phrase: "*"

Phrase: "*P < 0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with the control,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   770   C0243148:control [Qualitative Concept]
   770   C1550141:Control [Substance]
   770   C1707455:Compared [Activity]
   770   C1882979:Control [Conceptual Entity]
   770   C2587213:Control [Functional Concept]
   770   C3274648:Control [Qualitative Concept]

Phrase: "Student's t-test,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   827   C0022885:Test [Laboratory Procedure]
   827   C0038492:student [Professional or Occupational Group]
   827   C0039593:Test [Functional Concept]
   827   C0392366:test [Intellectual Product]
   827   C1551041:student [Idea or Concept]
   827   C1552573:student [Intellectual Product]

Phrase: "n = 98175 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.173: These results showed that postsynaptic signaling affected a protein in the GABAergic presynaptic terminals, suggesting the involvement of a retrograde mediator from post- to presynaptic terminals and/or signaling via adhesion. 

Phrase: "These results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "showed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that postsynaptic signaling"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0037083:Signaling [Cell Function]
   861   C3537152:signaling [Biologic Function]

Phrase: "affected"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0392760:Affected [Functional Concept]
  1000   C1314939:Affected [Functional Concept]
   966 E C0001721:Affect [Mental Process]

Phrase: "a protein in the GABAergic presynaptic terminals,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   778   C0038164:a protein [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "suggesting"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "the involvement of a retrograde mediator"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1314939:Involvement [Functional Concept]

Phrase: "from post-"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0687676:Post [Temporal Concept]
  1000   C1704687:Post [Manufactured Object]
   928 E C1514253:Postal [Functional Concept]

Phrase: "to presynaptic terminals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0206181:Presynaptic Terminals [Cell Component]
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]

Phrase: "and/or"

Phrase: "signaling via adhesion."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0037083:Signaling [Cell Function]
   790   C3537152:signaling [Biologic Function]
Processing 00000000.tx.174: The known retrograde mediators, NO and cannabinoid (Arancio et al., 1996; Kreitzer et al., 2002; Ohno-Shosaku et al., 2002), would not be involved, because neither L-NAME, an inhibitor of NO synthesis, nor AM281, a cannabinoid receptor (CB1) antagonist, significantly attenuated the increases in GAD65 immunofluorescence intensity (ratio of cultures without BDNF: BDNF only, 1.6  0.06; 

Phrase: "The known retrograde mediators,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0127400:mediators [Organic Chemical,Pharmacologic Substance]
   793 E C1363844:Mediator [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "NO"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1298908:no [Idea or Concept]
  1000   C1549444:No [Idea or Concept]

Phrase: "and"

Phrase: "cannabinoid"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0006864:Cannabinoid [Organic Chemical,Pharmacologic Substance]
  1000   C3536852:Cannabinoid [Pharmacologic Substance]

Phrase: "(Arancio et al.,"

Phrase: "1996"

Phrase: "; Kreitzer et al.,"

Phrase: "2002"

Phrase: "; Ohno-Shosaku et al.,"

Phrase: "2002"

Phrase: ")"

Phrase: ","

Phrase: "would"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "be"

Phrase: "involved"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involved [Functional Concept]

Phrase: ","

Phrase: "because"

Phrase: "neither L-NAME,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0083536:L-NAME [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0027365:Name [Intellectual Product]
   861   C1547383:Name [Intellectual Product]

Phrase: "an inhibitor of NO synthesis,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C1999216:Inhibitor [Qualitative Concept]

Phrase: "nor"

Phrase: "AM281,"

Phrase: "a cannabinoid receptor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0054594:cannabinoid receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0006864:Cannabinoid [Organic Chemical,Pharmacologic Substance]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C3536852:Cannabinoid [Pharmacologic Substance]

Phrase: "(CB1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1413554:CB1 [Gene or Genome]

Phrase: ")"

Phrase: "antagonist,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0231491:Antagonist [Organ or Tissue Function]
   900 E C0680242:antagonism [Social Behavior]

Phrase: "significantly"

Phrase: "attenuated"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332161:Attenuated [Qualitative Concept]
  1000   C0599946:Attenuated [Activity]

Phrase: "the increases in GAD65 immunofluorescence intensity"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:increases [Functional Concept]

Phrase: "(ratio of cultures"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0456603:Ratio [Quantitative Concept]
   790   C1547037:Ratio [Intellectual Product]

Phrase: "without BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: ":"

Phrase: "BDNF only,"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   937   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   840   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   840   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]
   804   C1441547:Derived [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   804   C3245521:derived [Idea or Concept]

Phrase: "1.6  0.06"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.175: +L-NAME, 1.6  0.01; 

Phrase: "+L-NAME,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0083536:L-NAME [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0027365:Name [Intellectual Product]
   861   C1547383:Name [Intellectual Product]

Phrase: "1.6  0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.176: and +AM281, 1.6  0.01; 

Phrase: "and +"

Phrase: "AM281,"

Phrase: "1.6  0.01"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C2827734:1+ [Quantitative Concept]
   812   C2981698:1+ [Classification]

Phrase: ";"
Processing 00000000.tx.177: n = 7 wells, respectively). 

Phrase: "n = 7 wells,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0205170:Well [Qualitative Concept]
   793   C3146287:Well [Manufactured Object]

Phrase: "respectively"

Phrase: ")."
Processing 00000000.tx.178: The levels of two of the main postsynaptic machineries  dystrophin, a scaffold protein for mature GABAergic synapses (Brunig et al., 2002), and extracellular GABAA receptor (detected without detergent treatment) (Brunig et al., 2001)  were not significantly affected by exogenously applied BDNF (10 ng/ml, 96  3.5% and 106  2.8%; 50 ng/ml, 108  3.5% and 104  6.8% of control for dystrophin and GABAA receptor, respectively; n = 7 wells). 

Phrase: "The levels of two of the main postsynaptic machineries  dystrophin,"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   739   C0441889:Levels [Qualitative Concept]
   706 E C0456079:Level [Classification]
   706 E C1547707:Level [Geographic Area]
   706 E C2946261:Level [Pharmacologic Substance]

Phrase: "a scaffold protein for mature GABAergic synapses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1179132:Scaffold protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   774   C0038164:Protein A [Amino Acid, Peptide, or Protein,Immunologic Factor,Indicator, Reagent, or Diagnostic Aid]
   748   C0033684:Protein [Amino Acid, Peptide, or Protein,Biologically Active Substance]

Phrase: "(Brunig et al.,"

Phrase: "2002"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "extracellular GABAA receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0034807:GABA(A) Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "("

Phrase: "detected without detergent treatment"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0011740:Detergent [Chemical Viewed Functionally]
   770   C0039798:treatment [Functional Concept]
   770   C0087111:Treatment [Therapeutic or Preventive Procedure]
   770   C0442726:Detected [Finding]
   770   C1511790:Detected [Therapeutic or Preventive Procedure]
   770   C1522326:Treatment [Functional Concept]
   770   C1533734:Treatment [Therapeutic or Preventive Procedure]
   770   C1705169:Treatment [Conceptual Entity]
   770   C3538994:TREATMENT [Research Activity]

Phrase: ")"

Phrase: "(Brunig et al.,"

Phrase: "2001"

Phrase: ")"

Phrase: "were"

Phrase: "not significantly"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "affected by exogenously applied BDNF"
Meta Candidates (Total=15; Excluded=1; Pruned=0; Remaining=14)
   833   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   770   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   770   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   744   C0006104:Brain [Body Part, Organ, or Organ Component]
   744   C0185125:Applied [Health Care Activity]
   744   C0392760:Affected [Functional Concept]
   744   C1269537:Brain [Body Part, Organ, or Organ Component]
   744   C1314939:Affected [Functional Concept]
   744   C1441547:Derived [Qualitative Concept]
   744   C1521761:Factor [Functional Concept]
   744   C2827422:Factor [Conceptual Entity]
   744   C3245521:derived [Idea or Concept]
   711 E C0001721:Affect [Mental Process]

Phrase: "(10 ng/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439275:ng/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "96  3.5%"

Phrase: "and"

Phrase: "106  2.8%"

Phrase: "; 50 ng/ml,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0439275:ng/mL [Quantitative Concept]
   827   C0439526:/mL [Quantitative Concept]

Phrase: "108  3.5%"

Phrase: "and"

Phrase: "104  6.8% of control"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0243148:control [Qualitative Concept]
   760   C1550141:Control [Substance]
   760   C1882979:Control [Conceptual Entity]
   760   C2587213:Control [Functional Concept]
   760   C3274648:Control [Qualitative Concept]

Phrase: "for dystrophin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079259:Dystrophin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1414083:DYSTROPHIN [Gene or Genome]

Phrase: "and"

Phrase: "GABAA receptor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0034807:GABA(A) Receptor [Amino Acid, Peptide, or Protein,Receptor]
   861   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "respectively"

Phrase: "; n = 7 wells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   793   C0205170:Well [Qualitative Concept]
   793   C3146287:Well [Manufactured Object]

Phrase: ")."
Processing 00000000.tx.179: The BDNF-induced Enhancement of GABA Release Probability Was not Observed in tTrkB-expressing Neurons To evaluate the effect of tTrkB expression on synaptic transmission, we recorded spontaneous and miniature GABAergic postsynaptic currents (sIPSCs and mIPSCs, respectively) in the cDNA-transfected excitatory neurons. 

Phrase: "The BDNF-induced Enhancement of GABA Release Probability"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   738   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   738   C2349975:Enhancement [Activity]

Phrase: "Was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "Observed in tTrkB-expressing Neurons To"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0027882:Neurons [Cell]
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C1441672:Observed [Functional Concept]
   742   C1522492:Form [Functional Concept]

Phrase: "evaluate"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0220825:Evaluate [Functional Concept]

Phrase: "the effect of tTrkB expression"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on synaptic transmission,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0027793:Synaptic Transmission [Cell Function]
   861   C0040722:transmission [Idea or Concept]
   861   C0242781:Transmission [Pathologic Function]
   861   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "we"

Phrase: "recorded"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0034869:Record [Intellectual Product]

Phrase: "spontaneous"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205359:Spontaneous [Functional Concept]

Phrase: "and"

Phrase: "miniature GABAergic postsynaptic currents"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C2350340:Postsynaptic Currents [Organ or Tissue Function]
   812   C0521116:currents [Temporal Concept]
   779 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "(sIPSCs"

Phrase: "and"

Phrase: "mIPSCs,"

Phrase: "respectively"

Phrase: ")"

Phrase: "in the cDNA-transfected excitatory neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.180: Following 48 h of BDNF treatment, the average frequency of sIPSCs, which indicates GABA-release probability, was clearly increased in the control lacZ-expressing neurons, while this effect was suppressed in the tTrkB-expressing neurons (Table 1, Fig. 5A,B). 

Phrase: "Following"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332282:Following [Temporal Concept]
   966 E C0332283:follow [Temporal Concept]
   966 E C1719822:Follow [Intellectual Product]

Phrase: "48 h of BDNF treatment,"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   767   C0056207:Factor H [Amino Acid, Peptide, or Protein,Immunologic Factor]
   767   C1538440:FACTOR H [Gene or Genome]
   744   C0033727:H+ [Element, Ion, or Isotope]
   744   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   744   C0441932:H+ [Classification]
   744   C0564385:/h [Quantitative Concept]

Phrase: "the average frequency of sIPSCs,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0376249:frequency [Quantitative Concept]
   760   C0439603:Frequency [Temporal Concept]
   760   C0871396:Frequency [Quantitative Concept]
   760   C1561548:Frequency [Qualitative Concept]
   760   C1705502:Frequency [Quantitative Concept]

Phrase: "which"

Phrase: "indicates"

Phrase: "GABA-release probability,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0033204:Probability [Quantitative Concept]
   755 E C0332148:Probable [Qualitative Concept]

Phrase: "was"

Phrase: "clearly"

Phrase: "increased in the control lacZ-expressing neurons,"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   748   C0022959:LacZ [Gene or Genome]
   748   C0027882:Neurons [Cell]
   748   C0205217:Increased [Quantitative Concept]
   748   C0243148:control [Qualitative Concept]
   748   C0442805:Increased [Functional Concept]
   748   C1550141:Control [Substance]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "while"

Phrase: "this effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "was"

Phrase: "suppressed in the tTrkB-expressing neurons"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   742   C0027882:Neurons [Cell]
   742   C0348078:Form [Qualitative Concept]
   742   C0376315:Form [Manufactured Object]
   742   C1260953:Suppressed [Functional Concept]
   742   C1522492:Form [Functional Concept]

Phrase: "(Table 1,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: "Fig. 5A,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1553637:5a [Medical Device]

Phrase: "B"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2347469:/B [Quantitative Concept]

Phrase: ")."
Processing 00000000.tx.181: These data for the control are consistent with those obtained from previous studies (Rutherford et al., 1997, 1998). 

Phrase: "These data for the control"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C1511726:Data [Idea or Concept]
   760   C3245479:data [Medical Device]

Phrase: "are"

Phrase: "consistent with those"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   882   C0332290:Consistent with [Idea or Concept]
           Consistent
   718 E C0332529:Consistencies [Qualitative Concept]
   718 E C1547017:Consistency [Quantitative Concept]

Phrase: "obtained from previous studies"
Meta Candidates (Total=7; Excluded=3; Pruned=0; Remaining=4)
   770   C0205156:Previous [Temporal Concept]
   770   C0947630:studies [Laboratory Procedure]
   770   C1301820:Obtained [Functional Concept]
   770   C1552607:previous [Temporal Concept]
   737 E C0557651:Study [Manufactured Object]
   737 E C1706701:Obtain [Activity]
   737 E C2603343:Study [Research Activity]

Phrase: "(Rutherford et al.,"

Phrase: "1997,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.182: In this experiment, CNQX, AP5 and intracellular QX314 were used to block excitatory neurotransmission and recurrent transmission from the neurons being analyzed. 

Phrase: "In this experiment,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0681814:Experiment [Research Activity]
  1000   C1706386:Experiment [Conceptual Entity]
   928 E C1517586:Experimental [Qualitative Concept]

Phrase: "CNQX,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0099122:CNQX [Organic Chemical,Pharmacologic Substance]

Phrase: "AP5"

Phrase: "and"

Phrase: "intracellular QX314"

Phrase: "were"

Phrase: "used"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C1273517:used [Finding]
   966 E C0042153:use [Functional Concept]
   966 E C0457083:Use [Functional Concept]
   966 E C1947944:Use [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "block"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0028778:Block [Pathologic Function]
  1000   C0332206:Block [Functional Concept]
  1000   C1533157:Block [Substance]
  1000   C1706084:Block [Geographic Area]
  1000   C2828370:Block [Quantitative Concept]

Phrase: "excitatory neurotransmission"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0027793:Neurotransmission [Cell Function]

Phrase: "and"

Phrase: "recurrent transmission from the neurons"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   760   C0040722:transmission [Idea or Concept]
   760   C0242781:Transmission [Pathologic Function]
   760   C1521797:Transmission [Natural Phenomenon or Process]
   756   C0027793:Neuronal Transmission [Cell Function]

Phrase: "being"

Phrase: "analyzed."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0936012:Analyzed [Research Activity]
Processing 00000000.tx.183: View this table: [in this window] [in a new window]  Table 1 BDNF increases the frequency of sIPSC in control lacZ-expressing neurons but not in tTrkB-expressing neurons  View larger version (14K): [in this window] [in a new window]  Figure 5. 

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "this table"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0039224:Table [Manufactured Object]
  1000   C1706073:Table [Medical Device]
  1000   C1706074:Table [Intellectual Product]

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Table 1 BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   901   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   799   C0006104:Brain [Body Part, Organ, or Organ Component]
   799   C1269537:Brain [Body Part, Organ, or Organ Component]
   799   C1441547:Derived [Qualitative Concept]
   799   C1521761:Factor [Functional Concept]
   799   C2827422:Factor [Conceptual Entity]
   799   C3245521:derived [Idea or Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "the frequency of sIPSC"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0376249:frequency [Quantitative Concept]
   770   C0439603:Frequency [Temporal Concept]
   770   C0871396:Frequency [Quantitative Concept]
   770   C1561548:Frequency [Qualitative Concept]
   770   C1705502:Frequency [Quantitative Concept]

Phrase: "in control lacZ-expressing neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "but"

Phrase: "not in tTrkB-expressing neurons"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0027882:Neurons [Cell]
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1518422:Not [Functional Concept]
   744   C1522492:Form [Functional Concept]

Phrase: "View"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0449911:View [Spatial Concept]

Phrase: "larger version"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0333052:Version [Functional Concept]
   861   C2607870:Version [Spatial Concept]

Phrase: "(14K"

Phrase: ")"

Phrase: ":"

Phrase: "["

Phrase: "in this window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0557702:Window [Manufactured Object]
  1000   C1272706:Window [Temporal Concept]
  1000   C1704674:Window [Manufactured Object]

Phrase: "]"

Phrase: "["

Phrase: "in a new window"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0557702:Window [Manufactured Object]
   861   C1272706:Window [Temporal Concept]
   861   C1704674:Window [Manufactured Object]

Phrase: "]  Figure 5."
Processing 00000000.tx.184: Contribution of BDNF-TrkB signaling in postsynaptic neurons to presynaptic change: BDNF increases GABA-release probability recorded in lacZ-expressing neurons but not in tTrkB-expressing neurons. 

Phrase: "Contribution of BDNF-TrkB signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1880177:Contribution [Activity]

Phrase: "in postsynaptic neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "to presynaptic change"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0392747:Change [Functional Concept]
   861   C0443172:change [Quantitative Concept]
   861   C1705241:Change [Quantitative Concept]

Phrase: ":"

Phrase: "BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "GABA-release probability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0033204:Probability [Quantitative Concept]
   755 E C0332148:Probable [Qualitative Concept]

Phrase: "recorded in lacZ-expressing neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0022959:LacZ [Gene or Genome]
   760   C0027882:Neurons [Cell]
   726   C0034869:Record [Intellectual Product]

Phrase: "but"

Phrase: "not in tTrkB-expressing neurons."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   744   C0027882:Neurons [Cell]
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1518422:Not [Functional Concept]
   744   C1522492:Form [Functional Concept]
Processing 00000000.tx.185: (A) Traces of spontaneous GABAergic postsynaptic currents recorded from lacZ- or tTrkB-expressing neurons cultured in the presence or absence of 10 ng/ml BDNF for 48 h from 7 days in vitro. 

Phrase: "(A)"

Phrase: "Traces of spontaneous GABAergic postsynaptic currents"
Meta Candidates (Total=7; Excluded=1; Pruned=0; Remaining=6)
   790   C2350340:Postsynaptic Currents [Organ or Tissue Function]
   753   C0205359:Spontaneous [Functional Concept]
   753   C0442822:Trace [Quantitative Concept]
   753   C0521116:currents [Temporal Concept]
   753   C1524031:Trace [Qualitative Concept]
   753   C1883002:Trace [Functional Concept]
   719 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "recorded from lacZ-"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0022959:LacZ [Gene or Genome]
   756   C0034869:Record [Intellectual Product]

Phrase: "or"

Phrase: "tTrkB-expressing neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "cultured in the presence"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0392148:Presence [Therapeutic or Preventive Procedure]
   737   C0010453:Culture [Idea or Concept]
   737   C0220814:culture [Functional Concept]
   737   C0430400:Culture [Laboratory Procedure]
   737   C2242979:Culture [Laboratory Procedure]

Phrase: "or"

Phrase: "absence of 10 ng/ml BDNF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0332197:absence [Quantitative Concept]
   742   C1689985:Absence [Anatomical Abnormality]

Phrase: "for 48 h"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "from 7 days in vitro."
Meta Candidates (Total=8; Excluded=2; Pruned=0; Remaining=6)
   861   C0021135:In Vitro [Intellectual Product]
   861   C1533691:in vitro [Qualitative Concept]
           vitro
   861   C1547085:7 days [Temporal Concept]
   861   C2827718:In Vitro [Functional Concept]
   812   C0439228:days [Temporal Concept]
   779 E C0332173:/day [Temporal Concept]
   779 E C0439505:/day [Temporal Concept]
Processing 00000000.tx.186: Scales, 100 pA, 5 s. 

Phrase: "Scales,"
Meta Candidates (Total=6; Excluded=4; Pruned=0; Remaining=2)
  1000   C0175659:Scales [Medical Device]
  1000   C0222045:Scales [Body Part, Organ, or Organ Component]
   966 E C0349674:Scale [Intellectual Product]
   966 E C1947916:Scale [Activity]
   966 E C3536777:Scale [Manufactured Object]
   916 E C1710017:Scalar [Qualitative Concept]

Phrase: "100 pA,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3541314:PA [Idea or Concept]

Phrase: "5 s."
Processing 00000000.tx.187: (B) BDNF-induced increases in GABA-release probability to the transfected neurons shown as percentages of the frequency of control neurons (*P < 0.05 compared with the control lacZ-expressing neurons, Mann-Whitney U-test, n = 3132 neurons).  

Phrase: "(B) BDNF-induced increases"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0442805:increases [Functional Concept]
   710   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "in GABA-release probability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0033204:Probability [Quantitative Concept]
   755 E C0332148:Probable [Qualitative Concept]

Phrase: "to the transfected neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "shown as percentages of the frequency of control neurons"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   742   C0027882:Neurons [Cell]
   742   C0243148:control [Qualitative Concept]
   742   C0376249:frequency [Quantitative Concept]
   742   C0439603:Frequency [Temporal Concept]
   742   C0871396:Frequency [Quantitative Concept]
   742   C1550141:Control [Substance]
   742   C1561548:Frequency [Qualitative Concept]
   742   C1705502:Frequency [Quantitative Concept]
   742   C1882979:Control [Conceptual Entity]
   742   C2587213:Control [Functional Concept]
   742   C3274648:Control [Qualitative Concept]
   708   C0439165:Percentage [Quantitative Concept]
   708   C1547282:Show [Intellectual Product]
   708   C1549488:Percentage [Idea or Concept]
   708   C1561533:Percentage [Idea or Concept]

Phrase: "("

Phrase: "*P < 0.05"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0369773:P NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C2603361:P' [Clinical Attribute]

Phrase: "compared with the control lacZ-expressing neurons,"
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   748   C0022959:LacZ [Gene or Genome]
   748   C0027882:Neurons [Cell]
   748   C0243148:control [Qualitative Concept]
   748   C1550141:Control [Substance]
   748   C1707455:Compared [Activity]
   748   C1882979:Control [Conceptual Entity]
   748   C2587213:Control [Functional Concept]
   748   C3274648:Control [Qualitative Concept]

Phrase: "Mann-Whitney U-test,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
  1000   C0242927:Mann-Whitney U Test [Quantitative Concept]
   923   C1708930:Mann-Whitney Test [Intellectual Product]
   812   C0022885:Test [Laboratory Procedure]
   812   C0039593:Test [Functional Concept]
   812   C0392366:test [Intellectual Product]

Phrase: "n = 3132 neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: ")."
Processing 00000000.tx.188: Postsynaptic TrkB signaling in a neuron was probably required for the BDNF-induced increase in GABA-release probability to the neurons.  

Phrase: "Postsynaptic TrkB signaling in a neuron"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0037083:Signaling [Cell Function]
   753   C3537152:signaling [Biologic Function]

Phrase: "was"

Phrase: "probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "required for the BDNF-induced increase"
Meta Candidates (Total=14; Excluded=0; Pruned=0; Remaining=14)
   818   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   764   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   764   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   742   C0006104:Brain [Body Part, Organ, or Organ Component]
   742   C0205263:Induced [Functional Concept]
   742   C0442805:Increase [Functional Concept]
   742   C1269537:Brain [Body Part, Organ, or Organ Component]
   742   C1441547:Derived [Qualitative Concept]
   742   C1514873:Required [Functional Concept]
   742   C1521761:Factor [Functional Concept]
   742   C2827422:Factor [Conceptual Entity]
   742   C3245521:derived [Idea or Concept]

Phrase: "in GABA-release probability"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0033204:Probability [Quantitative Concept]
   755 E C0332148:Probable [Qualitative Concept]

Phrase: "to the neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.189: Discussion Top Abstract Introduction Materials and Methods Results Discussion References  We have shown here that GABAergic presynaptic machinery was potentiated in a target-selective manner, and we suggest that BDNF-TrkB signaling in postsynaptic neurons contributes significantly to the underlying mechanism. 

Phrase: "Discussion Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "We"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "here"

Phrase: "that GABAergic presynaptic machinery"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0337076:machinery [Manufactured Object]

Phrase: "was"

Phrase: "potentiated in a target-selective manner,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C1521840:Target [Functional Concept]
   753   C2986546:TARGET [Diagnostic Procedure]

Phrase: "and"

Phrase: "we"

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that BDNF-TrkB signaling in postsynaptic neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C0037083:Signaling [Cell Function]
   739   C3537152:signaling [Biologic Function]

Phrase: "contributes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1880177:Contribute [Activity]

Phrase: "significantly to the underlying mechanism."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0441712:Mechanism [Functional Concept]
   760   C1706376:Mechanism [Manufactured Object]
Processing 00000000.tx.190: We observed that the signal level of GAD was selectively enhanced around neurons overexpressing BDNF. 

Phrase: "We"

Phrase: "observed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1441672:Observed [Functional Concept]

Phrase: "that"

Phrase: "the signal level of GAD"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0441889:Level [Qualitative Concept]
   748   C0456079:Level [Classification]
   748   C1547707:Level [Geographic Area]
   748   C2946261:Level [Pharmacologic Substance]

Phrase: "was"

Phrase: "selectively"

Phrase: "enhanced around neurons"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0027882:Neurons [Cell]
   790   C2349975:Enhanced [Activity]
   706 E C0521390:Neuronal [Immunologic Factor]

Phrase: "overexpressing"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1514559:overexpress [Genetic Function]

Phrase: "BDNF."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]
Processing 00000000.tx.191: This selectivity was confirmed by a quantitative analysis (Fig. 1C), even in comparison with neighboring neurons interposed between the BDNF-overexpressing neurons and inhibitory neurons, which probably receive GABAergic inputs from the same neurons. 

Phrase: "This selectivity"

Phrase: "was"

Phrase: "confirmed by a quantitative analysis"
Meta Candidates (Total=8; Excluded=1; Pruned=0; Remaining=7)
   806   C0521093:Confirmed by [Qualitative Concept]
           confirmed
   760   C0002778:Analysis [Laboratory Procedure]
   760   C0392762:Quantitative [Quantitative Concept]
   760   C0750484:Confirmed [Idea or Concept]
   760   C0936012:Analysis [Research Activity]
   760   C1524024:analysis [Functional Concept]
   726 E C1456348:Confirm [Qualitative Concept]

Phrase: "(Fig. 1C"

Phrase: ")"

Phrase: ","

Phrase: "even in comparison"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Comparison [Activity]

Phrase: "with neighboring neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "interposed between the BDNF-overexpressing neurons"
Meta Candidates (Total=15; Excluded=0; Pruned=0; Remaining=15)
   818   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   798   C1826397:NEURON-DERIVED NEUROTROPHIC FACTOR [Gene or Genome]
   798   C3472710:neuron-derived neurotrophic factor [Gene or Genome]
   764   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   764   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   742   C0006104:Brain [Body Part, Organ, or Organ Component]
   742   C0027882:Neurons [Cell]
   742   C1269537:Brain [Body Part, Organ, or Organ Component]
   742   C1441547:Derived [Qualitative Concept]
   742   C1521761:Factor [Functional Concept]
   742   C2827422:Factor [Conceptual Entity]
   742   C3245521:derived [Idea or Concept]
   708   C1514559:overexpress [Genetic Function]

Phrase: "and"

Phrase: "inhibitory neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "which probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "receive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Receive [Qualitative Concept]

Phrase: "GABAergic inputs from the same neurons."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1708517:Input [Conceptual Entity]
Processing 00000000.tx.192: This enhancement in the GAD signal probably reflects an increase in the protein level of the GAD enzyme within the presynaptic terminals, rather than synaptogenesis. 

Phrase: "This enhancement in the GAD signal probably"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   742   C2349975:Enhancement [Activity]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "an increase in the protein level of the GAD enzyme"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0442805:Increase [Functional Concept]

Phrase: "within the presynaptic terminals,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0206181:Presynaptic Terminals [Cell Component]
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]

Phrase: "rather than"

Phrase: "synaptogenesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597545:synaptogenesis [Organ or Tissue Function]
Processing 00000000.tx.193: This is because GAD-immunoreactive puncta, which probably represent presynaptic terminals, were found around almost all of the neurons but with less intensity, as shown in Figure 1B. 

Phrase: "This"

Phrase: "is"

Phrase: "because"

Phrase: "GAD-immunoreactive puncta,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C1500338:Punctum [Eukaryote]
   717   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "which probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "presynaptic terminals,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0206181:Presynaptic Terminals [Cell Component]
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]

Phrase: "were"

Phrase: "found around almost"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   790   C0150312:Found [Quantitative Concept]
   756 E C0243095:Find [Finding]

Phrase: "all of the neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0027882:Neurons [Cell]
   770   C0444868:All [Quantitative Concept]
   770   C3539085:All [Idea or Concept]

Phrase: "but with less intensity,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0233535:but [Mental or Behavioral Dysfunction]
   770   C0522510:Intensity [Qualitative Concept]

Phrase: "as"

Phrase: "shown in Figure 1B."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0450345:1B [Intellectual Product]
   737   C1547282:Show [Intellectual Product]
Processing 00000000.tx.194: Another possibility is that synaptogenesis is selectively enhanced in BDNF-treated neurons and that the newly generated synapses have intense GAD. 

Phrase: "Another possibility"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   928   C0332149:Possible [Qualitative Concept]
   928   C1705910:Possible [Qualitative Concept]
   928   C2362652:Possible [Qualitative Concept]

Phrase: "is"

Phrase: "that synaptogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0597545:synaptogenesis [Organ or Tissue Function]

Phrase: "is"

Phrase: "selectively"

Phrase: "enhanced in BDNF-treated neurons"
Meta Candidates (Total=18; Excluded=1; Pruned=0; Remaining=17)
   833   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   811   C1826397:NEURON-DERIVED NEUROTROPHIC FACTOR [Gene or Genome]
   811   C3472710:neuron-derived neurotrophic factor [Gene or Genome]
   770   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   770   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   744   C0006104:Brain [Body Part, Organ, or Organ Component]
   744   C0027882:Neurons [Cell]
   744   C0332293:treated [Therapeutic or Preventive Procedure]
   744   C1269537:Brain [Body Part, Organ, or Organ Component]
   744   C1441547:Derived [Qualitative Concept]
   744   C1521761:Factor [Functional Concept]
   744   C1522326:Treated [Functional Concept]
   744   C2349975:Enhanced [Activity]
   744   C2827422:Factor [Conceptual Entity]
   744   C3245521:derived [Idea or Concept]
   711 E C1292734:TREAT [Functional Concept]

Phrase: "and"

Phrase: "that"

Phrase: "the newly generated synapses"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0039062:Synapses [Body Space or Junction]
   793 E C0598501:Synapsis [Cell Function]
   793 E C1633000:Synapsis [Plant]

Phrase: "have"

Phrase: "intense GAD."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   923   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   861   C0061472:Glutamic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   861   C0523665:Glutamic Acid [Laboratory Procedure]
   812   C0001128:Acid [Chemical]
   812   C0007054:Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.195: However, this was not the case, at least for the similar GAD enhancement induced by exogenously applied BDNF (Fig. 3), because neither the frequency of the mIPSCs (Table 1) nor the levels of other synaptic proteins, dystrophin and extracellular GABAA receptor, were increased. 

Phrase: "However,"

Phrase: "this"

Phrase: "was"

Phrase: "not"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1518422:Not [Functional Concept]

Phrase: "the case,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0868928:Case [Functional Concept]
  1000   C1706255:CASE [Medical Device]
  1000   C1706256:Case [Conceptual Entity]

Phrase: "at least"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0439092:less [Intellectual Product]
   966   C0547044:Less [Qualitative Concept]

Phrase: "for the similar GAD enhancement"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   804   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   804   C2349975:Enhancement [Activity]
   717   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "induced by exogenously applied BDNF"
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   833   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   770   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   770   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   744   C0006104:Brain [Body Part, Organ, or Organ Component]
   744   C0185125:Applied [Health Care Activity]
   744   C0205263:Induced [Functional Concept]
   744   C1269537:Brain [Body Part, Organ, or Organ Component]
   744   C1441547:Derived [Qualitative Concept]
   744   C1521761:Factor [Functional Concept]
   744   C2827422:Factor [Conceptual Entity]
   744   C3245521:derived [Idea or Concept]

Phrase: "(Fig. 3"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0349966:Fig [Food]
   861   C1337208:FIG [Food]

Phrase: ")"

Phrase: ","

Phrase: "because"

Phrase: "neither the frequency of the mIPSCs"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0376249:frequency [Quantitative Concept]
   753   C0439603:Frequency [Temporal Concept]
   753   C0871396:Frequency [Quantitative Concept]
   753   C1561548:Frequency [Qualitative Concept]
   753   C1705502:Frequency [Quantitative Concept]

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")"

Phrase: "nor"

Phrase: "the levels of other synaptic proteins,"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   753   C0441889:Levels [Qualitative Concept]
   750   C0428479:Protein level [Laboratory or Test Result]
   719 E C0456079:Level [Classification]
   719 E C1547707:Level [Geographic Area]
   719 E C2946261:Level [Pharmacologic Substance]

Phrase: "dystrophin"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0079259:Dystrophin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1414083:DYSTROPHIN [Gene or Genome]

Phrase: "and"

Phrase: "extracellular GABAA receptor,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   901   C0034807:GABA(A) Receptor [Amino Acid, Peptide, or Protein,Receptor]
   827   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "were"

Phrase: "increased."
Meta Candidates (Total=8; Excluded=6; Pruned=0; Remaining=2)
  1000   C0205217:Increased [Quantitative Concept]
  1000   C0442805:Increased [Functional Concept]
   928 E C1517378:Gain [Quantitative Concept]
   907 E C0439661:Acquired [Temporal Concept]
   907 E C0442808:Increasing [Functional Concept]
   907 E C1301820:Obtain [Functional Concept]
   907 E C1706701:Acquire [Activity]
   907 E C3245488:acquired [Intellectual Product]
Processing 00000000.tx.196: Even if the results are due to synaptogenesis, the validity of this type of modulation is not necessarily limited to cultures, because inhibitory synaptogenesis occurs in the adult brain in an activity-dependent manner (Zito and Svoboda, 2002). 

Phrase: "Even"

Phrase: "if"

Phrase: "the results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "are due to synaptogenesis,"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   833   C0678226:Due to [Functional Concept]
           due
   770   C0597545:synaptogenesis [Organ or Tissue Function]
   770   C1551058:Are [Quantitative Concept]
   770   C3146286:Due [Idea or Concept]

Phrase: "the validity of this type of modulation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C2349101:Validity [Quantitative Concept]

Phrase: "is"

Phrase: "not necessarily"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1518422:Not [Functional Concept]

Phrase: "limited to cultures,"
Meta Candidates (Total=8; Excluded=5; Pruned=0; Remaining=3)
   790   C0010453:Cultures [Idea or Concept]
   790   C0439801:Limited [Functional Concept]
   790   C3542948:Limited [Intellectual Product]
   756 E C0220814:culture [Functional Concept]
   756 E C0430400:Culture [Laboratory Procedure]
   756 E C1549649:Limit [Idea or Concept]
   756 E C2242979:Culture [Laboratory Procedure]
   756 E C2349209:Limit [Conceptual Entity]

Phrase: "because"

Phrase: "inhibitory synaptogenesis"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597545:synaptogenesis [Organ or Tissue Function]

Phrase: "occurs in the adult brain"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0001675:Adult [Age Group]
   760   C0006104:Brain [Body Part, Organ, or Organ Component]
   760   C1269537:Brain [Body Part, Organ, or Organ Component]
   760   C1706450:Adult [Human]
   760   C1709305:Occur [Activity]
   760   C2745955:OCCUR [Temporal Concept]

Phrase: "in an activity-dependent manner"

Phrase: "(Zito"

Phrase: "and"

Phrase: "Svoboda,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.197: The most important finding presented here is that inhibitory potentiation like GAD increase can be found selectively in target neurons that are secreting BDNF. 

Phrase: "The most important finding"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0037088:Finding [Sign or Symptom]
   827   C0243095:Finding [Finding]
   827   C2825141:Finding [Finding]

Phrase: "presented"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0449450:Presented [Idea or Concept]
   966 E C0150312:Present [Quantitative Concept]

Phrase: "here"

Phrase: "is"

Phrase: "that inhibitory potentiation like GAD increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0279023:Potentiation [Therapeutic or Preventive Procedure]

Phrase: "can"

Phrase: "be"

Phrase: "found"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0150312:Found [Quantitative Concept]
   966 E C0243095:Find [Finding]

Phrase: "selectively in target neurons"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0027882:Neurons [Cell]
   770   C1521840:Target [Functional Concept]
   770   C2986546:TARGET [Diagnostic Procedure]

Phrase: "that"

Phrase: "are"

Phrase: "secreting BDNF."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   937   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   840   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   840   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]
   804   C1441547:Derived [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   804   C3245521:derived [Idea or Concept]
Processing 00000000.tx.198: Between the two possible underlying mechanisms of selectivity, our results support an initial effect of BDNF on postsynaptic neurons, which activates GABAergic presynaptic terminals via another trans-synaptic retrograde signal. 

Phrase: "Between the two possible underlying mechanisms"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0441712:Mechanisms [Functional Concept]
   779 E C1706376:Mechanism [Manufactured Object]

Phrase: "of selectivity,"

Phrase: "our results"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   966   C1274040:Result [Functional Concept]
   966   C1546471:Result [Idea or Concept]
   966   C2825142:Result [Finding]

Phrase: "support"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "an initial effect of BDNF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1280500:Effect [Qualitative Concept]
   744   C2348382:Effect [Qualitative Concept]

Phrase: "on postsynaptic neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "which"

Phrase: "activates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515877:Activate [Functional Concept]
  1000   C1879547:Activate [Activity]

Phrase: "GABAergic presynaptic terminals via another trans-synaptic retrograde signal."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   764   C0206181:Presynaptic Terminals [Cell Component]
           Synaptic Terminals
   708   C0205088:Terminal [Temporal Concept]
   708   C1705314:Terminal [Manufactured Object]
   708   C1705315:Terminal [Spatial Concept]
Processing 00000000.tx.199: This conclusion is drawn from the case of exogenous BDNF, in which the BDNF-induced increase in GAD signals was suppressed in terminals on the postsynaptic neurons deficient in BDNF-TrkB signaling. 

Phrase: "This conclusion"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707478:Conclusion [Idea or Concept]

Phrase: "is"

Phrase: "drawn from the case of exogenous BDNF,"
Meta Candidates (Total=18; Excluded=0; Pruned=0; Remaining=18)
   806   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   806   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   760   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   757   C0230041:brain case [Body Space or Junction]
   739   C0006104:Brain [Body Part, Organ, or Organ Component]
   739   C0205101:Exogenous [Spatial Concept]
   739   C0205228:Exogenous [Functional Concept]
   739   C0868928:Case [Functional Concept]
   739   C1269537:Brain [Body Part, Organ, or Organ Component]
   739   C1441547:Derived [Qualitative Concept]
   739   C1521761:Factor [Functional Concept]
   739   C1706255:CASE [Medical Device]
   739   C1706256:Case [Conceptual Entity]
   739   C2827422:Factor [Conceptual Entity]
   739   C3245521:derived [Idea or Concept]
   706   C0013113:Draw [Intellectual Product]

Phrase: "in which"

Phrase: "the BDNF-induced increase in GAD signals"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   736   C0442805:Increase [Functional Concept]

Phrase: "was"

Phrase: "suppressed in terminals"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C1260953:Suppressed [Functional Concept]
   756   C0205088:Terminal [Temporal Concept]
   756   C1705314:Terminal [Manufactured Object]
   756   C1705315:Terminal [Spatial Concept]

Phrase: "on the postsynaptic neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "deficient in BDNF-TrkB signaling."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0011155:Deficient [Functional Concept]
   744   C1636779:% deficient [Quantitative Concept]
Processing 00000000.tx.200: In this study, a small but significant increase in GAD due to BDNF was also observed in data from tTrkB-expressing neurons at the same time as the attenuation. 

Phrase: "In this study,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0557651:Study [Manufactured Object]
  1000   C2603343:Study [Research Activity]

Phrase: "a small"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0700321:Small [Quantitative Concept]

Phrase: "but"

Phrase: "significant increase in GAD"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0442805:Increase [Functional Concept]

Phrase: "due to BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "was"

Phrase: "also"

Phrase: "observed in data"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C1441672:Observed [Functional Concept]
   790   C1511726:Data [Idea or Concept]
   790   C3245479:data [Medical Device]

Phrase: "from tTrkB-expressing neurons"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   795   C0027882:Neurons [Cell]
   795   C0348078:Form [Qualitative Concept]
   795   C0376315:Form [Manufactured Object]
   795   C1517320:From [Qualitative Concept]
   795   C1522492:Form [Functional Concept]
   712 E C0521390:Neuronal [Immunologic Factor]

Phrase: "at the same time"
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
   861   C0040223:Time [Temporal Concept]
   861   C3541383:Time [Temporal Concept]
   805 E C0442043:Temporal [Spatial Concept]
   805 E C2362314:Temporal [Temporal Concept]
   777 E C1632851:Times [Quantitative Concept]

Phrase: "as the attenuation."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0599946:Attenuation [Activity]
Processing 00000000.tx.201: We believe that the main reason for this observation is the passing of enhanced signals from axons through the clipped images of the tTrkB-expressing neurons. 

Phrase: "We"

Phrase: "believe"

Phrase: "that"

Phrase: "the main reason for this observation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0392360:Reason [Idea or Concept]

Phrase: "is"

Phrase: "the passing of enhanced signals"

Phrase: "from axons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0004461:Axons [Cell Component]

Phrase: "through the clipped images"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C1704254:Image [Intellectual Product]
   827   C1704922:Image [Entity]
   827   C3542466:Image [Intellectual Product]

Phrase: "of the tTrkB-expressing neurons."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   793   C0027882:Neurons [Cell]
   793   C0332285:Of [Spatial Concept]
   793   C0348078:Form [Qualitative Concept]
   793   C0376315:Form [Manufactured Object]
   793   C1522492:Form [Functional Concept]
   710 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.202: BDNF has been shown to enhance the elongation and branching of axons of GABAergic neurons (Vicario-Abejon et al., 1998), and is thought to directly affect the soma and dendrites of inhibitory neurons in a similar fashion (Fawcett et al., 2000; Kohara et al., 2003). 

Phrase: "BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "has"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "enhance"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349975:Enhance [Activity]

Phrase: "the elongation"

Phrase: "and"

Phrase: "branching of axons of GABAergic neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   767   C3546325:axon branching [Cell Function]
   753   C0205384:Branching [Spatial Concept]

Phrase: "(Vicario-Abejon et al.,"

Phrase: "1998"

Phrase: ")"

Phrase: ","

Phrase: "and"

Phrase: "is"

Phrase: "thought"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039869:Thought [Mental Process]

Phrase: "to directly"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1883351:To [Qualitative Concept]
   861   C1947931:Directly [Qualitative Concept]

Phrase: "affect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0001721:Affect [Mental Process]

Phrase: "the soma"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
  1000   C0599444:soma [Cell Component]
  1000   C0702216:Soma [Organic Chemical,Pharmacologic Substance]
   944 E C0007248:Carisoprodol [Organic Chemical,Pharmacologic Substance]
   907 E C2986476:Somatic [Qualitative Concept]

Phrase: "and"

Phrase: "dendrites of inhibitory neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0011305:Dendrites [Cell Component]

Phrase: "in a similar fashion"

Phrase: "(Fawcett et al.,"

Phrase: "2000"

Phrase: "; Kohara et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.203: The increase in tTrkB-expressing neurons may be due to these direct actions of BDNF on GABAergic neurons, since BDNF was applied in the medium, thus affecting all the neurons, including the inhibitory neurons. 

Phrase: "The increase in tTrkB-expressing neurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0442805:Increase [Functional Concept]

Phrase: "may"

Phrase: "be due to these direct actions of BDNF"
Meta Candidates (Total=19; Excluded=1; Pruned=0; Remaining=18)
   797   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   797   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   756   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   756   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   756   C0678226:Due to [Functional Concept]
           due
   756   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   738   C0006104:Brain [Body Part, Organ, or Organ Component]
   738   C0439851:Direct [Qualitative Concept]
   738   C0441472:actions [Functional Concept]
   738   C1269537:Brain [Body Part, Organ, or Organ Component]
   738   C1441547:Derived [Qualitative Concept]
   738   C1521761:Factor [Functional Concept]
   738   C1947931:Direct [Qualitative Concept]
   738   C2827422:Factor [Conceptual Entity]
   738   C2987476:Be [Conceptual Entity]
   738   C3146286:Due [Idea or Concept]
   738   C3245521:derived [Idea or Concept]
   704 E C3266814:Action [Activity]

Phrase: "on GABAergic neurons,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C0815002:GABAergic Neurons [Cell]
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "since"

Phrase: "BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "was"

Phrase: "applied in the medium,"
Meta Candidates (Total=7; Excluded=2; Pruned=0; Remaining=5)
   770   C0009458:Medium [Intellectual Product]
   770   C0185125:Applied [Health Care Activity]
   770   C0439536:Medium [Quantitative Concept]
   770   C1705217:Medium [Substance]
   770   C3244283:medium [Intellectual Product]
   737 E C1632850:Apply [Functional Concept]
   737 E C1879355:Apply [Functional Concept]

Phrase: "thus affecting"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0392760:Affecting [Functional Concept]
   861   C1314939:Affecting [Functional Concept]
   827 E C0001721:Affect [Mental Process]

Phrase: "all the neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "including"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0332257:Including [Functional Concept]
   966 E C1552866:include [Idea or Concept]
   966 E C2700399:Include [Activity]

Phrase: "the inhibitory neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.204: Alternatively, the suppression by tTrkB might be partial. 

Phrase: "Alternatively,"

Phrase: "the suppression by tTrkB"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0221103:Suppression [Pathologic Function]
   748   C0301625:Suppression [Organism Function]
   748   C0439181:% suppression [Quantitative Concept]
   748   C0728721:suppression [Mental Process]

Phrase: "might"

Phrase: "be"

Phrase: "partial."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0728938:Partial [Quantitative Concept]
  1000   C1550516:partial [Idea or Concept]
Processing 00000000.tx.205: This is possible because there was an upward tendency in the amplitudes of mIPSCs and sIPSCs in the tTrkB-expressing neurons cultured without exogenous BDNF. 

Phrase: "This"

Phrase: "is"

Phrase: "possible"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0332149:Possible [Qualitative Concept]
  1000   C1705910:Possible [Qualitative Concept]
  1000   C2362652:Possible [Qualitative Concept]

Phrase: "because"

Phrase: "there"

Phrase: "was"

Phrase: "an upward tendency in the amplitudes of mIPSCs"

Phrase: "and"

Phrase: "sIPSCs in the tTrkB-expressing neurons"

Phrase: "cultured without exogenous BDNF."
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   853   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   853   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   778   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   778   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   778   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   748   C0006104:Brain [Body Part, Organ, or Organ Component]
   748   C0205101:Exogenous [Spatial Concept]
   748   C0205228:Exogenous [Functional Concept]
   748   C1269537:Brain [Body Part, Organ, or Organ Component]
   748   C1441547:Derived [Qualitative Concept]
   748   C1521761:Factor [Functional Concept]
   748   C2827422:Factor [Conceptual Entity]
   748   C3245521:derived [Idea or Concept]
   714   C0010453:Culture [Idea or Concept]
   714   C0220814:culture [Functional Concept]
   714   C0430400:Culture [Laboratory Procedure]
   714   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.206: This probably reflects an acute inhibitory effect of endogenous BDNF mediated by GABAA receptor phosphorylation (Jovanovic et al., 2004) (Table 1). 

Phrase: "This probably"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0750492:Probably [Idea or Concept]

Phrase: "reflects"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: "an acute inhibitory effect of endogenous BDNF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   739   C1280500:Effect [Qualitative Concept]
   739   C2348382:Effect [Qualitative Concept]

Phrase: "mediated by GABAA receptor phosphorylation"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   806   C0034807:GABA(A) Receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C0031715:Phosphorylation [Molecular Function]
   760   C0086597:mediated [Social Behavior]
   760   C0127400:Mediated [Organic Chemical,Pharmacologic Substance]
   760   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]
   760   C1158886:Phosphorylation [Molecular Function]

Phrase: "(Jovanovic et al.,"

Phrase: "2004"

Phrase: ")"

Phrase: "(Table 1"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0039224:Table [Manufactured Object]
   861   C1706073:Table [Medical Device]
   861   C1706074:Table [Intellectual Product]

Phrase: ")."
Processing 00000000.tx.207: This tendency was not significant, but it suggests that exogenous BDNF partially acts in the longer term as compared with Fos induction. 

Phrase: "This tendency"

Phrase: "was"

Phrase: "not significant,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C1273937:Not significant [Finding]
   861   C0237881:significant [Quantitative Concept]
   861   C0750502:Significant [Idea or Concept]
   861   C1546944:Significant [Qualitative Concept]

Phrase: "but"

Phrase: "it"

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that exogenous BDNF partially"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   901   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   901   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   827   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   827   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   799   C0006104:Brain [Body Part, Organ, or Organ Component]
   799   C1269537:Brain [Body Part, Organ, or Organ Component]
   799   C1441547:Derived [Qualitative Concept]
   799   C1521761:Factor [Functional Concept]
   799   C2827422:Factor [Conceptual Entity]
   799   C3245521:derived [Idea or Concept]

Phrase: "acts in the longer term"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   773   C0443252:Long-term [Temporal Concept]
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C1515273:Term [Temporal Concept]
   760   C1705313:Term [Idea or Concept]
   760   C2826302:TERM [Intellectual Product]
   726   C0205166:Long [Qualitative Concept]
   726   C1706317:Long [Qualitative Concept]

Phrase: "as"

Phrase: "compared with Fos induction."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0205263:Induction [Functional Concept]
   770   C0857127:induction [Therapeutic or Preventive Procedure]
   770   C1707455:Compared [Activity]
Processing 00000000.tx.208: Nevertheless, a significant suppression of BDNF action on GAD intensity and frequency of sIPSCs was found in tTrkB-expressing neurons. 

Phrase: "Nevertheless,"

Phrase: "a significant suppression of BDNF action"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   742   C0221103:Suppression [Pathologic Function]
   742   C0301625:Suppression [Organism Function]
   742   C0439181:% suppression [Quantitative Concept]
   742   C0728721:suppression [Mental Process]

Phrase: "on GAD intensity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   812   C0522510:Intensity [Qualitative Concept]
   756   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "frequency of sIPSCs"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   790   C0376249:frequency [Quantitative Concept]
   790   C0439603:Frequency [Temporal Concept]
   790   C0871396:Frequency [Quantitative Concept]
   790   C1561548:Frequency [Qualitative Concept]
   790   C1705502:Frequency [Quantitative Concept]
   718 E C0332183:Frequent [Temporal Concept]

Phrase: "was"

Phrase: "found in tTrkB-expressing neurons."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   744   C0027882:Neurons [Cell]
   744   C0150312:Found [Quantitative Concept]
   744   C0348078:Form [Qualitative Concept]
   744   C0376315:Form [Manufactured Object]
   744   C1522492:Form [Functional Concept]
   711 E C0243095:Find [Finding]
Processing 00000000.tx.209: This supports the observation that BDNF acts via a mechanism involving postsynaptic TrkB signaling, resulting in these effects. 

Phrase: "This"

Phrase: "supports"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0183683:Support [Medical Device]
  1000   C1521721:Support [Conceptual Entity]

Phrase: "the observation"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
  1000   C0302523:Observation [Research Activity]
  1000   C0700325:observation [Health Care Activity]
  1000   C1964257:Observation [Diagnostic Procedure]
   928 E C1518527:OBSERVATIONAL [Research Activity]

Phrase: "that BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "acts via a mechanism"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0079613:ACT [Therapeutic or Preventive Procedure]
   770   C0441712:Mechanism [Functional Concept]
   770   C1706376:Mechanism [Manufactured Object]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "postsynaptic TrkB signaling,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0037083:Signaling [Cell Function]
   827   C3537152:signaling [Biologic Function]

Phrase: "resulting in these effects."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   833   C0332294:Resulting in [Functional Concept]
   770   C0678226:resulting [Functional Concept]
   770   C1280500:effects [Qualitative Concept]
   737 E C1274040:Result [Functional Concept]
   737 E C1546471:Result [Idea or Concept]
   737 E C2348382:Effect [Qualitative Concept]
   737 E C2825142:Result [Finding]
Processing 00000000.tx.210: The underlying mechanism of this increase in the frequency of sIPSCs is hardly attributable to an increase in the firing rate of presynaptic GABAergic neurons, because the tTrkB neurons, which represent only one of many target neurons of GABAergic neurons, are few in number as compared with the other intact target neurons. 

Phrase: "The underlying mechanism of this increase"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0441712:Mechanism [Functional Concept]
   753   C1706376:Mechanism [Manufactured Object]

Phrase: "in the frequency"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
  1000   C0376249:frequency [Quantitative Concept]
  1000   C0439603:Frequency [Temporal Concept]
  1000   C0871396:Frequency [Quantitative Concept]
  1000   C1561548:Frequency [Qualitative Concept]
  1000   C1705502:Frequency [Quantitative Concept]
   928 E C0332183:Frequent [Temporal Concept]

Phrase: "of sIPSCs"

Phrase: "is"

Phrase: "hardly attributable to an increase"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0596130:Attributable [Mental Process]

Phrase: "in the firing rate"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   861   C0871208:Rate [Activity]
   861   C1521828:Rate [Quantitative Concept]
   827   C0016141:Fire [Phenomenon or Process]
   827   C0700614:Fire [Natural Phenomenon or Process]
   827   C0702194:Fire [Human-caused Phenomenon or Process]
   827   C1880775:FIRE [Event]

Phrase: "of presynaptic GABAergic neurons,"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   901   C0815002:GABAergic Neurons [Cell]
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "because"

Phrase: "the tTrkB neurons,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0348078:Form [Qualitative Concept]
   753   C0376315:Form [Manufactured Object]
   753   C1522492:Form [Functional Concept]

Phrase: "which"

Phrase: "represent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1882932:Represent [Activity]

Phrase: "only one of many target neurons of GABAergic neurons,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0205447:One [Quantitative Concept]

Phrase: "are"

Phrase: "few in number"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   790   C0205388:Few [Quantitative Concept]
   790   C0237753:*Number [Quantitative Concept]
   790   C0449788:Number [Quantitative Concept]

Phrase: "as"

Phrase: "compared with the"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C1707455:Compared [Activity]

Phrase: "other intact target neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.211: Alternatively, a change in the failure rate of GABAergic synapses is probable. 

Phrase: "Alternatively,"

Phrase: "a change in the failure rate of GABAergic synapses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0392747:Change [Functional Concept]
   742   C0443172:change [Quantitative Concept]
   742   C1705241:Change [Quantitative Concept]

Phrase: "is"

Phrase: "probable."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0033204:Probable [Quantitative Concept]
  1000   C0332148:Probable [Qualitative Concept]
Processing 00000000.tx.212: Failure is a property of synapses that miss transmitter release upon cell firing and is observed in many types of GABAergic synapses. 

Phrase: "Failure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231174:Failure [Functional Concept]
  1000   C0680095:failure [Individual Behavior]

Phrase: "is"

Phrase: "a property of synapses"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0871161:Property [Qualitative Concept]
   770   C1882134:Property [Conceptual Entity]
   770   C2347695:Property [Entity]

Phrase: "that"

Phrase: "miss"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2349206:Miss [Conceptual Entity]

Phrase: "transmitter release upon cell firing"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   760   C0030685:Release [Health Care Activity]
   760   C0391871:Release [Functional Concept]
   760   C0439180:% release [Quantitative Concept]
   760   C0680255:release [Health Care Activity]
   760   C1283071:Release [Functional Concept]
   760   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "and"

Phrase: "is"

Phrase: "observed in many types of GABAergic synapses."
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
   748   C0039062:Synapses [Body Space or Junction]
   748   C0332307:Types [Qualitative Concept]
   748   C1441672:Observed [Functional Concept]
   714 E C0598501:Synapsis [Cell Function]
   714 E C1547052:*Type [Quantitative Concept]
   714 E C1633000:Synapsis [Plant]
Processing 00000000.tx.213: For example, the connections between lacunosum-moleculare interneurons and pyramidal cells in the hippocampus exhibit a high failure rate ranging from 22 to 93% (Bertrand and Lacaille, 2001). 

Phrase: "For example,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1707959:Example [Conceptual Entity]

Phrase: "the connections between lacunosum-moleculare interneurons"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0449379:connections [Intellectual Product]

Phrase: "and"

Phrase: "pyramidal cells in the hippocampus"
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   806   C0206441:Pyramidal Cells [Cell]
   773 E C2334588:Pyramidal cell [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]

Phrase: "exhibit"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0015272:Exhibit [Intellectual Product]

Phrase: "a high failure rate ranging from 22"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   714   C1514721:Range [Quantitative Concept]
   714   C2348147:Range [Quantitative Concept]
   714   C3542016:Range [Intellectual Product]

Phrase: "to 93%"

Phrase: "(Bertrand"

Phrase: "and"

Phrase: "Lacaille,"

Phrase: "2001"

Phrase: ")."
Processing 00000000.tx.214: Since this failure is a process that can be controlled at each presynaptic site, it is hypothesized that BDNF decreases the failure, and the sIPSC thus becomes more frequent. 

Phrase: "Since"

Phrase: "this failure"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231174:Failure [Functional Concept]
  1000   C0680095:failure [Individual Behavior]

Phrase: "is"

Phrase: "a process"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1184743:Process [Body Part, Organ, or Organ Component]
  1000   C1522240:Process [Phenomenon or Process]

Phrase: "that"

Phrase: "can"

Phrase: "be"

Phrase: "controlled at each presynaptic site,"
Meta Candidates (Total=8; Excluded=4; Pruned=0; Remaining=4)
   760   C0205145:Site [Spatial Concept]
   760   C1515974:Site [Body Location or Region]
   760   C2587213:Controlled [Functional Concept]
   760   C2825164:Site [Spatial Concept]
   726 E C0243148:control [Qualitative Concept]
   726 E C1550141:Control [Substance]
   726 E C1882979:Control [Conceptual Entity]
   726 E C3274648:Control [Qualitative Concept]

Phrase: "it"

Phrase: "is"

Phrase: "hypothesized"

Phrase: "that BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "decreases"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0392756:Decrease [Qualitative Concept]
  1000   C0547047:Decrease [Quantitative Concept]

Phrase: "the failure,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231174:Failure [Functional Concept]
  1000   C0680095:failure [Individual Behavior]

Phrase: "and"

Phrase: "the sIPSC thus"

Phrase: "becomes"

Phrase: "more frequent."
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0332183:Frequent [Temporal Concept]
   789 E C0376249:frequency [Quantitative Concept]
   789 E C0439603:Frequencies [Temporal Concept]
   789 E C0871396:Frequency [Quantitative Concept]
   789 E C1561548:Frequency [Qualitative Concept]
   789 E C1705502:Frequency [Quantitative Concept]
Processing 00000000.tx.215: This effect would be influential in discriminating between one of several target neurons, and even between one of several synapses. 

Phrase: "This effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "would"

Phrase: "be"

Phrase: "influential in discriminating"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   790   C0021399:influential [Idea or Concept]

Phrase: "between one"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205447:One [Quantitative Concept]

Phrase: "of several target neurons,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]

Phrase: "and"

Phrase: "even between one of several synapses."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   753   C0039062:Synapses [Body Space or Junction]
   753   C0205447:One [Quantitative Concept]
   719 E C0598501:Synapsis [Cell Function]
   719 E C1633000:Synapsis [Plant]
Processing 00000000.tx.216: Our findings suggest that the frequency of GABAergic input onto a neuron can reflect, at least partially, the amount of BDNF expressed by the postsynaptic neuron. 

Phrase: "Our findings"
Meta Candidates (Total=6; Excluded=3; Pruned=0; Remaining=3)
  1000   C2607943:findings [Functional Concept]
  1000   C2926606:Findings [Clinical Attribute]
  1000   C3539655:Findings [Intellectual Product]
   966 E C0037088:Finding [Sign or Symptom]
   966 E C0243095:Finding [Finding]
   966 E C2825141:Finding [Finding]

Phrase: "suggest"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "that"

Phrase: "the frequency of GABAergic input"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0376249:frequency [Quantitative Concept]
   760   C0439603:Frequency [Temporal Concept]
   760   C0871396:Frequency [Quantitative Concept]
   760   C1561548:Frequency [Qualitative Concept]
   760   C1705502:Frequency [Quantitative Concept]

Phrase: "onto a neuron"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neuron [Cell]
   928 E C0521390:Neuronal [Immunologic Factor]

Phrase: "can"

Phrase: "reflect"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0558058:reflect [Mental Process]

Phrase: ","

Phrase: "at least partially,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0439092:less [Intellectual Product]
   827   C0547044:Less [Qualitative Concept]

Phrase: "the amount of BDNF"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1265611:Amount [Quantitative Concept]

Phrase: "expressed by the postsynaptic neuron."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0027882:Neuron [Cell]
Processing 00000000.tx.217: Since BDNF is expressed in an activity-dependent manner, this BDNF action would contribute to a method by which neurons in existing neural circuits avoid excess intervention by new inputs or new information (Abbott and Nelson, 2000; Hasselmo, 1994). 

Phrase: "Since"

Phrase: "BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "is"

Phrase: "expressed in an activity-dependent manner,"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   753   C0205177:Activity [Functional Concept]
   753   C0439167:% activity [Quantitative Concept]
   753   C0441655:Activity [Activity]
   753   C0851827:Dependent [Qualitative Concept]
   753   C1561536:*Activity [Idea or Concept]
   753   C1701901:Dependent [Qualitative Concept]
   753   C3244310:dependent [Functional Concept]

Phrase: "this BDNF action"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C0441472:Action [Functional Concept]
   804   C3266814:Action [Activity]
   771   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   771   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "would"

Phrase: "contribute to a method"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0025663:Method [Intellectual Product]
   770   C0449851:Method [Functional Concept]
   770   C0871511:METHOD [Intellectual Product]
   770   C1880177:Contribute [Activity]

Phrase: "by which neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "in existing neural circuits"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   901   C0814033:neural circuits [Body Part, Organ, or Organ Component]

Phrase: "avoid"

Phrase: "excess intervention by new inputs"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0886296:intervention [Health Care Activity]
   760   C1273869:Intervention [Health Care Activity]
   760   C1948041:Intervention [Therapeutic or Preventive Procedure]

Phrase: "or"

Phrase: "new information"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C3242228:new information [Intellectual Product]
   861   C1533716:Information [Idea or Concept]
   789 E C3242430:informational [Idea or Concept]

Phrase: "(Abbott"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0331761:Abbott [Health Care Related Organization]

Phrase: "and"

Phrase: "Nelson,"

Phrase: "2000"

Phrase: "; Hasselmo,"

Phrase: "1994"

Phrase: ")."
Processing 00000000.tx.218: This would be in addition to the homeostatic stabilization, which has been suggested earlier (Rutherford et al., 1997, 1998). 

Phrase: "This"

Phrase: "would"

Phrase: "be in addition to the homeostatic stabilization,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0019868:homeostatic [Biologic Function]
   748   C1293130:Stabilisation [Therapeutic or Preventive Procedure]
   748   C1883712:Addition [Functional Concept]
   748   C2987476:Be [Conceptual Entity]

Phrase: "which"

Phrase: "has"

Phrase: "been"

Phrase: "suggested"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1705535:Suggest [Idea or Concept]

Phrase: "earlier"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1279919:Early [Temporal Concept]

Phrase: "(Rutherford et al.,"

Phrase: "1997,"

Phrase: "1998"

Phrase: ")."
Processing 00000000.tx.219: Recently, GABAergic neurons in the hippocampus have been shown to fire synchronously in response to the rhythmic brain waves (theta waves) often observed in exploring animals (Klausberger et al., 2003). 

Phrase: "Recently,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332185:Recently [Temporal Concept]

Phrase: "GABAergic neurons in the hippocampus"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   806   C0815002:GABAergic Neurons [Cell]
   760   C0027882:Neurons [Cell]

Phrase: "have"

Phrase: "been"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "fire"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0016141:Fire [Phenomenon or Process]
  1000   C0700614:Fire [Natural Phenomenon or Process]
  1000   C0702194:Fire [Human-caused Phenomenon or Process]
  1000   C1880775:FIRE [Event]

Phrase: "synchronously in response"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0871261:Response [Organism Attribute]
   790   C1704632:Response [Finding]
   790   C1706817:Response [Intellectual Product]
   790   C2911692:Response [Mental Process]

Phrase: "to the rhythmic brain waves"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   901   C0678909:Brain Waves [Organ or Tissue Function]
   827   C0006104:Brain [Body Part, Organ, or Organ Component]
   827   C0678544:waves [Natural Phenomenon or Process]
   827   C1269537:Brain [Body Part, Organ, or Organ Component]
   793 E C1421479:WAVE [Gene or Genome]

Phrase: "(theta waves"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0439101:Theta [Intellectual Product]
   861   C0678544:waves [Natural Phenomenon or Process]
   861   C1422662:THETA [Gene or Genome]
   827 E C1421479:WAVE [Gene or Genome]

Phrase: ")"

Phrase: "often"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332183:Often [Temporal Concept]

Phrase: "observed in exploring animals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0003062:Animals [Animal]
   770   C1441672:Observed [Functional Concept]

Phrase: "(Klausberger et al.,"

Phrase: "2003"

Phrase: ")."
Processing 00000000.tx.220: It is likely that such synchronous oscillations of inhibitory inputs would delay or prevent the firings of neurons. 

Phrase: "It"

Phrase: "is"

Phrase: "likely"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0332148:Likely [Qualitative Concept]
  1000   C0750492:Likely [Idea or Concept]

Phrase: "that"

Phrase: "such synchronous oscillations of inhibitory inputs"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C0695434:oscillations [Therapeutic or Preventive Procedure]

Phrase: "would"

Phrase: "delay"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205421:Delay [Temporal Concept]

Phrase: "or"

Phrase: "prevent"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0309872:PREVENT [Pharmacologic Substance]

Phrase: "the firings of neurons."
Processing 00000000.tx.221: In such environments, neurons that are innervated by more enforced inhibitory presynaptic terminals would remain silent as compared with other neurons, and would fail to reinforce their connections with excitatory inputs. 

Phrase: "In such environments,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0014406:Environments [Spatial Concept]

Phrase: "neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0027882:Neurons [Cell]
   916 E C0521390:Neuronal [Immunologic Factor]

Phrase: "that"

Phrase: "are"

Phrase: "innervated by more enforced inhibitory presynaptic terminals"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   778   C0206181:Presynaptic Terminals [Cell Component]
   748   C3463820:Inhibitory [Activity]
   714   C0205088:Terminal [Temporal Concept]
   714   C1705314:Terminal [Manufactured Object]
   714   C1705315:Terminal [Spatial Concept]

Phrase: "would"

Phrase: "remain"

Phrase: "silent"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C0443304:Silent [Qualitative Concept]
   928 E C0858952:silence [Mental or Behavioral Dysfunction]

Phrase: "as"

Phrase: "compared with other neurons,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0027882:Neurons [Cell]
   770   C1707455:Compared [Activity]

Phrase: "and"

Phrase: "would"

Phrase: "fail"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0231175:fail [Functional Concept]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "reinforce"

Phrase: "their connections with excitatory inputs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0449379:connections [Intellectual Product]
Processing 00000000.tx.222: Several hours after the repeated activation of a circuit, BDNF should be expressed by constituent neurons and should act to induce these neurons to receive such potentiated inhibitory inputs. 

Phrase: "Several hours after the repeated activation of a circuit,"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C0439227:hours [Temporal Concept]
   708 E C0564385:/hour [Quantitative Concept]

Phrase: "BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "should"

Phrase: "be"

Phrase: "expressed by constituent neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0027882:Neurons [Cell]
   770   C0729650:constituent [Substance]

Phrase: "and"

Phrase: "should"

Phrase: "act"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0079613:ACT [Therapeutic or Preventive Procedure]

Phrase: "to"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1883351:To [Qualitative Concept]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "these neurons to"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]

Phrase: "receive"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1514756:Receive [Qualitative Concept]

Phrase: "such potentiated inhibitory inputs."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1708517:Input [Conceptual Entity]
Processing 00000000.tx.223: This role of BDNF may have relation to a phenotype of mice which is deficient for the TrkB in the forebrain. 

Phrase: "This role of BDNF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0035820:Role [Social Behavior]
   748   C1705810:Role [Conceptual Entity]

Phrase: "may"

Phrase: "have"

Phrase: "relation to a phenotype of mice"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0080103:Relation [Family Group]
   753   C0869014:relation [Social Behavior]

Phrase: "which"

Phrase: "is"

Phrase: "deficient for the TrkB"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0011155:Deficient [Functional Concept]
   770   C1636779:% deficient [Quantitative Concept]

Phrase: "in the forebrain."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0085140:Fore-Brain [Body Part, Organ, or Organ Component]
Processing 00000000.tx.224: This phenotype is the impairment in adaptation to new information (Vyssotski et al., 2002). 

Phrase: "This phenotype"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0031437:Phenotype [Organism Attribute]
  1000   C1285572:Phenotype [Laboratory Procedure]

Phrase: "is"

Phrase: "the impairment in adaptation"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0684336:Impairment [Pathologic Function]

Phrase: "to new information"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
  1000   C3242228:new information [Intellectual Product]
   861   C1533716:Information [Idea or Concept]
   789 E C3242430:informational [Idea or Concept]

Phrase: "(Vyssotski et al.,"

Phrase: "2002"

Phrase: ")."
Processing 00000000.tx.225: In summary, we have shown that BDNF induces target-selective potentiation of GABAergic presynaptic terminals, an effect that at least partially requires BDNF-TrkB signaling in postsynaptic neurons. 

Phrase: "In summary,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1552616:summary [Intellectual Product]
  1000   C1706244:Summary [Intellectual Product]

Phrase: "we"

Phrase: "have"

Phrase: "shown"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C1547282:Show [Intellectual Product]

Phrase: "that BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "target-selective potentiation of GABAergic presynaptic terminals,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C0279023:Potentiation [Therapeutic or Preventive Procedure]

Phrase: "an effect"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1280500:Effect [Qualitative Concept]
  1000   C2348382:Effect [Qualitative Concept]

Phrase: "that at least partially"

Phrase: "requires"

Phrase: "BDNF-TrkB signaling in postsynaptic neurons."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0037083:Signaling [Cell Function]
   742   C3537152:signaling [Biologic Function]
Processing 00000000.tx.226: This action of BDNF may constitute a part of the activity-dependent plasticity, which maintains the independence of functional neuronal circuits.  

Phrase: "This action of BDNF"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0441472:Action [Functional Concept]
   748   C3266814:Action [Activity]

Phrase: "may"

Phrase: "constitute"

Phrase: "a part of the activity-dependent plasticity,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   778   C1292711:Part of [Spatial Concept]
   748   C0449719:Part [Spatial Concept]
   748   C1709471:Part [Quantitative Concept]

Phrase: "which"

Phrase: "maintains"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0024501:Maintain [Activity]

Phrase: "the independence of functional neuronal circuits."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   754   C0332291:Independent of [Functional Concept]
   753   C0085862:Independence [Idea or Concept]
Processing 00000000.tx.227: Acknowledgments  We thank Dr Rita Balice-Gordon for the tTrkB cDNA, Dr Masami Kojima for the pre-pro-BDNF cDNA, and Dr Xiang Yu for technical advice on the protocols for transfection. 

Phrase: "Acknowledgments"

Phrase: "We"

Phrase: "thank"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2986676:THANK [Gene or Genome]

Phrase: "Dr Rita Balice-Gordon for the tTrkB cDNA,"

Phrase: "Dr Masami Kojima"

Phrase: "for the pre-pro-BDNF cDNA,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   795   C0006556:cDNA [Nucleic Acid, Nucleoside, or Nucleotide]
   710   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   710   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "Dr Xiang Yu for technical advice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   753   C1006780:yu [Plant]

Phrase: "on the protocols"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0442711:Protocols [Intellectual Product]
   966 E C1507394:Protocol [Intellectual Product]
   966 E C1522729:Protocol [Intellectual Product]
   966 E C2348563:Protocol [Intellectual Product]

Phrase: "for transfection."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0040669:Transfection [Genetic Function,Molecular Biology Research Technique]
Processing 00000000.tx.228: This work was supported by grants from the Mochida Memorial Foundation, the Katoh Foundation, the Hayashi Memorial Foundation, and the Ministry of Education, Culture, Sports, Science and Technology.  

Phrase: "This work"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0043227:Work [Occupational Activity]

Phrase: "was"

Phrase: "supported by grants"
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   790   C0018173:Grants [Quantitative Concept]
   790   C1521721:Supported [Conceptual Entity]
   756 E C0183683:Support [Medical Device]
   756 E C1548284:Grant [Idea or Concept]

Phrase: "from the Mochida Memorial Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "the Katoh Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   861   C0016617:Foundation [Organization]
   777 E C0002055:base [Inorganic Chemical]
   777 E C0178499:Base [Chemical Viewed Functionally]
   777 E C1626935:Bases [Quantitative Concept]
   777 E C1880279:Base [Biomedical or Dental Material]
   755 E C0205112:Basal [Spatial Concept]

Phrase: "the Hayashi Memorial Foundation,"
Meta Candidates (Total=6; Excluded=5; Pruned=0; Remaining=1)
   827   C0016617:Foundation [Organization]
   743 E C0002055:base [Inorganic Chemical]
   743 E C0178499:Base [Chemical Viewed Functionally]
   743 E C1626935:Bases [Quantitative Concept]
   743 E C1880279:Base [Biomedical or Dental Material]
   721 E C0205112:Basal [Spatial Concept]

Phrase: "and"

Phrase: "the Ministry of Education,"

Phrase: "Culture,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0010453:Culture [Idea or Concept]
  1000   C0220814:culture [Functional Concept]
  1000   C0430400:Culture [Laboratory Procedure]
  1000   C2242979:Culture [Laboratory Procedure]

Phrase: "Sports,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0038039:Sports [Daily or Recreational Activity]
  1000   C1552306:Sports [Professional or Occupational Group]

Phrase: "Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0036397:Science [Occupation or Discipline]

Phrase: "and"

Phrase: "Technology."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0039421:Technology [Occupation or Discipline]
Processing 00000000.tx.229: References Top Abstract Introduction Materials and Methods Results Discussion References  Abbott LF, Nelson SB (2000) Synaptic plasticity: taming the beast. 

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Top Abstract Introduction Materials"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0520510:Materials [Substance]

Phrase: "and"

Phrase: "Methods Results Discussion"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0557061:Discussion [Therapeutic or Preventive Procedure]
   827   C2584313:Discussion [Social Behavior]

Phrase: "References"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1514811:Reference [Idea or Concept]
  1000   C1706462:Reference [Conceptual Entity]

Phrase: "Abbott LF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416933:LF [Gene or Genome]
   861   C2986618:LF [Gene or Genome]

Phrase: "Nelson SB (2000"

Phrase: ")"

Phrase: "Synaptic plasticity"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0678558:Plasticity [Natural Phenomenon or Process]
   789 E C0032167:Plastic [Substance]

Phrase: ":"

Phrase: "taming"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   966   C0040494:TAME [Amino Acid, Peptide, or Protein,Indicator, Reagent, or Diagnostic Aid]

Phrase: "the beast."
Processing 00000000.tx.230: Nat Neurosci 3(Suppl):11781183.[CrossRef][Medline] Aoki C, Wu K, Elste A, Len G, Lin S, McAuliffe G, Black IB (2000) Localization of brain-derived neurotrophic factor and TrkB receptors to postsynaptic densities of adult rat cerebral cortex. 

Phrase: "Nat Neurosci 3"

Phrase: "(Suppl):11781183."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Aoki C,"

Phrase: "Wu K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Elste A,"

Phrase: "Len G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Lin S,"

Phrase: "McAuliffe G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Black IB (2000"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0005680:Black [Population Group]
   827   C0027567:Black [Population Group]
   827   C0085756:Black [Population Group]
   827   C0439541:Black [Qualitative Concept]

Phrase: ")"

Phrase: "Localization of brain-derived neurotrophic factor"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0475264:Localisation [Functional Concept]
   753   C1744691:localisation [Biologic Function]
   716   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   716   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "and"

Phrase: "TrkB receptors to postsynaptic densities of adult rat cerebral cortex."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   743   C0084873:Receptor, trkB [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   739   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   724   C0599283:receptor density [Genetic Function]
Processing 00000000.tx.231: J Neurosci Res 59:454463.[CrossRef][ISI][Medline] Arancio O, Lev-Ram V, Tsien RY, Kandel ER, Hawkins RD (1996) Nitric oxide acts as a retrograde messenger during long-term potentiation in cultured hippocampal neurons. 

Phrase: "J Neurosci Res 59"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347379:RES [Finding]

Phrase: ":"

Phrase: "454463."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Arancio O,"

Phrase: "Lev-Ram V,"

Phrase: "Tsien RY,"

Phrase: "Kandel ER,"

Phrase: "Hawkins RD (1996"

Phrase: ")"

Phrase: "Nitric oxide"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0028128:Nitric Oxide [Biologically Active Substance,Inorganic Chemical,Pharmacologic Substance]
   861   C0030015:oxide [Inorganic Chemical]
   861   C2986642:oxide [Chemical Viewed Functionally]

Phrase: "acts as a retrograde messenger"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   760   C0079613:ACT [Therapeutic or Preventive Procedure]
   760   C0169911:messenger [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   760   C0335218:Messenger [Professional or Occupational Group]
   760   C0439784:Retrograde [Spatial Concept]
   760   C0589500:Retrograde [Spatial Concept]

Phrase: "during long-term potentiation"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
  1000   C0206249:Long-Term Potentiation [Organ or Tissue Function]
  1000   C2984294:Long-term potentiation [Functional Concept]
   901   C0443252:Long-term [Temporal Concept]
   827   C0205166:Long [Qualitative Concept]
   827   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   827   C1515273:Term [Temporal Concept]
   827   C1705313:Term [Idea or Concept]
   827   C1706317:Long [Qualitative Concept]
   827   C2826302:TERM [Intellectual Product]

Phrase: "in cultured hippocampal neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.232: J Physiol Paris 90:321322.[CrossRef][ISI][Medline] Baldelli P, Novara M, Carabelli V, Hernandez-Guijo JM, Carbone E (2002) BDNF up-regulates evoked GABAergic transmission in developing hippocampus by potentiating presynaptic N- and P/Q-type Ca2+ channels signalling. 

Phrase: "J Physiol Paris 90"
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   812   C0030561:Paris [Geographic Area]
   812   C0331677:Paris [Plant]
   812   C0439083:>90 [Quantitative Concept]
   812   C0439087:<90 [Quantitative Concept]
   812   C1824032:PARIS [Gene or Genome]
   779 E C1824369:PARI [Gene or Genome]

Phrase: ":"

Phrase: "321322."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Baldelli P,"

Phrase: "Novara M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Carabelli V,"

Phrase: "Hernandez-Guijo JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0022337:JM [Geographic Area]

Phrase: "Carbone E (2002"

Phrase: ")"

Phrase: "BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "up-regulates"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0547043:Up [Spatial Concept]
   861   C1282911:Up [Spatial Concept]

Phrase: "evoked GABAergic transmission in developing hippocampus"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   753   C0040722:transmission [Idea or Concept]
   753   C0242781:Transmission [Pathologic Function]
   753   C1521797:Transmission [Natural Phenomenon or Process]

Phrase: "by potentiating presynaptic N-"

Phrase: "and"

Phrase: "P/Q-type Ca2+ channels"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   771   C0439799:Channel [Spatial Concept]
   771   C1706095:Channel [Conceptual Entity]

Phrase: "signalling."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
  1000   C3537152:signalling [Biologic Function]
   966 E C1710082:Signal [Phenomenon or Process]
Processing 00000000.tx.233: Eur J Neurosci 16:22972310.[CrossRef][ISI][Medline] Bertrand S, Lacaille JC (2001) Unitary synaptic currents between lacunosum-moleculare interneurones and pyramidal cells in rat hippocampus. 

Phrase: "Eur J Neurosci 16"

Phrase: ":"

Phrase: "22972310."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Bertrand S,"

Phrase: "Lacaille JC"

Phrase: "(2001"

Phrase: ")"

Phrase: "Unitary synaptic currents between lacunosum-moleculare interneurones"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   748   C0521116:currents [Temporal Concept]
   714 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "and"

Phrase: "pyramidal cells in rat hippocampus."
Meta Candidates (Total=7; Excluded=4; Pruned=0; Remaining=3)
   806   C0206441:Pyramidal Cells [Cell]
   773 E C2334588:Pyramidal cell [Cell]
   760   C0007634:Cells [Cell]
   760   C3282337:Cells [Cell]
   726 E C1269647:Cell [Cell]
   726 E C1704653:Cell [Medical Device]
   726 E C1948049:Cell [Spatial Concept]
Processing 00000000.tx.234: J Physiol 532:369384.[Abstract/Free FullText] Bolton MM, Pittman AJ, Lo DC (2000) Brain-derived neurotrophic factor differentially regulates excitatory and inhibitory synaptic transmission in hippocampal cultures. 

Phrase: "J Physiol 532"

Phrase: ":"

Phrase: "369384."

Phrase: "[Abstract/Free FullText"

Phrase: "] Bolton MM,"

Phrase: "Pittman AJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0230613:AJ [Cell Component]

Phrase: "Lo DC (2000"

Phrase: ")"

Phrase: "Brain-derived neurotrophic factor differentially"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   937   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   840   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   840   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]
   804   C1441547:Derived [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   804   C3245521:derived [Idea or Concept]

Phrase: "regulates"

Phrase: "excitatory"

Phrase: "and"

Phrase: "inhibitory synaptic transmission in hippocampal cultures."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0027793:Synaptic Transmission [Cell Function]
   753   C0040722:transmission [Idea or Concept]
   753   C0242781:Transmission [Pathologic Function]
   753   C1521797:Transmission [Natural Phenomenon or Process]
Processing 00000000.tx.235: J Neurosci 20:32213232.[Abstract/Free FullText] Brunig I, Penschuck S, Berninger B, Benson J, Fritschy JM (2001) BDNF reduces miniature inhibitory postsynaptic currents by rapid downregulation of GABA(A) receptor surface expression. 

Phrase: "J Neurosci 20"

Phrase: ":"

Phrase: "32213232."

Phrase: "[Abstract/Free FullText"

Phrase: "] Brunig I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Penschuck S,"

Phrase: "Berninger B,"

Phrase: "Benson J,"

Phrase: "Fritschy JM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "(2001"

Phrase: ")"

Phrase: "BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "reduces"

Phrase: "miniature inhibitory postsynaptic currents by rapid downregulation"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   814   C2350182:Inhibitory Postsynaptic Currents [Organ or Tissue Function]
   778   C2350340:Postsynaptic Currents [Organ or Tissue Function]
   748   C0521116:currents [Temporal Concept]
   748   C3463820:Inhibitory [Activity]
   714 E C1705970:Current [Natural Phenomenon or Process]

Phrase: "of GABA(A) receptor surface expression."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   853   C0597360:receptor expression [Genetic Function]
   804   C0185117:Expression [Therapeutic or Preventive Procedure]
   804   C0205148:Surface [Spatial Concept]
   717   C0034807:GABA(A) Receptor [Amino Acid, Peptide, or Protein,Receptor]
Processing 00000000.tx.236: Eur J Neurosci 13:13201328.[CrossRef][ISI][Medline] Brunig I, Suter A, Knuesel I, Luscher B, Fritschy JM (2002) GABAergic terminals are required for postsynaptic clustering of dystrophin but not of GABA(A) receptors and gephyrin. 

Phrase: "Eur J Neurosci 13"

Phrase: ":"

Phrase: "13201328."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Brunig I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Suter A,"

Phrase: "Knuesel I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Luscher B,"

Phrase: "Fritschy JM"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "(2002"

Phrase: ")"

Phrase: "GABAergic terminals"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205088:Terminal [Temporal Concept]
   827   C1705314:Terminal [Manufactured Object]
   827   C1705315:Terminal [Spatial Concept]

Phrase: "are"

Phrase: "required for postsynaptic clustering of dystrophin"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   753   C0009085:Clustering [Research Activity]
   753   C0079259:Dystrophin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   753   C1414083:DYSTROPHIN [Gene or Genome]
   753   C1514873:Required [Functional Concept]

Phrase: "but"

Phrase: "not of GABA(A) receptors"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   862   C0034807:GABA-A Receptors [Amino Acid, Peptide, or Protein,Receptor]
   797   C0206518:Receptors, GABA [Amino Acid, Peptide, or Protein,Receptor]
   760   C0016904:GABA [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   760   C1518422:Not [Functional Concept]

Phrase: "and"

Phrase: "gephyrin."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0119082:gephyrin [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1423507:GEPHYRIN [Gene or Genome]
Processing 00000000.tx.237: J Neurosci 22:48054813.[Abstract/Free FullText] Castren E, Zafra F, Thoenen H, Lindholm D (1992) Light regulates expression of brain-derived neurotrophic factor mRNA in rat visual cortex. 

Phrase: "J Neurosci 22"

Phrase: ":"

Phrase: "48054813."

Phrase: "[Abstract/Free FullText"

Phrase: "] Castren E,"

Phrase: "Zafra F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
   861   C0439133:(f) [Intellectual Product]
   861   C1553038:[f] [Quantitative Concept]

Phrase: "Thoenen H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Lindholm"

Phrase: "D ("

Phrase: "1992"

Phrase: ")"

Phrase: "Light"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0023693:Light [Natural Phenomenon or Process]
  1000   C1306462:Light [Functional Concept]
  1000   C1881376:Light [Qualitative Concept]

Phrase: "regulates"

Phrase: "expression of brain-derived neurotrophic factor mRNA"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   774   C1515670:mRNA Expression [Genetic Function]
   748   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "in rat visual cortex."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0042817:Visual Cortex [Body Part, Organ, or Organ Component]
   827   C0007776:Cortex [Body Part, Organ, or Organ Component]
   827   C0234621:Visual [Functional Concept]
   827   C1176472:Cortex [Body Part, Organ, or Organ Component]
   827   C2700441:Cortex [Plant]
Processing 00000000.tx.238: Proc Natl Acad Sci U S A 89:94449448.[Abstract/Free FullText] Chang YC, Gottlieb DI (1988) Characterization of the proteins purified with monoclonal antibodies to glutamic acid decarboxylase. 

Phrase: "Proc Natl Acad Sci U S A 89"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   835   C0041703:U.S.A. [Geographic Area]
           U S
   793   C0268596:ACAD [Disease or Syndrome]
   793   C1418943:PROC [Gene or Genome]
   793   C2700624:ACAD [Cell Function]
   793   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "94449448."

Phrase: "[Abstract/Free FullText"

Phrase: "] Chang YC,"

Phrase: "Gottlieb DI (1988"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C3538902:DI [Gene or Genome]
   827   C3541881:DI [Idea or Concept]

Phrase: ")"

Phrase: "Characterization of the proteins"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1880022:Characterization [Activity]

Phrase: "purified with monoclonal antibodies"
Meta Candidates (Total=5; Excluded=1; Pruned=0; Remaining=4)
   833   C0003250:Monoclonal Antibodies [Amino Acid, Peptide, or Protein,Immunologic Factor]
   770   C0003241:Antibodies [Amino Acid, Peptide, or Protein,Cell Component,Immunologic Factor]
   770   C0746619:monoclonal [Finding]
   770   C1998793:Purified [Functional Concept]
   737 E C0021027:Antibody [Amino Acid, Peptide, or Protein,Immunologic Factor,Pharmacologic Substance]

Phrase: "to glutamic acid decarboxylase."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
  1000   C0017785:Glutamic Acid Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   901   C0061472:Glutamic Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   901   C0523665:Glutamic Acid [Laboratory Procedure]
   827   C0001128:Acid [Chemical]
   827   C0007054:Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   827   C0202406:Acid [Laboratory Procedure]
Processing 00000000.tx.239: J Neurosci 8:21232130.[Abstract] Drake CT, Milner TA, Patterson SL (1999) Ultrastructural localization of full-length trkB immunoreactivity in rat hippocampus suggests multiple roles in modulating activity-dependent synaptic plasticity. 

Phrase: "J Neurosci 8"

Phrase: ":"

Phrase: "21232130."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Drake CT,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3540513:CT [Gene or Genome]

Phrase: "Milner TA,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1506978:Ta [Immunologic Factor]
   861   C1705538:TA [Idea or Concept]

Phrase: "Patterson SL (1999"

Phrase: ")"

Phrase: "Ultrastructural localization of full-length trkB immunoreactivity"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0475264:Localisation [Functional Concept]
   748   C1744691:localisation [Biologic Function]

Phrase: "in rat hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "suggests"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1705535:Suggest [Idea or Concept]

Phrase: "multiple roles in modulating activity-dependent synaptic plasticity."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   744   C0035820:Roles [Social Behavior]
   711 E C1705810:Role [Conceptual Entity]
Processing 00000000.tx.240: J Neurosci 19:80098026.[Abstract/Free FullText] Du J, Feng L, Yang F, Lu B (2000) Activity- and Ca(2+)-dependent modulation of surface expression of brain-derived neurotrophic factor receptors in hippocampal neurons. 

Phrase: "J Neurosci 19"

Phrase: ":"

Phrase: "80098026."

Phrase: "[Abstract/Free FullText"

Phrase: "] Du J,"

Phrase: "Feng L,"

Phrase: "Yang"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2945617:yang [Idea or Concept]

Phrase: "F,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0016327:F- [Inorganic Chemical,Pharmacologic Substance]
  1000   C0439133:(f) [Intellectual Product]
  1000   C1553038:[f] [Quantitative Concept]

Phrase: "Lu B (2000"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0024171:LU [Body System]
   827   C0024176:LU [Geographic Area]
   827   C2697939:LU [Quantitative Concept]

Phrase: ")"

Phrase: "Activity-"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "Ca(2+"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0596235:CA+2 [Element, Ion, or Isotope,Pharmacologic Substance]

Phrase: ")-"

Phrase: "dependent modulation of surface expression of brain-derived neurotrophic factor receptors"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   738   C0443264:Modulation [Spatial Concept]

Phrase: "in hippocampal neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.241: J Cell Biol 150:14231434.[Abstract/Free FullText] Ernfors P, Wetmore C, Olson L, Persson H (1990) Identification of cells in rat brain and peripheral tissues expressing mRNA for members of the nerve growth factor family. 

Phrase: "J Cell Biol 150"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0007634:Cell [Cell]
   812   C1269647:Cell [Cell]
   812   C1704653:Cell [Medical Device]
   812   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "14231434."

Phrase: "[Abstract/Free FullText"

Phrase: "] Ernfors P,"

Phrase: "Wetmore C,"

Phrase: "Olson L,"

Phrase: "Persson H (1990"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: "Identification of cells"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   790   C0020792:Identification [Mental Process]
   790   C0205396:Identification [Qualitative Concept]

Phrase: "in rat brain"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C1882598:Rat Brain [Body Part, Organ, or Organ Component]
   861   C0006104:Brain [Body Part, Organ, or Organ Component]
   861   C1269537:Brain [Body Part, Organ, or Organ Component]

Phrase: "and"

Phrase: "peripheral tissues"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0040300:Tissues [Tissue]
   827 E C1547928:Tissue [Intellectual Product]

Phrase: "expressing"

Phrase: "mRNA for members of the nerve growth factor family."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C0035696:mRNA [Biologically Active Substance,Nucleic Acid, Nucleoside, or Nucleotide]
Processing 00000000.tx.242: Neuron 5:511526.[ISI][Medline] Fawcett JP, Alonso-Vanegas MA, Morris SJ, Miller FD, Sadikot AF, Murphy RA (2000) Evidence that brain-derived neurotrophic factor from presynaptic nerve terminals regulates the phenotype of calbindin-containing neurons in the lateral septum. 

Phrase: "Neuron 5"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: ":"

Phrase: "511526."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Fawcett JP,"

Phrase: "Alonso-Vanegas MA,"

Phrase: "Morris SJ,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1515101:SJ [Geographic Area]
   861   C2986905:SJ [Idea or Concept]

Phrase: "Miller FD,"

Phrase: "Sadikot AF,"

Phrase: "Murphy RA (2000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C3538806:Ra [Spatial Concept]

Phrase: ")"

Phrase: "Evidence"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332120:Evidence [Functional Concept]

Phrase: "that brain-derived neurotrophic factor from presynaptic nerve terminals"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   818   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   818   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   764   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   764   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   764   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   742   C0006104:Brain [Body Part, Organ, or Organ Component]
   742   C1269537:Brain [Body Part, Organ, or Organ Component]
   742   C1441547:Derived [Qualitative Concept]
   742   C1521761:Factor [Functional Concept]
   742   C2827422:Factor [Conceptual Entity]
   742   C3245521:derived [Idea or Concept]

Phrase: "regulates"

Phrase: "the phenotype of calbindin-containing neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0031437:Phenotype [Organism Attribute]
   753   C1285572:Phenotype [Laboratory Procedure]

Phrase: "in the lateral septum."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0205093:Lateral [Spatial Concept]
   861   C1327729:septum [Cell Component]
   861   C2362924:Septum [Classification]
   789 E C0442004:Septal [Spatial Concept]
Processing 00000000.tx.243: J Neurosci 20:274282.[Abstract/Free FullText] Freund TF, Buzsaki G (1996) Interneurons of the hippocampus. 

Phrase: "J Neurosci 20"

Phrase: ":"

Phrase: "274282."

Phrase: "[Abstract/Free FullText"

Phrase: "] Freund TF,"

Phrase: "Buzsaki G (1996"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "Interneurons of the hippocampus."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0021792:Interneurons [Cell]
Processing 00000000.tx.244: Hippocampus 6:347470.[CrossRef][ISI][Medline] Gartner A, Shostak Y, Hackel N, Ethell IM, Thoenen H (2000) Ultrastructural identification of storage compartments and localization of activity-dependent secretion of neurotrophin 6 in hippocampal neurons. 

Phrase: "Hippocampus 6"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "347470."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gartner A,"

Phrase: "Shostak Y,"

Phrase: "Hackel N,"

Phrase: "Ethell IM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539078:IM [Idea or Concept]

Phrase: "Thoenen H (2000"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: "Ultrastructural identification of storage compartments"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0020792:Identification [Mental Process]
   760   C0205396:Identification [Qualitative Concept]

Phrase: "and"

Phrase: "localization of activity-dependent secretion of neurotrophin 6"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0475264:Localisation [Functional Concept]
   744   C1744691:localisation [Biologic Function]

Phrase: "in hippocampal neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neurons [Cell]
   777 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.245: Mol Cell Neurosci 15:215234.[CrossRef][ISI][Medline] Gonzalez M, Ruggiero FP, Chang Q, Shi YJ, Rich MM, Kraner S, Balice-Gordon RJ (1999) Disruption of Trkb-mediated signaling induces disassembly of postsynaptic receptor clusters at neuromuscular junctions. 

Phrase: "Mol Cell Neurosci 15"
Meta Candidates (Total=11; Excluded=2; Pruned=0; Remaining=9)
   812   C0007634:Cell [Cell]
   812   C0027960:Mole [Neoplastic Process]
   812   C0324740:Mole [Mammal]
   812   C0439189:Mole [Quantitative Concept]
   812   C1269647:Cell [Cell]
   812   C1456781:mole [Neoplastic Process]
   812   C1704653:Cell [Medical Device]
   812   C1824986:mol [Gene or Genome]
   812   C1948049:Cell [Spatial Concept]
   729 E C0026367:Molar [Body Part, Organ, or Organ Component]
   712 E C0027962:moles [Neoplastic Process]

Phrase: ":"

Phrase: "215234."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gonzalez M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Ruggiero FP,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C1419068:FP [Gene or Genome]
   861   C1419906:FP [Gene or Genome]
   861   C3541238:Fp [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3541412:FP [Gene or Genome]

Phrase: "Chang Q,"

Phrase: "Shi YJ,"

Phrase: "Rich MM,"

Phrase: "Kraner S,"

Phrase: "Balice-Gordon RJ (1999"

Phrase: ")"

Phrase: "Disruption of Trkb-mediated signaling"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0332453:Disruption [Functional Concept]

Phrase: "induces"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "disassembly of postsynaptic receptor"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C1707798:Disassembly [Activity]
   770   C1880352:DISASSEMBLY [Phenomenon or Process]

Phrase: "clusters at neuromuscular junctions."
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   833   C0027869:Neuromuscular Junctions [Cell Component]
   770   C1555715:Cluster [Idea or Concept]
   770   C1704332:Cluster [Quantitative Concept]
   770   C1979768:Neuromuscular [Qualitative Concept]
   737   C0205144:Junction [Spatial Concept]
   737   C1706311:Junction [Medical Device]
Processing 00000000.tx.246: Neuron 24:567583.[ISI][Medline] Gorski JA, Balogh SA, Wehner JM, Jones KR (2003) Learning deficits in forebrain-restricted brain-derived neurotrophic factor mutant mice. 

Phrase: "Neuron 24"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: ":"

Phrase: "567583."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Gorski JA,"

Phrase: "Balogh SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Wehner JM,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0022337:JM [Geographic Area]

Phrase: "Jones KR (2003"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0022773:KR [Geographic Area]
   827   C0443013:Jones [Intellectual Product]

Phrase: ")"

Phrase: "Learning deficits in forebrain-restricted brain-derived neurotrophic factor mutant mice."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   738   C2987487:deficits [Qualitative Concept]
   704 E C0162429:Deficit, NOS [Disease or Syndrome]
Processing 00000000.tx.247: Neuroscience 121:341354.[CrossRef][ISI][Medline] Haapasalo A, Koponen E, Hoppe E, Wong G, Castren E (2001) Truncated trkB.T1 is dominant negative inhibitor of trkB.TK+-mediated cell survival. 

Phrase: "Neuroscience 121"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0027910:Neuroscience [Biomedical Occupation or Discipline]
   861   C1552241:Neuroscience [Professional or Occupational Group]
   861   C1555991:Neuroscience [Professional or Occupational Group]

Phrase: ":"

Phrase: "341354."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Haapasalo A,"

Phrase: "Koponen E,"

Phrase: "Hoppe E,"

Phrase: "Wong G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0439267:g% [Quantitative Concept]

Phrase: "Castren E (2001"

Phrase: ")"

Phrase: "Truncated trkB.T1"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1413227:T1 [Gene or Genome]

Phrase: "is"

Phrase: "dominant negative inhibitor of trkB.TK+-mediated cell survival."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   742   C1999216:Inhibitor [Qualitative Concept]
Processing 00000000.tx.248: Biochem Biophys Res Commun 280:13521358.[CrossRef][ISI][Medline] Hasselmo ME (1994) Runaway synaptic modification in models of cortex  implications for alzheimers-disease. 

Phrase: "Biochem Biophys Res Commun 280"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   804   C2347379:RES [Finding]

Phrase: ":"

Phrase: "13521358."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Hasselmo ME (1994"

Phrase: ")"

Phrase: "Runaway synaptic modification in models of cortex  implications"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C0392747:Modification [Functional Concept]
   744   C1554963:modification [Qualitative Concept]

Phrase: "for alzheimers-disease."
Meta Candidates (Total=5; Excluded=3; Pruned=0; Remaining=2)
  1000   C0002395:Alzheimers disease [Disease or Syndrome]
   861   C0012634:Disease [Disease or Syndrome]
   805 E C1836721:MALS [Finding]
   805 E C3538764:MALS [Gene or Genome]
   805 E C3540595:MAL [Gene or Genome]
Processing 00000000.tx.249: Neural Networks 7:1340.[CrossRef][ISI] Henze DA, Borhegyi Z, Csicsvari J, Mamiya A, Harris KD, Buzsaki G (2000) Intracellular features predicted by extracellular recordings in the hippocampus in vivo. 

Phrase: "Neural Networks 7"
Meta Candidates (Total=10; Excluded=7; Pruned=0; Remaining=3)
   901   C0870951:neural networks [Intellectual Product]
   867 E C0598941:Neural network [Organism Function]
   827   C0599851:Neural [Functional Concept]
   827   C1882071:networks [Conceptual Entity]
   793 E C1513822:Network [Professional or Occupational Group]
   793 E C1705739:Network [Manufactured Object]
   771 E C0027740:Nerve [Tissue]
   771 E C0027757:NERVE [Tissue]
   771 E C1280541:Nerve [Body Part, Organ, or Organ Component]
   734 E C0027769:nervy [Sign or Symptom]

Phrase: ":"

Phrase: "1340."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI] Henze DA,"

Phrase: "Borhegyi Z,"

Phrase: "Csicsvari J,"

Phrase: "Mamiya A,"

Phrase: "Harris KD,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0026691:KD [Disease or Syndrome]
   861   C1705240:KD [Gene or Genome]
   861   C1839259:KD [Disease or Syndrome]

Phrase: "Buzsaki G (2000"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: ")"

Phrase: "Intracellular features"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C1521970:Feature [Qualitative Concept]
   827   C1706388:Feature [Conceptual Entity]
   827   C2346469:Feature [Qualitative Concept]
   827   C2348519:Feature [Qualitative Concept]

Phrase: "predicted by extracellular recordings"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0521119:Extracellular [Cell Component]
   770   C0681842:Predicted [Idea or Concept]
   770   C1882327:%{Predicted} [Quantitative Concept]

Phrase: "in the hippocampus"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
  1000   C0949582:Hippocampus [Fish]
  1000   C1029104:Hippocampus [Fish]
  1000   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.250: J Neurophysiol 84:390400.[Abstract/Free FullText] Huang ZJ, Kirkwood A, Pizzorusso T, Porciatti V, Morales B, Bear MF, Maffei L, Tonegawa S (1999) BDNF regulates the maturation of inhibition and the critical period of plasticity in mouse visual cortex. 

Phrase: "J Neurophysiol 84"

Phrase: ":"

Phrase: "390400."

Phrase: "[Abstract/Free FullText"

Phrase: "] Huang ZJ,"

Phrase: "Kirkwood A,"

Phrase: "Pizzorusso T,"

Phrase: "Porciatti V,"

Phrase: "Morales B,"

Phrase: "Bear MF,"

Phrase: "Maffei L,"

Phrase: "Tonegawa"

Phrase: "S ("

Phrase: "1999"

Phrase: ")"

Phrase: "BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "regulates"

Phrase: "the maturation of inhibition"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0678723:Maturation [Organism Function]
   770   C0870861:maturation [Phenomenon or Process]
   770   C1254042:Maturation [Physiologic Function]

Phrase: "and"

Phrase: "the critical period of plasticity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   806   C0010339:Critical Period [Temporal Concept]
   760   C0439531:/period [Temporal Concept]
   760   C1511545:Critical [Qualitative Concept]
   760   C1948053:Period [Temporal Concept]

Phrase: "in mouse visual cortex."
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   901   C0042817:Visual Cortex [Body Part, Organ, or Organ Component]
   827   C0007776:Cortex [Body Part, Organ, or Organ Component]
   827   C0234621:Visual [Functional Concept]
   827   C1176472:Cortex [Body Part, Organ, or Organ Component]
   827   C2700441:Cortex [Plant]
Processing 00000000.tx.251: Cell 98:739755.[ISI][Medline] Jovanovic JN, Thomas P, Kittler JT, Smart TG, Moss SJ (2004) Brain-derived neurotrophic factor modulates fast synaptic inhibition by regulating GABA(A) receptor phosphorylation, activity, and cell-surface stability. 

Phrase: "Cell 98"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0007634:Cell [Cell]
   861   C1269647:Cell [Cell]
   861   C1704653:Cell [Medical Device]
   861   C1948049:Cell [Spatial Concept]

Phrase: ":"

Phrase: "739755."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Jovanovic JN,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1428813:JN [Gene or Genome]

Phrase: "Thomas P,"

Phrase: "Kittler JT,"

Phrase: "Smart TG,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0337445:TG [Laboratory Procedure]

Phrase: "Moss SJ (2004"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0282635:Moss [Plant]
   827   C1515101:SJ [Geographic Area]
   827   C2986905:SJ [Idea or Concept]

Phrase: ")"

Phrase: "Brain-derived neurotrophic factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "modulates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0443264:modulate [Spatial Concept]

Phrase: "fast synaptic inhibition by"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "regulating"

Phrase: "GABA(A) receptor phosphorylation,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   812   C0031715:Phosphorylation [Molecular Function]
   812   C1158886:Phosphorylation [Molecular Function]
   756   C0034807:GABA(A) Receptor [Amino Acid, Peptide, or Protein,Receptor]
   708   C0206518:GABA Receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "activity,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0205177:Activity [Functional Concept]
  1000   C0439167:% activity [Quantitative Concept]
  1000   C0441655:Activity [Activity]
  1000   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "cell-surface stability."
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   827   C0205360:Stability [Qualitative Concept]
   827   C2347098:Stability [Qualitative Concept]
   755 E C1547311:Stable [Intellectual Product]
   734   C0699040:Cell surface [Cell Component]
Processing 00000000.tx.252: J Neurosci 24:522530.[Abstract/Free FullText] Kang H, Schuman EM (1995) Long-lasting neurotrophin-induced enhancement of synaptic transmission in the adult hippocampus. 

Phrase: "J Neurosci 24"

Phrase: ":"

Phrase: "522530."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kang H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Schuman EM (1995"

Phrase: ")"

Phrase: "Long-lasting neurotrophin-induced enhancement of synaptic transmission"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   744   C1627358:Enhancement [Therapeutic or Preventive Procedure]
   744   C2349975:Enhancement [Activity]

Phrase: "in the adult hippocampus."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.253: Science 267:16581662.[ISI][Medline] Kaufman DL, Houser CR, Tobin AJ (1991) Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. 

Phrase: "Science 267"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0036397:Science [Occupation or Discipline]

Phrase: ":"

Phrase: "16581662."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Kaufman DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Houser CR,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0201975:Cr [Laboratory Procedure]
   861   C3539604:CR [Gene or Genome]

Phrase: "Tobin AJ (1991"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0230613:AJ [Cell Component]

Phrase: ")"

Phrase: "Two"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205448:Two [Quantitative Concept]

Phrase: "forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase"
Meta Candidates (Total=17; Excluded=0; Pruned=0; Remaining=17)
   782   C0016904:.gamma.-aminobutyric Acid [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   760   C0017785:Glutamate Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   760   C0220780:Aminobutyric Acid [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   760   C0597548:synthetic enzyme [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0001128:Acid [Chemical]
   739   C0007054:Decarboxylase [Amino Acid, Peptide, or Protein,Enzyme]
   739   C0014442:Enzyme [Enzyme,Organic Chemical]
   739   C0017011:Gamma [Natural Phenomenon or Process]
   739   C0017789:glutamate [Amino Acid, Peptide, or Protein]
   739   C0202406:Acid [Laboratory Procedure]
   739   C0220839:Glutamate [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   739   C0348078:Form [Qualitative Concept]
   739   C0376315:Form [Manufactured Object]
   739   C1522492:Form [Functional Concept]
   739   C1552644:Gamma [Intellectual Product]
   739   C1883254:synthetic [Activity]
   739   C2349976:Gamma [Quantitative Concept]

Phrase: "have"

Phrase: "distinct intraneuronal distributions"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0037775:Distributions [Spatial Concept]
   793 E C0520511:distribution [Idea or Concept]
   793 E C1704711:Distribution [Functional Concept]

Phrase: "and"

Phrase: "cofactor interactions."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1704675:Interaction [Functional Concept]
Processing 00000000.tx.254: J Neurochem 56:720723.[ISI][Medline] Klausberger T, Magill PJ, Marton LF, Roberts JD, Cobden PM, Buzsaki G, Somogyi P (2003) Brain-state- and cell-type-specific firing of hippocampal interneurons in vivo. 

Phrase: "J Neurochem 56"

Phrase: ":"

Phrase: "720723."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Klausberger T,"

Phrase: "Magill PJ,"

Phrase: "Marton LF,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1416933:LF [Gene or Genome]
   861   C2986618:LF [Gene or Genome]

Phrase: "Roberts JD,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1549972:JD [Intellectual Product]

Phrase: "Cobden PM, Buzsaki G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0439267:g% [Quantitative Concept]

Phrase: "Somogyi P (2003"

Phrase: ")"

Phrase: "Brain-state-"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1301808:State [Geographic Area]
   861   C1442792:State [Functional Concept]
   861   C3148680:State [Geographic Area]

Phrase: "and"

Phrase: "cell-type-specific firing of hippocampal interneurons"

Phrase: "in vivo."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1515655:In Vivo [Spatial Concept]
           vivo
Processing 00000000.tx.255: Nature 421:844848.[CrossRef][ISI][Medline] Klein R, Martin-Zanca D, Barbacid M, Parada LF (1990) Expression of the tyrosine kinase receptor gene trkB is confined to the murine embryonic and adult nervous system. 

Phrase: "Nature 421"
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   861   C0349590:Nature [Idea or Concept]
   861   C1262865:Nature [Functional Concept]
   789 E C0205296:Natural [Functional Concept]

Phrase: ":"

Phrase: "844848."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Klein R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Martin-Zanca D,"

Phrase: "Barbacid M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Parada LF (1990"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1416933:LF [Gene or Genome]
   827   C2986618:LF [Gene or Genome]

Phrase: ")"

Phrase: "Expression of the tyrosine kinase receptor gene trkB"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   767   C0017262:Gene Expression [Genetic Function]
   767   C0597360:receptor expression [Genetic Function]
   744   C0185117:Expression [Therapeutic or Preventive Procedure]

Phrase: "is"

Phrase: "confined to the murine embryonic"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0013935:Embryonic [Embryonic Structure]
   760   C0026809:Murine [Mammal]
   760   C0591833:Murine [Organic Chemical,Pharmacologic Substance]

Phrase: "and"

Phrase: "adult nervous system."
Meta Candidates (Total=15; Excluded=7; Pruned=0; Remaining=8)
   901   C0027763:Nervous System [Body System]
   901   C0422837:NERVOUS SYSTEM [Finding]
   901   C1269560:Nervous system [Body System]
   845 E C0205494:Neurologic [Qualitative Concept]
   827   C0027769:Nervous [Sign or Symptom]
   827   C0449913:System [Functional Concept]
   827   C0599851:Nervous [Functional Concept]
   827   C1553451:System [Manufactured Object]
   827   C1704459:System [Medical Device]
   808 E C0027855:Neurology [Biomedical Occupation or Discipline]
   790 E C2707261:Neurological [Clinical Attribute]
   755 E C0205373:Systemic [Functional Concept]
   711 E C0027740:Nerve [Tissue]
   711 E C0027757:NERVE [Tissue]
   711 E C1280541:Nerve [Body Part, Organ, or Organ Component]
Processing 00000000.tx.256: Development 109:845850.[Abstract] Kohara K, Kitamura A, Adachi N, Nishida M, Itami C, Nakamura S, Tsumoto T (2003) Inhibitory but not excitatory cortical neurons require presynaptic brain-derived neurotrophic factor for dendritic development, as revealed by chimera cell culture. 

Phrase: "Development 109"
Meta Candidates (Total=4; Excluded=1; Pruned=0; Remaining=3)
   861   C0243107:development [Physiologic Function]
   861   C0678723:Development [Organism Function]
   861   C1527148:Development [Functional Concept]
   789 E C0458003:Developmental [Qualitative Concept]

Phrase: ":"

Phrase: "845850."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Kohara K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Kitamura A,"

Phrase: "Adachi N,"

Phrase: "Nishida M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Itami C,"

Phrase: "Nakamura S,"

Phrase: "Tsumoto T (2003"

Phrase: ")"

Phrase: "Inhibitory"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C3463820:Inhibitory [Activity]

Phrase: "but"

Phrase: "not excitatory cortical neurons"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   812   C0027882:Neurons [Cell]
   729 E C0521390:Neuronal [Immunologic Factor]

Phrase: "require"

Phrase: "presynaptic brain-derived neurotrophic factor for dendritic development,"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   833   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   833   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   770   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   770   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   770   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   767   C1160340:brain development [Organ or Tissue Function]
   744   C0006104:Brain [Body Part, Organ, or Organ Component]
   744   C1269537:Brain [Body Part, Organ, or Organ Component]
   744   C1441547:Derived [Qualitative Concept]
   744   C1521761:Factor [Functional Concept]
   744   C2827422:Factor [Conceptual Entity]
   744   C3245521:derived [Idea or Concept]

Phrase: "as"

Phrase: "revealed by chimera cell culture."
Meta Candidates (Total=13; Excluded=0; Pruned=0; Remaining=13)
   806   C0007585:Cell Culture [Laboratory Procedure]
   760   C0007634:Cell [Cell]
   760   C0008109:Chimera [Organism]
   760   C0010453:Culture [Idea or Concept]
   760   C0220814:culture [Functional Concept]
   760   C0430400:Culture [Laboratory Procedure]
   760   C0443289:Revealed [Qualitative Concept]
   760   C1262946:Chimaera [Fish]
   760   C1269647:Cell [Cell]
   760   C1318484:Chimera [Disease or Syndrome]
   760   C1704653:Cell [Medical Device]
   760   C1948049:Cell [Spatial Concept]
   760   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.257: J Neurosci 23:61236131.[Abstract/Free FullText] Kokaia Z, Bengzon J, Metsis M, Kokaia M, Persson H, Lindvall O (1993) Coexpression of neurotrophins and their receptors in neurons of the central nervous system. 

Phrase: "J Neurosci 23"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0450348:23 [Quantitative Concept]

Phrase: ":"

Phrase: "61236131."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kokaia Z,"

Phrase: "Bengzon J,"

Phrase: "Metsis M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Kokaia M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Persson H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Lindvall O (1993"

Phrase: ")"

Phrase: "Coexpression of neurotrophins"

Phrase: "and"

Phrase: "their receptors in neurons of the central nervous system."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   742   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]
   703   C2325760:Neuronal receptor [Cell Component]
   700   C0034837:Receptors, Neural [Cell Component]
Processing 00000000.tx.258: Proc Natl Acad Sci U S A 90:67116715.[Abstract/Free FullText] Komatsu Y (1996) GABA(B) receptors, monoamine receptors, and postsynaptic inositol trisphosphate-induced Ca2+ release are involved in the induction of long-term potentiation at visual cortical inhibitory synapses. 

Phrase: "Proc Natl Acad Sci U S A 90"
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   836   C2919042:U-90 [Organic Chemical,Pharmacologic Substance]
   835   C0041703:U.S.A. [Geographic Area]
           U S
   793   C0268596:ACAD [Disease or Syndrome]
   793   C0439083:>90 [Quantitative Concept]
   793   C0439087:<90 [Quantitative Concept]
   793   C1418943:PROC [Gene or Genome]
   793   C2700624:ACAD [Cell Function]
   793   C3642273:SCI [Professional or Occupational Group]

Phrase: ":"

Phrase: "67116715."

Phrase: "[Abstract/Free FullText"

Phrase: "] Komatsu Y (1996"

Phrase: ")"

Phrase: "GABA"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0016904:GABA [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]

Phrase: "(B) receptors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "monoamine receptors,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0597357:receptors [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "and"

Phrase: "postsynaptic inositol trisphosphate-induced Ca2+ release"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   799   C0030685:Release [Health Care Activity]
   799   C0391871:Release [Functional Concept]
   799   C0439180:% release [Quantitative Concept]
   799   C0680255:release [Health Care Activity]
   799   C1283071:Release [Functional Concept]
   799   C1963578:Release [Therapeutic or Preventive Procedure]

Phrase: "are"

Phrase: "involved in the induction of long-term potentiation"
Meta Candidates (Total=12; Excluded=0; Pruned=0; Remaining=12)
   800   C0206249:Long-Term Potentiation [Organ or Tissue Function]
   800   C2984294:Long-term potentiation [Functional Concept]
   770   C0443252:Long-term [Temporal Concept]
   744   C0205166:Long [Qualitative Concept]
   744   C0205263:Induction [Functional Concept]
   744   C0279023:Potentiation [Therapeutic or Preventive Procedure]
   744   C0857127:induction [Therapeutic or Preventive Procedure]
   744   C1314939:Involved [Functional Concept]
   744   C1515273:Term [Temporal Concept]
   744   C1705313:Term [Idea or Concept]
   744   C1706317:Long [Qualitative Concept]
   744   C2826302:TERM [Intellectual Product]

Phrase: "at visual cortical inhibitory synapses."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   844   C1512777:Inhibitory Synapse [Cell Component]
   812   C0039062:Synapses [Body Space or Junction]
   779 E C0598501:Synapsis [Cell Function]
   779 E C1633000:Synapsis [Plant]
Processing 00000000.tx.259: J Neurosci 16:63426352.[Abstract/Free FullText] Kreitzer AC, Carter AG, Regehr WG (2002) Inhibition of interneuron firing extends the spread of endocannabinoid signaling in the cerebellum. 

Phrase: "J Neurosci 16"

Phrase: ":"

Phrase: "63426352."

Phrase: "[Abstract/Free FullText"

Phrase: "] Kreitzer AC,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C1412573:AC [Gene or Genome]
   861   C2350443:AC [Amino Acid, Peptide, or Protein,Enzyme]
   861   C3539770:AC [Gene or Genome]

Phrase: "Carter AG,"

Phrase: "Regehr WG (2002"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0043092:WG [Disease or Syndrome]

Phrase: ")"

Phrase: "Inhibition of interneuron firing"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   770   C0021467:Inhibition [Mental Process]
   770   C0021469:Inhibition [Molecular Function]
   770   C1628982:% inhibition [Quantitative Concept]
   770   C3463820:Inhibition [Activity]

Phrase: "extends"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0231448:Extend [Functional Concept]
  1000   C0439792:extend [Spatial Concept]

Phrase: "the"

Phrase: "spread of endocannabinoid signaling"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   770   C0037083:Signaling [Cell Function]
   770   C0332261:Spread [Qualitative Concept]
   770   C1172779:Endocannabinoid [Biologically Active Substance,Organic Chemical]
   770   C1947932:Spread [Activity]
   770   C3537152:signaling [Biologic Function]

Phrase: "in the cerebellum."
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0007765:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1268981:Cerebellum [Body Part, Organ, or Organ Component]
  1000   C1707522:Cerebellum [Tissue]
Processing 00000000.tx.260: Neuron 34:787796.[ISI][Medline] Lewin GR, Barde YA (1996) Physiology of neurotrophins. 

Phrase: "Neuron 34"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: ":"

Phrase: "787796."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Lewin GR,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1552950:[gr] [Quantitative Concept]

Phrase: "Barde YA (1996"

Phrase: ")"

Phrase: "Physiology of neurotrophins."
Meta Candidates (Total=3; Excluded=1; Pruned=0; Remaining=2)
   790   C0031842:Physiology [Biomedical Occupation or Discipline]
   790   C0031843:physiology [Physiologic Function]
   718 E C0205463:Physiologic [Functional Concept]
Processing 00000000.tx.261: Annu Rev Neurosci 19:289317.[CrossRef][ISI][Medline] Linnarsson S, Bjorklund A, Ernfors P (1997) Learning deficit in BDNF mutant mice. 

Phrase: "Annu Rev Neurosci 19"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C2347961:Rev. [Professional or Occupational Group]

Phrase: ":"

Phrase: "289317."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Linnarsson S,"

Phrase: "Bjorklund A,"

Phrase: "Ernfors P (1997"

Phrase: ")"

Phrase: "Learning deficit in BDNF mutant mice."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0162429:Deficit, NOS [Disease or Syndrome]
   742   C2987487:Deficit [Qualitative Concept]
Processing 00000000.tx.262: Eur J Neurosci 9:25812587.[ISI][Medline] Marty S, Berninger B, Carroll P, Thoenen H (1996) GABAergic stimulation regulates the phenotype of hippocampal interneurons through the regulation of brain-derived neurotrophic factor. 

Phrase: "Eur J Neurosci 9"

Phrase: ":"

Phrase: "25812587."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Marty S,"

Phrase: "Berninger B,"

Phrase: "Carroll P,"

Phrase: "Thoenen H (1996"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: "GABAergic stimulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C1292856:Stimulation [Therapeutic or Preventive Procedure]
   861   C1948023:Stimulation [Natural Phenomenon or Process]

Phrase: "regulates"

Phrase: "the phenotype of hippocampal interneurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0031437:Phenotype [Organism Attribute]
   760   C1285572:Phenotype [Laboratory Procedure]

Phrase: "through the regulation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0851285:Regulation [Governmental or Regulatory Activity]
  1000   C1327622:Regulation [Biologic Function]

Phrase: "of brain-derived neurotrophic factor."
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]
Processing 00000000.tx.263: Neuron 16:565570.[ISI][Medline] Marty S, Wehrle R, Sotelo C (2000) Neuronal activity and brain-derived neurotrophic factor regulate the density of inhibitory synapses in organotypic slice cultures of postnatal hippocampus. 

Phrase: "Neuron 16"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: ":"

Phrase: "565570."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Marty S,"

Phrase: "Wehrle R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Sotelo C (2000"

Phrase: ")"

Phrase: "Neuronal activity"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0205177:Activity [Functional Concept]
   861   C0439167:% activity [Quantitative Concept]
   861   C0441655:Activity [Activity]
   861   C1561536:*Activity [Idea or Concept]

Phrase: "and"

Phrase: "brain-derived neurotrophic factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "regulate"

Phrase: "the density of inhibitory synapses"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   760   C0178587:density [Quantitative Concept]

Phrase: "in organotypic slice"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C1519355:Slice [Substance]

Phrase: "cultures of postnatal hippocampus."
Meta Candidates (Total=9; Excluded=0; Pruned=0; Remaining=9)
   770   C0010453:Culture [Idea or Concept]
   770   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   770   C0220814:culture [Functional Concept]
   770   C0430400:Culture [Laboratory Procedure]
   770   C0443281:Postnatal [Temporal Concept]
   770   C0949582:Hippocampus [Fish]
   770   C1029104:Hippocampus [Fish]
   770   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
   770   C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.264: J Neurosci 20:80878095.[Abstract/Free FullText] McCarty JH, Feinstein SC (1999) The TrkB receptor tyrosine kinase regulates cellular proliferation via signal transduction pathways involving SHC, PLCgamma, and CBL. 

Phrase: "J Neurosci 20"

Phrase: ":"

Phrase: "80878095."

Phrase: "[Abstract/Free FullText"

Phrase: "] McCarty JH,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0268060:JH [Disease or Syndrome]
   861   C1415529:JH [Gene or Genome]

Phrase: "Feinstein SC (1999"

Phrase: ")"

Phrase: "The TrkB receptor tyrosine kinase"
Meta Candidates (Total=7; Excluded=0; Pruned=0; Remaining=7)
   923   C0084873:TRKB Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
           Receptor, trkB
   923   C0206364:Receptor Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme,Receptor]
   861   C0033681:Tyrosine Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0031727:Kinase [Amino Acid, Peptide, or Protein,Enzyme]
   812   C0041485:Tyrosine [Amino Acid, Peptide, or Protein,Biologically Active Substance,Pharmacologic Substance]
   812   C0597357:receptor [Amino Acid, Peptide, or Protein,Receptor]

Phrase: "regulates"

Phrase: "cellular proliferation via signal transduction pathways"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   790   C0020507:Cellular proliferation [Pathologic Function]
   790   C0596290:Cellular Proliferation [Cell Function]
   753   C0334094:Proliferation [Pathologic Function]
   753   C1514485:Proliferation [Functional Concept]

Phrase: "involving"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1314939:Involving [Functional Concept]

Phrase: "SHC,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1312062:SHC [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1705297:SHC [Gene or Genome]

Phrase: "PLCgamma,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0250414:PLC-gamma [Amino Acid, Peptide, or Protein,Enzyme]

Phrase: "and"

Phrase: "CBL."
Processing 00000000.tx.265: J Recept Signal Transduct Res 19:953974.[ISI][Medline] Minichiello L, Korte M, Wolfer D, Kuhn R, Unsicker K, Cestari V, Rossi-Arnaud C, Lipp HP, Bonhoeffer T, Klein R (1999) Essential role for TrkB receptors in hippocampus-mediated learning. 

Phrase: "J Recept Signal Transduct Res 19"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   799   C1710082:Signal [Phenomenon or Process]
   799   C2347379:RES [Finding]

Phrase: ":"

Phrase: "953974."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Minichiello L,"

Phrase: "Korte M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Wolfer D,"

Phrase: "Kuhn R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Unsicker K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Cestari V,"

Phrase: "Rossi-Arnaud C,"

Phrase: "Lipp HP,"

Phrase: "Bonhoeffer T,"

Phrase: "Klein R (1999"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   827   C0205090:R- [Spatial Concept]
   827   C0684010:R. [Professional or Occupational Group]
   827   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: "Essential role for TrkB receptors"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0035820:Role [Social Behavior]
   760   C1705810:Role [Conceptual Entity]

Phrase: "in hippocampus-mediated learning."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0013621:learning [Educational Activity]
   827   C0023185:Learning [Mental Process]
Processing 00000000.tx.266: Neuron 24:401414.[ISI][Medline] Mizuno K, Carnahan J, Nawa H (1994) Brain-derived neurotrophic factor promotes differentiation of striatal GABAergic neurons. 

Phrase: "Neuron 24"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: ":"

Phrase: "401414."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Mizuno K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Carnahan J,"

Phrase: "Nawa H (1994"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: "Brain-derived neurotrophic factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "differentiation of striatal GABAergic neurons."
Meta Candidates (Total=6; Excluded=1; Pruned=0; Remaining=5)
   833   C3269101:GABAergic neuron differentiation [Cell Function]
   781   C1159970:neuron differentiation [Cell Function]
   760   C0007589:Differentiation [Cell Function]
   760   C1511938:Differentiation [Clinical Attribute]
   760   C2945687:Differentiation [Functional Concept]
   756 E C1518294:Neuronal Differentiation [Finding]
Processing 00000000.tx.267: Dev Biol 165:243256.[CrossRef][ISI][Medline] Ohno-Shosaku T, Tsubokawa H, Mizushima I, Yoneda N, Zimmer A, Kano M (2002) Presynaptic cannabinoid sensitivity is a major determinant of depolarization-induced retrograde suppression at hippocampal synapses. 

Phrase: "Dev Biol 165"

Phrase: ":"

Phrase: "243256."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Ohno-Shosaku T,"

Phrase: "Tsubokawa H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Mizushima I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Yoneda N,"

Phrase: "Zimmer A,"

Phrase: "Kano"

Phrase: "M ("

Phrase: "2002"

Phrase: ")"

Phrase: "Presynaptic cannabinoid sensitivity"
Meta Candidates (Total=9; Excluded=2; Pruned=0; Remaining=7)
   827   C0036667:Sensitivity [Quantitative Concept]
   827   C0312418:Sensitivity [Mental Process]
   827   C0427965:Sensitivity [Finding]
   827   C1511883:Sensitivity [Quantitative Concept]
   827   C1522640:Sensitivity [Qualitative Concept]
   827   C2346484:SENSITIVITY [Phenomenon or Process]
   827   C2349185:Sensitivity [Qualitative Concept]
   755 E C0332324:Sensitive [Functional Concept]
   755 E C1550474:sensitive [Idea or Concept]

Phrase: "is"

Phrase: "a major determinant of depolarization-induced retrograde suppression"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C1521761:Determinant [Functional Concept]

Phrase: "at hippocampal synapses."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   861   C0039062:Synapses [Body Space or Junction]
   827 E C0598501:Synapsis [Cell Function]
   827 E C1633000:Synapsis [Plant]
Processing 00000000.tx.268: J Neurosci 22:38643872.[Abstract/Free FullText] Rutherford LC, DeWan A, Lauer HM, Turrigiano GG (1997) Brain-derived neurotrophic factor mediates the activity-dependent regulation of inhibition in neocortical cultures. 

Phrase: "J Neurosci 22"

Phrase: ":"

Phrase: "38643872."

Phrase: "[Abstract/Free FullText"

Phrase: "] Rutherford LC,"

Phrase: "DeWan A,"

Phrase: "Lauer HM,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0262500:hm [Health Care Activity]
   861   C1512358:HM [Geographic Area]
   861   C3538713:HM [Idea or Concept]

Phrase: "Turrigiano GG (1997"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018370:GG [Geographic Area]

Phrase: ")"

Phrase: "Brain-derived neurotrophic factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "mediates"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0086597:Mediate [Social Behavior]

Phrase: "the activity-dependent regulation of inhibition"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   753   C0851285:Regulation [Governmental or Regulatory Activity]
   753   C1327622:Regulation [Biologic Function]

Phrase: "in neocortical cultures."
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
   861   C0010453:Cultures [Idea or Concept]
   827 E C0220814:culture [Functional Concept]
   827 E C0430400:Culture [Laboratory Procedure]
   827 E C2242979:Culture [Laboratory Procedure]
Processing 00000000.tx.269: J Neurosci 17:45274535.[Abstract/Free FullText] Rutherford LC, Nelson SB, Turrigiano GG (1998) BDNF has opposite effects on the quantal amplitude of pyramidal neuron and interneuron excitatory synapses. 

Phrase: "J Neurosci 17"

Phrase: ":"

Phrase: "45274535."

Phrase: "[Abstract/Free FullText"

Phrase: "] Rutherford LC,"

Phrase: "Nelson SB,"

Phrase: "Turrigiano GG (1998"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0018370:GG [Geographic Area]

Phrase: ")"

Phrase: "BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "has"

Phrase: "opposite effects on the quantal amplitude of pyramidal neuron"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   742   C1280500:effects [Qualitative Concept]
   708 E C2348382:Effect [Qualitative Concept]

Phrase: "and"

Phrase: "interneuron excitatory synapses."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   884   C1516988:Excitatory Synapse [Cell Component]
   827   C0039062:Synapses [Body Space or Junction]
   793 E C0598501:Synapsis [Cell Function]
   793 E C1633000:Synapsis [Plant]
Processing 00000000.tx.270: Neuron 21:521530.[ISI][Medline] Seil FJ, Drake-Baumann R (2000) TrkB receptor ligands promote activity-dependent inhibitory synaptogenesis. 

Phrase: "Neuron 21"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: ":"

Phrase: "521530."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Seil FJ,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0016080:FJ [Geographic Area]

Phrase: "Drake-Baumann R (2000"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   812   C0205090:R- [Spatial Concept]
   812   C0684010:R. [Professional or Occupational Group]
   812   C2603358:R' [Clinical Attribute]

Phrase: ")"

Phrase: "TrkB receptor ligands"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   884   C1621296:receptor ligand [Molecular Function]
   827   C0023688:Ligands [Chemical]
   734   C0084873:Receptor, trkB [Amino Acid, Peptide, or Protein,Enzyme,Receptor]

Phrase: "promote"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "activity-dependent inhibitory synaptogenesis."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0597545:synaptogenesis [Organ or Tissue Function]
Processing 00000000.tx.271: J Neurosci 20:53675373.[Abstract/Free FullText] Shitaka Y, Matsuki N, Saito H, Katsuki H (1996) Basic fibroblast growth factor increases functional L-type Ca2+ channels in fetal rat hippocampal neurons: implications for neurite morphogenesis in vitro. 

Phrase: "J Neurosci 20"

Phrase: ":"

Phrase: "53675373."

Phrase: "[Abstract/Free FullText"

Phrase: "] Shitaka Y,"

Phrase: "Matsuki N,"

Phrase: "Saito H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Katsuki H (1996"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   827   C0033727:H+ [Element, Ion, or Isotope]
   827   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   827   C0441932:H+ [Classification]
   827   C0564385:/h [Quantitative Concept]

Phrase: ")"

Phrase: "Basic fibroblast growth factor"
Meta Candidates (Total=14; Excluded=1; Pruned=0; Remaining=13)
  1000   C0380603:Fibroblast Growth Factor, Basic [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C0919506:FIBROBLAST GROWTH FACTOR, BASIC [Gene or Genome]
  1000   C1522505:Basic Fibroblast Growth Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   923   C0016026:Fibroblast Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0018284:Growth Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   812   C0016030:Fibroblast [Cell]
   812   C0018270:'growth' NOS [Organism Function]
   812   C0220844:growth [Physiologic Function]
   812   C1521761:Factor [Functional Concept]
   812   C1527178:Basic [Functional Concept]
   812   C1621966:Growth [Organ or Tissue Function]
   812   C2827422:Factor [Conceptual Entity]
   812   C2911660:Growth [Activity]
   741 E C0920750:basicity [Quantitative Concept]

Phrase: "increases"
Meta Candidates (Total=8; Excluded=7; Pruned=0; Remaining=1)
  1000   C0442805:Increase [Functional Concept]
   944 E C1517378:Gain [Quantitative Concept]
   916 E C0205217:Increased [Quantitative Concept]
   916 E C0439661:Acquired [Temporal Concept]
   916 E C0442808:Increasing [Functional Concept]
   916 E C1301820:Obtain [Functional Concept]
   916 E C1706701:Acquire [Activity]
   916 E C3245488:acquired [Intellectual Product]

Phrase: "functional L-type Ca2+ channels in fetal rat hippocampal neurons"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   706   C0439799:Channel [Spatial Concept]
   706   C1706095:Channel [Conceptual Entity]

Phrase: ":"

Phrase: "implications for neurite morphogenesis"

Phrase: "in vitro."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
  1000   C0021135:In Vitro [Intellectual Product]
  1000   C1533691:in vitro [Qualitative Concept]
           vitro
  1000   C2827718:In Vitro [Functional Concept]
Processing 00000000.tx.272: J Neurosci 16:64766489.[Abstract/Free FullText] Tabuchi A, Nakaoka R, Amano K, Yukimine M, Andoh T, Kuraishi Y, Tsuda M (2000) Differential activation of brain-derived neurotrophic factor gene promoters I and III by Ca2+ signals evoked via L-type voltage-dependent and N-methyl-D-aspartate receptor Ca2+ channels. 

Phrase: "J Neurosci 16"

Phrase: ":"

Phrase: "64766489."

Phrase: "[Abstract/Free FullText"

Phrase: "] Tabuchi A,"

Phrase: "Nakaoka R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Amano K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Yukimine M,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441923:M+ [Intellectual Product]

Phrase: "Andoh T,"

Phrase: "Kuraishi Y,"

Phrase: "Tsuda"

Phrase: "M ("

Phrase: "2000"

Phrase: ")"

Phrase: "Differential activation of brain-derived neurotrophic factor gene promoters I"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   757   C0017255:Gene Activation [Genetic Function]
   739   C1879547:Activation [Activity]

Phrase: "and"

Phrase: "III by Ca2+ signals"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   770   C0439070:III [Intellectual Product]
   770   C1705160:III [Qualitative Concept]

Phrase: "evoked via L-type"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0332307:Type [Qualitative Concept]
   770   C1444748:Evoked [Qualitative Concept]
   770   C1547052:*Type [Quantitative Concept]

Phrase: "voltage-dependent"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0598352:Voltage [Quantitative Concept]
   861   C0851827:Dependent [Qualitative Concept]
   861   C1701901:Dependent [Qualitative Concept]
   861   C3244310:dependent [Functional Concept]

Phrase: "and"

Phrase: "N-methyl-"

Phrase: "D-"

Phrase: "aspartate receptor Ca2+ channels."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   779   C0439799:Channel [Spatial Concept]
   779   C1706095:Channel [Conceptual Entity]
Processing 00000000.tx.273: J Biol Chem 275:1726917275.[Abstract/Free FullText] Tanaka T, Saito H, Matsuki N (1997) Inhibition of GABAA synaptic responses by brain-derived neurotrophic factor (BDNF) in rat hippocampus. 

Phrase: "J Biol Chem 275"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   812   C0201682:CHEM [Laboratory Procedure]

Phrase: ":"

Phrase: "1726917275."

Phrase: "[Abstract/Free FullText"

Phrase: "] Tanaka T,"

Phrase: "Saito H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Matsuki N (1997"

Phrase: ")"

Phrase: "Inhibition of GABAA synaptic responses"
Meta Candidates (Total=6; Excluded=0; Pruned=0; Remaining=6)
   781   C1510574:Response Inhibition [Mental Process]
   781   C3463820:Response Inhibition [Activity]
           Inhibition
   760   C0021467:Inhibition [Mental Process]
   760   C0021469:Inhibition [Molecular Function]
   760   C1628982:% inhibition [Quantitative Concept]

Phrase: "by brain-derived neurotrophic factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "(BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: ")"

Phrase: "in rat hippocampus."
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]
Processing 00000000.tx.274: J Neurosci 17:29592966.[Abstract/Free FullText] Tokuyama W, Okuno H, Hashimoto T, Xin LY and Miyashita Y (2000) BDNF upregulation during declarative memory formation in monkey inferior temporal cortex. 

Phrase: "J Neurosci 17"

Phrase: ":"

Phrase: "29592966."

Phrase: "[Abstract/Free FullText"

Phrase: "] Tokuyama W,"

Phrase: "Okuno H,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0033727:H+ [Element, Ion, or Isotope]
   861   C0369286:H NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
   861   C0441932:H+ [Classification]
   861   C0564385:/h [Quantitative Concept]

Phrase: "Hashimoto T,"

Phrase: "Xin LY"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0023634:LY [Geographic Area]

Phrase: "and"

Phrase: "Miyashita Y (2000"

Phrase: ")"

Phrase: "BDNF upregulation during declarative memory formation"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   742   C0041904:Up-Regulation [Cell Function,Molecular Function]
   742   C0162493:Up-Regulation [Genetic Function]

Phrase: "in monkey inferior temporal cortex."
Meta Candidates (Total=8; Excluded=0; Pruned=0; Remaining=8)
   861   C0039485:Temporal cortex [Body Part, Organ, or Organ Component]
   812   C0007776:Cortex [Body Part, Organ, or Organ Component]
   812   C0442043:Temporal [Spatial Concept]
   812   C0542339:Inferior [Spatial Concept]
   812   C0678975:inferior [Social Behavior]
   812   C1176472:Cortex [Body Part, Organ, or Organ Component]
   812   C2362314:Temporal [Temporal Concept]
   812   C2700441:Cortex [Plant]
Processing 00000000.tx.275: Nat Neurosci 3:11341142.[CrossRef][ISI][Medline] Vicario-Abejon C, Collin C, McKay RD, Segal M (1998) Neurotrophins induce formation of functional excitatory and inhibitory synapses between cultured hippocampal neurons. 

Phrase: "Nat Neurosci 3"

Phrase: ":"

Phrase: "11341142."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Vicario-Abejon C,"

Phrase: "Collin C,"

Phrase: "McKay RD,"

Phrase: "Segal"

Phrase: "M ("

Phrase: "1998"

Phrase: ")"

Phrase: "Neurotrophins"
Meta Candidates (Total=4; Excluded=3; Pruned=0; Remaining=1)
  1000   C0027754:Neurotrophins [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   966 E C0132298:Neurotrophin [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   966 E C1323315:neurotrophin [Molecular Function]
   966 E C1332408:neurotrophin [Gene or Genome]

Phrase: "induce"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0205263:Induce [Functional Concept]

Phrase: "formation of functional excitatory"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   770   C0220781:formation [Biologic Function]
   770   C0439634:formation [Spatial Concept]
   770   C1522492:Formation [Functional Concept]

Phrase: "and"

Phrase: "inhibitory synapses between cultured hippocampal neurons."
Meta Candidates (Total=4; Excluded=2; Pruned=0; Remaining=2)
   773   C1512777:Inhibitory Synapse [Cell Component]
   753   C0039062:Synapses [Body Space or Junction]
   719 E C0598501:Synapsis [Cell Function]
   719 E C1633000:Synapsis [Plant]
Processing 00000000.tx.276: J Neurosci 18:72567271.[Abstract] Vyssotski AL, Dell'Omo G, Poletaeva II, Vyssotsk DL, Minichiello L, Klein R, Wolfer DP, Lipp HP (2002) Long-term monitoring of hippocampus-dependent behavior in naturalistic settings: mutant mice lacking neurotrophin receptor TrkB in the forebrain show spatial learning but impaired behavioral flexibility. 

Phrase: "J Neurosci 18"

Phrase: ":"

Phrase: "72567271."

Phrase: "[Abstract"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0000857:Abstract [Occupational Activity]
  1000   C0600678:Abstract [Intellectual Product]
  1000   C1552863:Abstract [Idea or Concept]

Phrase: "] Vyssotski AL,"

Phrase: "Dell'Omo G,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C0439267:g% [Quantitative Concept]

Phrase: "Poletaeva II,"

Phrase: "Vyssotsk DL,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3642216:/dL [Quantitative Concept]

Phrase: "Minichiello L,"

Phrase: "Klein R,"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0205090:R- [Spatial Concept]
   861   C0684010:R. [Professional or Occupational Group]
   861   C2603358:R' [Clinical Attribute]

Phrase: "Wolfer DP,"

Phrase: "Lipp HP (2002"

Phrase: ")"

Phrase: "Long-term monitoring of hippocampus-dependent behavior"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   748   C0150369:Monitoring [Health Care Activity]
   748   C1516647:monitoring [Research Activity]

Phrase: "in naturalistic settings"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C0542559:setting [Functional Concept]
   827   C1318139:{Setting} [Quantitative Concept]

Phrase: ":"

Phrase: "mutant mice"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   861   C0025914:Mice [Mammal]
   861   C0025929:mice [Mammal]
   861   C0026809:Mice [Mammal]

Phrase: "lacking"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0332268:Lacking [Qualitative Concept]

Phrase: "neurotrophin receptor TrkB in the forebrain"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   783   C0084873:Receptor, trkB [Amino Acid, Peptide, or Protein,Enzyme,Receptor]

Phrase: "show"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1547282:Show [Intellectual Product]

Phrase: "spatial learning"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0582587:spatial learning [Mental Process]
   861   C0013621:learning [Educational Activity]
   861   C0023185:Learning [Mental Process]

Phrase: "but"

Phrase: "impaired behavioral flexibility."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0242808:Flexibility [Qualitative Concept]
   755 E C0443220:Flexible [Qualitative Concept]
Processing 00000000.tx.277: Hippocampus 12:2738.[ISI][Medline] Yamada MK, Nakanishi K, Ohba S, Nakamura T, Ikegaya Y, Nishiyama N, Matsuki N (2002) Brain-derived neurotrophic factor promotes the maturation of GABAergic mechanisms in cultured hippocampal neurons. 

Phrase: "Hippocampus 12"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0019564:Hippocampus [Body Part, Organ, or Organ Component]
   861   C0949582:Hippocampus [Fish]
   861   C1029104:Hippocampus [Fish]
   861   C1284077:Hippocampus [Body Part, Organ, or Organ Component]

Phrase: ":"

Phrase: "2738."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Yamada MK,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C3539059:MK [Idea or Concept]

Phrase: "Nakanishi K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Ohba S,"

Phrase: "Nakamura T,"

Phrase: "Ikegaya Y,"

Phrase: "Nishiyama N,"

Phrase: "Matsuki N (2002"

Phrase: ")"

Phrase: "Brain-derived neurotrophic factor"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
  1000   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
  1000   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   861   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   861   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   812   C0006104:Brain [Body Part, Organ, or Organ Component]
   812   C1269537:Brain [Body Part, Organ, or Organ Component]
   812   C1441547:Derived [Qualitative Concept]
   812   C1521761:Factor [Functional Concept]
   812   C2827422:Factor [Conceptual Entity]
   812   C3245521:derived [Idea or Concept]

Phrase: "promotes"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0033414:Promote [Activity]

Phrase: "the maturation of GABAergic mechanisms"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   760   C0678723:Maturation [Organism Function]
   760   C0870861:maturation [Phenomenon or Process]
   760   C1254042:Maturation [Physiologic Function]

Phrase: "in cultured hippocampal neurons."
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   827   C0027882:Neurons [Cell]
   743 E C0521390:Neuronal [Immunologic Factor]
Processing 00000000.tx.278: J Neurosci 22:75807585.[Abstract/Free FullText] Zakharenko SS, Patterson SL, Dragatsis I, Zeitlin SO, Siegelbaum SA, Kandel ER, Morozov A (2003) Presynaptic BDNF required for a presynaptic but not postsynaptic component of LTP at hippocampal CA1CA3 synapses. 

Phrase: "J Neurosci 22"

Phrase: ":"

Phrase: "75807585."

Phrase: "[Abstract/Free FullText"

Phrase: "] Zakharenko SS,"

Phrase: "Patterson SL,"

Phrase: "Dragatsis I,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0021966:I- [Inorganic Chemical]
   861   C0221138:I NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]

Phrase: "Zeitlin SO,"

Phrase: "Siegelbaum SA,"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   861   C0036243:SA [Geographic Area]
   861   C1539696:SA [Gene or Genome]
   861   C1825840:SA [Gene or Genome]
   861   C3539736:Sa [Spatial Concept]

Phrase: "Kandel ER,"

Phrase: "Morozov A (2003"

Phrase: ")"

Phrase: "Presynaptic BDNF"
Meta Candidates (Total=11; Excluded=0; Pruned=0; Remaining=11)
   937   C0107103:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   937   C1522561:Brain-Derived Neurotrophic Factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   840   C0083735:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Biologically Active Substance]
   840   C0132298:neurotrophic factor [Amino Acid, Peptide, or Protein,Neuroreactive Substance or Biogenic Amine]
   840   C1522444:Neurotrophic Factor [Amino Acid, Peptide, or Protein,Pharmacologic Substance]
   804   C0006104:Brain [Body Part, Organ, or Organ Component]
   804   C1269537:Brain [Body Part, Organ, or Organ Component]
   804   C1441547:Derived [Qualitative Concept]
   804   C1521761:Factor [Functional Concept]
   804   C2827422:Factor [Conceptual Entity]
   804   C3245521:derived [Idea or Concept]

Phrase: "required for a presynaptic"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C1514873:Required [Functional Concept]

Phrase: "but"

Phrase: "not postsynaptic component of LTP"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   760   C0449432:Component [Manufactured Object]
   760   C1705248:Component [Conceptual Entity]

Phrase: "at hippocampal CA1CA3 synapses."
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   827   C0039062:Synapses [Body Space or Junction]
   793 E C0598501:Synapsis [Cell Function]
   793 E C1633000:Synapsis [Plant]
Processing 00000000.tx.279: Neuron 39:975990.[CrossRef][ISI][Medline] Zito K, Svoboda K (2002) Activity-dependent synaptogenesis in the adult Mammalian cortex. 

Phrase: "Neuron 39"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: ":"

Phrase: "975990."

Phrase: "[CrossRef"

Phrase: "]"

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "] Zito K,"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   861   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   861   C1708601:K' [Quantitative Concept]

Phrase: "Svoboda K (2002"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   901   C0387867:K 2002 [Organic Chemical,Pharmacologic Substance]
   827   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
   827   C1708601:K' [Quantitative Concept]

Phrase: ")"

Phrase: "Activity-dependent synaptogenesis in the adult Mammalian cortex."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   744   C0597545:synaptogenesis [Organ or Tissue Function]
Processing 00000000.tx.280: Neuron 35:10151017.[ISI][Medline] This Article Abstract FREE Full Text (PDF) All Versions of this Article: 15/3/291 most recent bhh130v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to citation manager Search for citing articles in: ISI Web of Science (3) Request Permissions Google Scholar Articles by Ohba, S. 

Phrase: "Neuron 35"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   861   C0027882:Neuron [Cell]
   789 E C0521390:Neuronal [Immunologic Factor]

Phrase: ":"

Phrase: "10151017."

Phrase: "[ISI][Medline"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0025141:MEDLINE [Intellectual Product]

Phrase: "]"

Phrase: "This Article Abstract FREE Full Text"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   804   C1527021:Text [Intellectual Product]
   804   C1554111:Text [Idea or Concept]
   804   C1705606:Text [Intellectual Product]
   804   C3541382:Text [Intellectual Product]

Phrase: "(PDF)"

Phrase: "All Versions of this Article"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   760   C0333052:versions [Functional Concept]
   726 E C2607870:Version [Spatial Concept]

Phrase: ":"

Phrase: "15/3/291 most recent bhh130v1"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "when"

Phrase: "this article"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1706852:Article [Intellectual Product]

Phrase: "is"

Phrase: "cited"

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me"

Phrase: "if"

Phrase: "a correction"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C1705565:CORRECTION [Intellectual Product]
  1000   C1947976:Correction [Functional Concept]

Phrase: "is"

Phrase: "posted"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   966   C0687676:Post [Temporal Concept]
   966   C1704687:Post [Manufactured Object]

Phrase: "Services"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
  1000   C0557854:Services [Occupational Activity]
   966 E C2825316:Service [Manufactured Object]
   966 E C3245478:service [Idea or Concept]

Phrase: "Email"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0013849:E-Mail [Intellectual Product]
  1000   C1705961:E-mail [Intellectual Product]

Phrase: "this article to a friend Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   748   C1706852:Article [Intellectual Product]

Phrase: "in this journal Similar articles"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   896   C0282420:Journal Article [Intellectual Product]
   793   C1706852:Article [Intellectual Product]

Phrase: "in ISI Web"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   861   C0282111:Web [Manufactured Object]

Phrase: "of Science Similar articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   793   C1706852:Article [Intellectual Product]

Phrase: "in PubMed"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1138432:PubMed [Intellectual Product]

Phrase: "Alert"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C0239110:ALERT [Finding]

Phrase: "me to new issues of the journal"
Meta Candidates (Total=4; Excluded=0; Pruned=0; Remaining=4)
   748   C0162443:Journal [Intellectual Product,Manufactured Object]
   748   C0205314:New [Temporal Concept]
   714   C0033213:Issue [Finding]
   714   C1706387:Issue [Intellectual Product]

Phrase: "Add to My Personal Archive Download"
Meta Candidates (Total=5; Excluded=0; Pruned=0; Remaining=5)
   753   C0003738:archive [Manufactured Object]
   753   C0024552:MY [Geographic Area]
   753   C1519021:Personal [Organism Attribute]
   753   C1554162:Archive [Idea or Concept]
   753   C1883712:Add [Functional Concept]

Phrase: "to citation manager Search"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   827   C1552603:search [Intellectual Product]
   827   C1706202:Search [Activity]

Phrase: "for citing articles"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   827   C1706852:Article [Intellectual Product]

Phrase: "in"

Phrase: ":"

Phrase: "ISI Web of Science"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   770   C0282111:Web [Manufactured Object]

Phrase: "(3"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
  1000   C0439086:<3 [Quantitative Concept]
  1000   C2827736:3+ [Quantitative Concept]
  1000   C2981702:3+ [Classification]

Phrase: ")"

Phrase: "Request Permissions Google Scholar Articles by Ohba,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   714   C1706852:Article [Intellectual Product]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.281: Articles by Yamada, M. 

Phrase: "Articles by Yamada,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.282: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.283: PubMed PubMed Citation Articles by Ohba, S. 

Phrase: "PubMed PubMed Citation Articles by Ohba,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   719   C1706852:Article [Intellectual Product]

Phrase: "S."
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C2603362:S' [Clinical Attribute]
Processing 00000000.tx.284: Articles by Yamada, M. 

Phrase: "Articles by Yamada,"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   756   C1706852:Article [Intellectual Product]

Phrase: "M."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0369637:M NOS [Amino Acid, Peptide, or Protein,Immunologic Factor]
  1000   C0441923:M+ [Intellectual Product]
Processing 00000000.tx.285: K. 

Phrase: "K."
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
  1000   C0597277:K+ [Element, Ion, or Isotope,Pharmacologic Substance]
  1000   C1708601:K' [Quantitative Concept]
Processing 00000000.tx.286: Online ISSN 1460-2199 - Print ISSN 1047-3211 Copyright  2006 Oxford University Press Oxford Journals Oxford University Press Site Map Privacy Policy Frequently Asked Questions Other Oxford University Press sites: Oxford University Press American National Biography Booksellers' Information Service Children's Fiction and Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights and Permissions Science School Books Social Sciences Very Short Introductions World's Classics

Phrase: "Online ISSN 1460-2199 - Print ISSN 1047-3211 Copyright  2006 Oxford University Press Oxford Journals Oxford University Press Site Map Privacy Policy Frequently"
Meta Candidates (Total=2; Excluded=0; Pruned=0; Remaining=2)
   788   C2735290:Privacy policy [Intellectual Product]
   782   C0242456:Policy [Intellectual Product]

Phrase: "Asked"

Phrase: "Questions"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
  1000   C1522634:Question [Intellectual Product]

Phrase: "Other Oxford University Press sites"
Meta Candidates (Total=3; Excluded=2; Pruned=0; Remaining=1)
   812   C0205145:Sites [Spatial Concept]
   779 E C1515974:Site [Body Location or Region]
   779 E C2825164:Site [Spatial Concept]

Phrase: ":"

Phrase: "Oxford University Press American National Biography Booksellers' Information Service Children's Fiction"
Meta Candidates (Total=1; Excluded=0; Pruned=0; Remaining=1)
   788   C0887933:fiction [Intellectual Product]

Phrase: "and"

Phrase: "Poetry Children's Reference Corporate & Special Sales Dictionaries Dictionary"

Phrase: "of National Biography Digital Reference English Language Teaching Higher Education Textbooks Humanities International Education Unit Law Medicine Music Online Products Oxford English Dictionary Reference Rights"
Meta Candidates (Total=3; Excluded=0; Pruned=0; Remaining=3)
   852   C0947619:Finger.right [Body Part, Organ, or Organ Component]
   782   C0035621:Rights [Qualitative Concept]
   782   C0205090:Right [Spatial Concept]

Phrase: "and"

Phrase: "Permissions Science School Books Social Sciences Very Short Introductions World's Classics"
Meta Candidates (Total=2; Excluded=1; Pruned=0; Remaining=1)
   788   C0439658:classics [Qualitative Concept]
   755 E C0439858:Classic [Qualitative Concept]

